<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001792.pub3" GROUP_ID="SYMPT" ID="633199101813345099" MERGED_FROM="" MODIFIED="2016-07-25 11:49:30 +0100" MODIFIED_BY="Anna Erskine" NOTES="&lt;p&gt;2-We don&amp;#180;t know if should be better to accept all risk of bias in the meta-analyses (not only lower risk of bias) and then do a sensitivity analysis excluding high risk of bias and both, high and unclear risk of bias or should be better what we wrote in the protocol.&lt;/p&gt;&lt;p&gt;JT 0705: I'm not sure, consult the handbook in the first instance, but if you are still not sure, email me and I will check your thoughts with our Co-Ed - he was happy for the protocol to go through as it's published?&lt;/p&gt;&lt;p&gt;Jessica&lt;/p&gt;" NOTES_MODIFIED="2016-07-25 11:46:17 +0100" NOTES_MODIFIED_BY="Anna Erskine" REVIEW_NO="29a" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="10.0">
<COVER_SHEET MODIFIED="2016-07-25 11:45:40 +0100" MODIFIED_BY="Anna Erskine">
<TITLE MODIFIED="2008-07-15 10:14:59 +0100" MODIFIED_BY="Jessica Thomas">Drug therapy for preventing post-dural puncture headache</TITLE>
<CONTACT>
<PERSON ID="D41B946E82E26AA2001703762499771D" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Xavier</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Basurto Ona</LAST_NAME>
<SUFFIX/>
<POSITION>Emergency Physician</POSITION>
<EMAIL_1>basurto18@gmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Emergency Department</DEPARTMENT>
<ORGANISATION>Hospital de Figueres, Fundació Salut Empordà</ORGANISATION>
<ADDRESS_1>Rda Rector Aroles s/n</ADDRESS_1>
<ADDRESS_2/>
<CITY>Figueres</CITY>
<ZIP>17600</ZIP>
<REGION>Girona-Catalunya</REGION>
<COUNTRY CODE="ES">Spain</COUNTRY>
<PHONE_1>+ 97 251 2301</PHONE_1>
<PHONE_2>+ 636 500 422</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2016-07-25 11:45:10 +0100" MODIFIED_BY="Anna Erskine" NOTES="&lt;p&gt;'Iberoamerican Cochrane Centre, Institute of Biomedical Research' is not written the same for authors 3 and 4.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;YR   I don't think they are meant to be the same?&lt;/p&gt;" NOTES_MODIFIED="2016-07-25 11:45:10 +0100" NOTES_MODIFIED_BY="Anna Erskine">
<PERSON ID="D41B946E82E26AA2001703762499771D" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Xavier</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Basurto Ona</LAST_NAME>
<SUFFIX/>
<POSITION>Emergency Physician</POSITION>
<EMAIL_1>basurto18@gmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Emergency Department</DEPARTMENT>
<ORGANISATION>Hospital de Figueres, Fundació Salut Empordà</ORGANISATION>
<ADDRESS_1>Rda Rector Aroles s/n</ADDRESS_1>
<ADDRESS_2/>
<CITY>Figueres</CITY>
<ZIP>17600</ZIP>
<REGION>Girona-Catalunya</REGION>
<COUNTRY CODE="ES">Spain</COUNTRY>
<PHONE_1>+ 97 251 2301</PHONE_1>
<PHONE_2>+ 636 500 422</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="49646634089875690582120502154458" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Sonia Maria</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Uriona Tuma</LAST_NAME>
<SUFFIX/>
<POSITION>Research Assistant</POSITION>
<EMAIL_1>soniauriona@hotmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Preventive Medicine and Public Health</DEPARTMENT>
<ORGANISATION>Vall Hebron University Hospital</ORGANISATION>
<ADDRESS_1>Passeig Vall Hebron 119-129</ADDRESS_1>
<ADDRESS_2/>
<CITY>Barcelona</CITY>
<ZIP>08035</ZIP>
<REGION>Catalunya</REGION>
<COUNTRY CODE="ES">Spain</COUNTRY>
<PHONE_1>+34 931 854 646</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="87186567698944563500101124150735" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Laura</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Martínez García</LAST_NAME>
<SUFFIX/>
<POSITION>Researcher</POSITION>
<EMAIL_1>laura.martinez.garcia@cochrane.es</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Iberoamerican Cochrane Centre</DEPARTMENT>
<ORGANISATION>Biomedical Research Institute Sant Pau (IIB Sant Pau)</ORGANISATION>
<ADDRESS_1>Sant Antoni Mª Claret 167</ADDRESS_1>
<ADDRESS_2/>
<CITY>Barcelona</CITY>
<ZIP>08025</ZIP>
<REGION>Catalunya</REGION>
<COUNTRY CODE="ES">Spain</COUNTRY>
<PHONE_1>(+34) 93 553 78 08</PHONE_1>
<PHONE_2/>
<FAX_1>(+34) 93 553 78 09</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12177" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Ivan</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Solà</LAST_NAME>
<SUFFIX/>
<POSITION>Researcher</POSITION>
<EMAIL_1>isola@santpau.cat</EMAIL_1>
<EMAIL_2>ensayos@cochrane.es</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Iberoamerican Cochrane Centre - Biomedical Research Institute Sant Pau (IIB Sant Pau)</DEPARTMENT>
<ORGANISATION>CIBER Epidemiología y Salud Pública (CIBERESP) - Universitat Autònoma de Barcelona</ORGANISATION>
<ADDRESS_1>Sant Antoni Maria Claret 167</ADDRESS_1>
<ADDRESS_2>Pavilion 18</ADDRESS_2>
<CITY>Barcelona</CITY>
<ZIP>08025</ZIP>
<REGION>Catalunya</REGION>
<COUNTRY CODE="ES">Spain</COUNTRY>
<PHONE_1>+34 935 537 814</PHONE_1>
<PHONE_2/>
<FAX_1>+34 935 537 809</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="D3B1F77E82E26AA200831C1940F4DA2E" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Xavier</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Bonfill Cosp</LAST_NAME>
<SUFFIX/>
<POSITION>Director</POSITION>
<EMAIL_1>xbonfill@santpau.cat</EMAIL_1>
<EMAIL_2>director@cochrane.es, XBonfill@hsp.santpau.es</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Iberoamerican Cochrane Centre - Biomedical Research Institute Sant Pau (IIB Sant Pau)</DEPARTMENT>
<ORGANISATION>CIBER Epidemiología y Salud Pública (CIBERESP), Spain</ORGANISATION>
<ADDRESS_1>Sant Antoni Maria Claret, 167</ADDRESS_1>
<ADDRESS_2>Pavilion 18 (D-13)</ADDRESS_2>
<CITY>Barcelona</CITY>
<ZIP>08025</ZIP>
<REGION>Catalunya</REGION>
<COUNTRY CODE="ES">Spain</COUNTRY>
<PHONE_1>+34 93 553 78 10</PHONE_1>
<PHONE_2>+34 93 553 78 14</PHONE_2>
<FAX_1>+34 93 553 78 0</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2013-02-25 10:26:54 +0000" MODIFIED_BY="Anna Hobson" NOTES="&lt;p&gt;Date assessed as up-to-date is more than six months after date of search.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;YR corrected&lt;/p&gt;" NOTES_MODIFIED="2013-02-25 10:26:54 +0000" NOTES_MODIFIED_BY="Anna Hobson">
<UP_TO_DATE>
<DATE DAY="15" MONTH="10" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="1" MONTH="6" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="12" YEAR="2014"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2013"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2013"/>
</DATES>
<WHATS_NEW MODIFIED="2016-07-25 11:45:40 +0100" MODIFIED_BY="Anna Erskine">
<WHATS_NEW_ENTRY EVENT="STABLE" MODIFIED="2016-07-25 11:45:40 +0100" MODIFIED_BY="Anna Erskine">
<DATE DAY="25" MONTH="7" YEAR="2016"/>
<DESCRIPTION>
<P>See <LINK TAG="PUBLIC_NOTES" TYPE="SECTION">Published notes</LINK>.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2016-07-25 11:45:26 +0100" MODIFIED_BY="Anna Erskine">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-07-25 11:45:26 +0100" MODIFIED_BY="Anna Erskine">
<DATE DAY="25" MONTH="2" YEAR="2013"/>
<DESCRIPTION>
<P>Added link to Appendix 4.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2008-06-05 12:38:32 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2008-06-05 12:36:22 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2008-06-05 12:34:46 +0100" MODIFIED_BY="[Empty name]">
<NAME>Iberoamerican Cochrane Centre</NAME>
<COUNTRY CODE="ES">Spain</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2008-06-05 12:36:22 +0100" MODIFIED_BY="[Empty name]">
<NAME>CIBER de Epidemiología y Salud Pública (CIBERESP)</NAME>
<COUNTRY CODE="ES">Spain</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2008-06-05 12:38:32 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2008-06-05 12:38:32 +0100" MODIFIED_BY="[Empty name]">
<NAME>Agencia de Calidad del Sistema Nacional de Salud, Ministerio de Salud y Consumo</NAME>
<COUNTRY CODE="ES">Spain</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-07-25 11:46:17 +0100" MODIFIED_BY="Anna Erskine">
<SUMMARY MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JRT 140612: Complicated but do we want to be asking these authors to split this review in to one looking at children and one at adults?&lt;/p&gt;&lt;p&gt;XB: at this moment any children RCT has been included.&lt;/p&gt;&lt;p&gt;ok&lt;/p&gt;" NOTES_MODIFIED="2013-01-28 12:10:14 +0000" NOTES_MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2012-06-03 21:28:45 +0100" MODIFIED_BY="[Empty name]">Drugs for preventing headache after a lumbar puncture</TITLE>
<SUMMARY_BODY MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<P>Lumbar puncture is an invasive procedure that medical personnel use to get a sample of cerebrospinal fluid for diagnostic purposes (e.g. to diagnose meningitis or subarachnoid haemorrhage) by inserting a needle into the lower spinal region. It can also be used to inject medications such as anaesthetics and analgesics (to perform regional anaesthesia), chemotherapy or radiological contrast agents.</P>
<P>Post-dural puncture headache (PDPH) is the most common complication of a lumbar puncture. The symptoms are a constant headache that worsens in the upright position and improves when lying down and resolves spontaneously within five to seven days. Several interventions have been used before, during or immediately after lumbar puncture to prevent PDPH, but there are still uncertainties about their clinical effectiveness, especially regarding drug treatments. Therefore, the aim of this review was to determine the effectiveness of these medications to prevent PDPH in children and adults.</P>
<P>We included 10 randomised clinical trials (RCTs), with a total of 1611 participants, that assessed seven medications (epidural and spinal morphine, spinal fentanyl, oral caffeine, rectal indomethacin, intravenous cosyntropin, intravenous aminophylline and intravenous dexamethasone). Epidural morphine and intravenous cosyntropin proved to be effective at reducing the number of participants affected by PDPH of any severity after lumbar puncture compared to placebo. Aminophylline also reduced the number of participants affected by PDPH of any severity after a lumbar puncture compared to no intervention. Dexamethasone increased the risk of PDPH when compared to placebo after spinal anaesthesia for caesarean section.</P>
<P>Morphine also increased the number of participants affected by adverse events such as itching, nausea and vomiting. The other interventions (fentanyl, caffeine, indomethacin and dexamethasone) did not show conclusive evidence of effectiveness.</P>
<P>Combining data was possible only for subgroups of one study comparing different dosages of caffeine to placebo, because the other RCTs appraised diverse drugs, outcomes or populations.</P>
<P>A meta-analysis (combining of data) was not possible because all the included RCTs assessed different drugs, different doses, different outcomes or different baseline participants' characteristics.</P>
<P>These conclusions should be interpreted carefully, given the lack of information to evaluate the risk of bias properly, and the small number of participants in the included studies.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<P>Post-dural (post-lumbar or post-spinal) puncture headache (PDPH) is one of the most common complications of diagnostic, therapeutic or inadvertent lumbar punctures. Many drug options have been used to prevent headache in clinical practice and have also been tested in some clinical studies, but there are still some uncertainties about their clinical effectiveness.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2012-01-23 20:05:03 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Not exact wording as the objectives in the &amp;#8216;main text&amp;#8217;.&lt;/p&gt;" NOTES_MODIFIED="2012-01-23 20:05:03 +0000" NOTES_MODIFIED_BY="[Empty name]">
<P>To assess the effectiveness and safety of drugs for preventing PDPH in adults and children.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<P>The search strategy included the Cochrane Central Register of Controlled Trials (CENTRAL, <I>The Cochrane Library</I> 2012, Issue 5), MEDLINE (from 1950 to May 2012), EMBASE (from 1980 to May 2012) and CINAHL (from 1982 to June 2012). There was no language restriction.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2012-08-28 12:12:29 +0100" MODIFIED_BY="[Empty name]">
<P>We considered randomised controlled trials (RCTs) that assessed the effectiveness of any drug used for preventing PDPH.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2012-12-03 12:42:35 +0000" MODIFIED_BY="[Empty name]">
<P>Review authors independently selected studies, assessed risks of bias and extracted data. We estimated risk ratios (RR) for dichotomous data and mean differences (MD) for continuous outcomes. We calculated a 95% confidence interval (CI) for each RR and MD. We did not undertake meta-analysis because participants' characteristics or assessed doses of drugs were too different in the included studies. We performed an intention-to-treat (ITT) analysis.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<P>We included 10 RCTs (1611 participants) in this review with a majority of women (72%), mostly parturients (women in labour) (913), after a lumbar puncture for regional anaesthesia. Drugs assessed were epidural and spinal morphine, spinal fentanyl, oral caffeine, rectal indomethacin, intravenous cosyntropin, intravenous aminophylline and intravenous dexamethasone.</P>
<P>All the included RCTs reported data on the primary outcome, i.e. the number of participants affected by PDPH of any severity after a lumbar puncture. Epidural morphine and intravenous cosyntropin reduced the number of participants affected by PDPH of any severity after a lumbar puncture when compared to placebo. Also, intravenous aminophylline reduced the number of participants affected by PDPH of any severity after a lumbar puncture when compared to no intervention, while intravenous dexamethasone increased it. Spinal morphine increased the number of participants affected by pruritus when compared to placebo, and epidural morphine increased the number of participants affected by nausea and vomiting when compared to placebo. Oral caffeine increased the number of participants affected by insomnia when compared to placebo.</P>
<P>The remainder of the interventions analysed did not show any relevant effect for any of the outcomes.</P>
<P>None of the included RCTs reported the number of days that patients stayed in hospital.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<P>Morphine and cosyntropin have shown effectiveness for reducing the number of participants affected by PDPH of any severity after a lumbar puncture, when compared to placebo, especially in patients with high risk of PDPH, such as obstetric patients who have had an inadvertent dural puncture. Aminophylline also reduced the number of participants affected by PDPH of any severity after a lumbar puncture when compared to no intervention in patients undergoing elective caesarean section. Dexamethasone increased the risk of PDPH, after spinal anaesthesia for caesarean section, when compared to placebo. Morphine also increased the number of participants affected by adverse events (pruritus and nausea and vomiting)</P>
<P>There is a lack of conclusive evidence for the other drugs assessed (fentanyl, caffeine, indomethacin and dexamethasone).</P>
<P>These conclusions should be interpreted with caution, owing to the lack of information, to allow correct appraisal of risk of bias and the small sample sizes of studies.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-02-25 10:27:36 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JRT 140612: This text has been revised substantially since publishing the protocol, through Background and down the Types of studies etc - think it is intentional as imitating the text in the treatment review related...?&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;XB: Yes, it is intentional to be congruent with the treatment review.&lt;/p&gt;" NOTES_MODIFIED="2013-01-28 12:10:14 +0000" NOTES_MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<P>Post-dural (post-lumbar or post-spinal) puncture headache (PDPH) is one of the most common complications of diagnostic, therapeutic or inadvertent lumbar puncture (<LINK REF="REF-Bezov-2010" TYPE="REFERENCE">Bezov 2010</LINK>; <LINK REF="REF-Davignon-2002" TYPE="REFERENCE">Davignon 2002</LINK>). PDPH is defined as any headache after a lumbar puncture that worsens within 15 minutes of sitting or standing and is relieved within 15 minutes of lying down (<LINK REF="REF-International-Headache-Society-2004" TYPE="REFERENCE">International Headache Society 2004</LINK>). Ninety per cent of PDPHs occur within three days of the procedure and 66% start in the first 48 hours (<LINK REF="REF-Turnbull-2003" TYPE="REFERENCE">Turnbull 2003</LINK>).</P>
<P>The pathophysiology of PDPH has not been fully described. It is well known that the puncture in the dura allows cerebrospinal fluid (CSF) to leak from the subarachnoid space, resulting in a decrease of CSF volume and pressure (<LINK REF="REF-Grande-2005" TYPE="REFERENCE">Grande 2005</LINK>). This CSF volume loss may cause a downwards pull on pain-sensitive structures resulting in a headache (<LINK REF="REF-Ahmed-2006" TYPE="REFERENCE">Ahmed 2006</LINK>; <LINK REF="REF-Baumgarten-1987" TYPE="REFERENCE">Baumgarten 1987</LINK>; <LINK REF="REF-Davignon-2002" TYPE="REFERENCE">Davignon 2002</LINK>; <LINK REF="REF-Denny-1987" TYPE="REFERENCE">Denny 1987</LINK>; <LINK REF="REF-Harrington-2004" TYPE="REFERENCE">Harrington 2004</LINK>). Alternatively, the loss of CSF may cause an increase in blood flow, resulting in arterial and venous vasodilation and PDPH. A third explanation involves the role of substance P and the regulation of neurokinin-1 receptors (NK1R) (<LINK REF="REF-Clark-1996" TYPE="REFERENCE">Clark 1996</LINK>).</P>
<P>Occurrence of PDPH varies from 1% to 40%, according to the needle gauge, needle orientation, operator skill level and presence of risk factors such as age group or history of PDPH (<LINK REF="REF-Turnbull-2003" TYPE="REFERENCE">Turnbull 2003</LINK>). This frequency is related to the type of lumbar puncture. During anaesthetic procedures, such as epidural anaesthesia, PDPH is most commonly caused by an unintentional dural puncture (<LINK REF="REF-Thew-2008" TYPE="REFERENCE">Thew 2008</LINK>; <LINK REF="REF-Turnbull-2003" TYPE="REFERENCE">Turnbull 2003</LINK>). In contrast, in diagnostic or therapeutic lumbar puncture, the need for adequate CSF flow requires an intentional lesion that may generate the PDPH phenomenon (<LINK REF="REF-Kuczkowski-2006" TYPE="REFERENCE">Kuczkowski 2006</LINK>). Estimated frequencies vary from less than 10% following spinal anaesthesia (<LINK REF="REF-Hafer-1997" TYPE="REFERENCE">Hafer 1997</LINK>; <LINK REF="REF-Vallejo-2000" TYPE="REFERENCE">Vallejo 2000</LINK>) to 36% for diagnostic lumbar puncture (<LINK REF="REF-Lavi-2006" TYPE="REFERENCE">Lavi 2006</LINK>; <LINK REF="REF-Vallejo-2000" TYPE="REFERENCE">Vallejo 2000</LINK>) and up to 81% (<LINK REF="REF-Banks-2001" TYPE="REFERENCE">Banks 2001</LINK>) in obstetric patients with inadvertent dural puncture during active labour. Reported risk of inadvertent dural puncture placement during epidural anaesthesia in an obstetric population ranges from 0.04% to 6% (<LINK REF="REF-Berger-1998" TYPE="REFERENCE">Berger 1998</LINK>; <LINK REF="REF-Choi-2003" TYPE="REFERENCE">Choi 2003</LINK>). Therefore, obstetric analgesia is probably the main source of PDPH patients.</P>
<P>The features of PDPH are often variable. PDPH may be accompanied by neck stiffness, tinnitus, hearing loss, photophobia or nausea; other features, such as the location and duration, are also unpredictable (<LINK REF="REF-Lybecker-1995" TYPE="REFERENCE">Lybecker 1995</LINK>). Although PDPH is not a life-threatening condition, physical activity is often restricted. Likewise patients are usually required to stay in bed the whole day, and length of stay and medical care increases (<LINK REF="REF-Angle-2005" TYPE="REFERENCE">Angle 2005</LINK>).</P>
<P>The variability of symptoms makes PDPH a diagnosis of exclusion. Other alternative diagnoses should be ruled out (e.g. viral meningitis, sinus headache or intracranial haemorrhage) (<LINK REF="REF-Turnbull-2003" TYPE="REFERENCE">Turnbull 2003</LINK>). Once PDPH is diagnosed, the initial treatment involves conservative measures such as bed rest and analgesics. If PDPH continues for more than 72 hours, a more specific treatment is indicated (<LINK REF="REF-Ahmed-2006" TYPE="REFERENCE">Ahmed 2006</LINK>). Severe PDPH may respond to some therapeutic drugs and administration of an epidural blood patch (EBP) (<LINK REF="REF-Lavi-2006" TYPE="REFERENCE">Lavi 2006</LINK>).</P>
</CONDITION>
<THEORY MODIFIED="2013-01-24 11:08:55 +0000" MODIFIED_BY="[Empty name]">
<P>Owing to the fact that no clear pathophysiology has been asserted for PDPH, many drugs options are used to prevent headache in clinical practice and in clinical trials: for example EBP mechanically blocking the leakage of CSF, postures such as a prone position, reducing pressure in the subarachnoid space and allowing a seal to form over the dura, hydration increasing CSF production (<LINK REF="REF-Ahmed-2006" TYPE="REFERENCE">Ahmed 2006</LINK>), methylxanthines, sumatriptan and caffeine increasing vasoconstriction of cerebral blood vessels or adrenocorticotropic hormone (ACTH) (<LINK REF="REF-Kuczkowski-2006" TYPE="REFERENCE">Kuczkowski 2006</LINK>), or epidural saline infusion (<LINK REF="REF-Morewood-1993" TYPE="REFERENCE">Morewood 1993</LINK>) increasing intravascular volume.</P>
<P>Preventive drugs should help to decrease the frequency of patients with PDPH, reduce the headache severity as much as possible, avoid the need for any therapeutic option, improve daily activity, reduce the length of hospital stay and decrease the occurrence of adverse events overall.</P>
</THEORY>
<IMPORTANCE MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<P>Two Cochrane systematic reviews about treatment and management of PDPH have been published using EBP (<LINK REF="REF-Boonmak-2010" TYPE="REFERENCE">Boonmak 2010</LINK>) and drugs (<LINK REF="REF-Basurto-2011" TYPE="REFERENCE">Basurto 2011</LINK>). One Cochrane systematic review about prevention of PDPH with epidural catheter replacement and intrathecal catheter techniques is also in production (<LINK REF="REF-Newman-2010" TYPE="REFERENCE">Newman 2010</LINK>), alongside two published reviews using EBP (<LINK REF="REF-Boonmak-2010" TYPE="REFERENCE">Boonmak 2010</LINK>), and posture and fluids (<LINK REF="REF-Arevalo_x002d_Rodriguez-2011" TYPE="REFERENCE">Arevalo-Rodriguez 2011</LINK>).</P>
<P>Numerous preventive drugs have been proposed for treating this condition based on limited randomised controlled trials (RCTs) and case series, including: caffeine, morphine, paracetamol, fentanyl, vasopressin (<LINK REF="REF-Turnbull-2003" TYPE="REFERENCE">Turnbull 2003</LINK>) and epidural saline infusion (<LINK REF="REF-Morewood-1993" TYPE="REFERENCE">Morewood 1993</LINK>). Therefore, there is weak evidence to support the preventive treatment of PDPH with drugs and the existing uncertainties require a systematic review to clarify their potential benefits. In addition, this review would like to inspire future guidelines as well as future good-quality studies regarding this topic.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<P>To assess the effectiveness and safety of drugs for preventing PDPH in adults and children.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-02-25 10:27:36 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2012-08-28 12:43:47 +0100" MODIFIED_BY="[Empty name]">
<P>We included RCTs (parallel or cross-over) conducted in any setting. We excluded studies using alternation, date of birth, hospital record number or other quasi-randomised methods of allocation of treatment.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<P>Participants undergoing lumbar puncture for any of the reasons outlined: CSF sampling or pressure measurement, or both; spinal anaesthesia; myelography; intrathecal drug administration or accidental puncture of the dura during epidural anaesthesia. We included individuals of all ages and any gender.</P>
<P>The use of a standardised diagnostic criteria for PDPH was not required, but it should at least have been described as an orthostatic headache that worsened on standing and improved by lying down. We described the specific diagnostic criteria used in each included study.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<P>We considered any drug used for preventing PDPH. We considered interventions at any dose, formulation or route of administration given before, during or immediately after lumbar puncture.</P>
<P>Acceptable control groups included: placebo, no intervention, any other drug treatments, behavioural and physical therapies.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="Jessica R Thomas">
<P>Number of participants affected by PDPH of any severity after a lumbar puncture.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-01-24 13:57:26 +0000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Number of participants with severe PDPH (based on the author's definition of severity).</LI>
<LI>Number of participants with any headache, not only those explicitly described as PDPH.</LI>
<LI>Number of days that patients stayed in hospital.</LI>
<LI>Any possible adverse events of drugs taken to prevent PDPH.</LI>
<LI>Missing data (withdrawals, drop-outs and participants lost to follow-up).</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-02-25 10:27:36 +0000" MODIFIED_BY="[Empty name]">
<P>We designed the search in the context of an extensive review about prevention and treatment drugs used for PDPH. The Cochrane Central Register of Controlled Trials (CENTRAL) was our primary source for identifying studies. Our search terms were a combination of thesaurus-based and free-text terms covering both the procedure of interest (dural puncture performed for diagnosis, anaesthesia or myelography) and headache. For MEDLINE, EMBASE and CINAHL we used a modified version of the strategy used to search CENTRAL. We considered articles written in any language. </P>
<P>In addition, we searched the reference lists of all studies and review articles identified by electronic searching. We requested information about any potentially relevant studies when we contacted trialists from every included study.</P>
<ELECTRONIC_SEARCHES MODIFIED="2013-02-25 10:27:36 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JRT 140612: I think you are doing so already, but just a reminder to bring the search up to date prior to publication.&lt;/p&gt;&lt;p&gt;XB: it is now up to date.&lt;/p&gt;" NOTES_MODIFIED="2013-02-25 10:27:36 +0000" NOTES_MODIFIED_BY="[Empty name]">
<P>We searched:</P>
<UL>
<LI>CENTRAL (<I>The Cochrane Library</I> 2012, Issue 5);</LI>
<LI>MEDLINE (from 1950 to May 2012);</LI>
<LI>EMBASE (from 1980 to May 2012);</LI>
<LI>CINAHL (from 1982 to June 2012).</LI>
</UL>
<P>We include the complete search strategies designed for CENTRAL, MEDLINE, EMBASE and CINAHL in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>, <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>, <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK> and <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK> respectively.</P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JRT 140612: Please activate the RevMan 5 headings and copy the text under those instead of using the free-text headings - go to tree view on left and open up and then use right click to 'activate'&lt;/p&gt;&lt;p&gt;XB: done&lt;/p&gt;" NOTES_MODIFIED="2013-01-28 12:10:14 +0000" NOTES_MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2012-07-22 11:32:36 +0100" MODIFIED_BY="[Empty name]">
<P>Two independent review authors (XB, SU) screened titles and abstracts of studies identified by the literature search for eligibility. We resolved disagreements through discussion. We retrieved eligible studies in full to confirm whether or not they fulfilled the inclusion criteria. Review authors were not blinded to the authors' names and institutions, journal of publication or study results at this or any stage of the review.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<P>For included studies, we used specially designed, pre-tested data forms to extract information from the original studies on participants, methods of randomisation and blinding, the comparison(s) of interest, the number of participants originally randomised in each arm of the study, any losses to follow-up and the occurrence in each arm of the outcomes of interest. If information on any of these was incomplete, we attempted to obtain it by writing to the study author concerned. One review author (XB) extracted the data from studies and a second review author (SU) checked data for accuracy, resolving any disagreement by discussion. We entered data into Review Manager 5.1 (<LINK REF="REF-RevMan-2011" TYPE="REFERENCE">RevMan 2011</LINK>).</P>
<P>When efficacy outcomes were reported in dichotomous form (e.g. number of people with severe PDPH, number of people with any headache, any possible adverse events of drug and missing data), we recorded the number of participants assigned to each treatment arm and the number with each outcome. For outcomes reported on a continuous scale (e.g. number of days participants stayed in hospital), we recorded data on the variance associated with their means.<BR/>
</P>
<P>If reported we recorded the frequency and type of adverse events for each treatment arm.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<P>We used The Cochrane Collaboration's tool for assessing risk of bias in the studies included in this review, which addresses six specific domains (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) summarised in a specific table. For this review we assessed five of the domains (sequence generation, allocation concealment, blinding, incomplete outcome data and selective outcome reporting). Each domain has a description of what was reported. One review author (XB) completed the 'Risk of bias' judgements for each study and a second review author (SU) checked them for accuracy. Any disagreement was resolved by discussion.</P>
</QUALITY_ASSESSMENT>
<HETEROGENEITY_ASSESSMENT MODIFIED="2012-08-28 12:43:47 +0100" MODIFIED_BY="[Empty name]">
<P>This review did not include a meta-analysis.<BR/>We would have assessed heterogeneity of effect sizes by means of the Q (Chi<SUP>2</SUP> statistic) using the methods of Peto and Mantel-Haenszel. If statistical evidence had existed for homogeneity of effect sizes, the analysis would have used a fixed-effect model.<BR/>If significant heterogeneity had been present (Chi<SUP>2</SUP> test with P value &lt; 0.1 or I<SUP>2</SUP> statistic value &gt; 50%), we would have made an attempt to explain the differences based on the clinical characteristics of the included studies. We would not have combined studies that were dissimilar in terms of interventions and participants. However, if a group of studies with heterogeneous results had appeared to be similar, we would have combined the study estimates using a random-effects model (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>; <LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>).</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<P>The differences between the studies included in this review, in terms of participants' characteristics, interventions assessed and outcomes measured, only permitted a combined analysis in one of the comparisons (caffeine plus paracetamol versus placebo). For the other comparisons we presented a narrative summary. </P>
<P>We analysed the results for different drugs separately, except for caffeine plus paracetamol versus placebo, using Review Manager 5.1 (<LINK REF="REF-RevMan-2011" TYPE="REFERENCE">RevMan 2011</LINK>). We performed analysis on an intention-to-treat (ITT) basis (i.e. all participants remained in their original trial arm, whether or not they actually received the intervention allocated).</P>
<P>We used dichotomous data to calculate risk ratios (RR) with 95% confidence intervals (CI). In future updates of this review, we hope to be able to calculate the numbers needed to treat for an additional beneficial outcome (NNTB) with 95% CI, as the reciprocal of the risk difference (RD) (<LINK REF="REF-McQuay-1998" TYPE="REFERENCE">McQuay 1998</LINK>). We will use data on the proportion of participants reporting adverse events to calculate RD and numbers needed to treat for an additional harmful outcome (NNTH) with 95% CI for significant differences.</P>
<P>For continuous outcomes reported using the same scale, we calculated mean differences (MD) with 95% CI. In future updates of this review, we hope to be able to calculate standardised mean differences (SMD) for pooling results of continuous outcomes measured with different scales.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2012-08-28 12:43:47 +0100" MODIFIED_BY="[Empty name]">
<P>In future updates of this review, if sufficient data are available, we plan to carry out the following subgroup analyses:</P>
<SUBSECTION>
<HEADING LEVEL="4">Follow-up time subgroup analyses</HEADING>
<P>When possible, we will assess the impact of the assessed interventions at short-term (&lt; 24 hours), medium-term (24 to 48 hours) or long-term time periods (&gt; 48 hours) for the preventive drugs.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Population subgroup analyses</HEADING>
<P>Where data allow in the future, we plan to conduct separate outcome analyses to test the following null hypotheses:</P>
<OL>
<LI>there is no difference between obstetric participants and all other participants;</LI>
<LI>there is no difference between men and non-obstetric women participants;</LI>
<LI>there is no difference between young participants (18 to 35 years old) and all other adult participants.</LI>
</OL>
</SUBSECTION>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]">
<P>In future updates of this review, and depending on study availability, we will conduct a sensitivity analyses formulated a priori:</P>
<UL>
<LI>We will examine the effect on the primary outcome of excluding any study judged to be at a high risk of bias by two of the domains, sequence generation and allocation concealment.</LI>
<LI>If applicable we will also perform a sensitivity analysis excluding those trials with a cross-over design.</LI>
</UL>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<P>See the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>', '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>' and '<LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>' tables.</P>
<SEARCH_RESULTS MODIFIED="2013-01-28 12:10:14 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JRt 140612: update the search date here if you do bring the search up to date.&lt;/p&gt;&lt;p&gt;XB: done&lt;/p&gt;" NOTES_MODIFIED="2013-01-28 12:10:14 +0000" NOTES_MODIFIED_BY="[Empty name]">
<P>We identified 1894 references in primary electronic databases up to May 2012 from our extended search strategy for prevention and treatment with drugs for PDPH. We excluded 1768 references after a detailed reading of the title and abstract. We obtained the full-text reports for the remainder of the studies (137 papers) to check if they strictly fulfilled all the inclusion criteria. We finally excluded 127 studies after a complete full-text review and we contacted the study authors by email in some cases when more information was needed to decide eligibility. Ten studies completely fulfilled the inclusion criteria for this review (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>; <LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>; <LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>; <LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>).</P>
<P>See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<P>Included studies are described in detail in the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' table.</P>
<SUBSECTION>
<HEADING LEVEL="4">Study design</HEADING>
<P>All 10 included studies (involving a total of 1611 participants) were RCTs with a parallel design. Most of them were placebo-controlled, except <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK> and <LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>, which used a control group without an intervention.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Setting</HEADING>
<P>All included studies were single-centre studies. Three studies were conducted in the US (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>), three studies in Iran (<LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>) and the remainder in Norway (<LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>), Turkey (<LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>), Egypt (<LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>) and Saudi Arabia (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>).</P>
<P>All the studies recruited the participants from hospital settings and the intervention took place while they were admitted.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Sample size</HEADING>
<P>The studies included a total of 1611 participants. The smallest study had 50 participants (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>) and the largest had 372 (<LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>).<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>The majority of participants were women (1160/1611; 72%), mostly parturients (woman in labour) (913) that required a lumbar puncture for regional anaesthesia (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>; <LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>; <LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>). There were four studies that included men (451); three with surgical patients after a spinal anaesthesia (<LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>) and one with lumbar puncture for myelography (<LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>).</P>
<P>The median age among participants from all studies ranged from 26.1 to 48.5 years old.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intervention</HEADING>
<P>Three included studies assessed two different opioid drugs to prevent PDPH; morphine (administered into the subarachnoid space (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>) or into the epidural space (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>)) and fentanyl (administered into the subarachnoid space (<LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>)) .</P>
<P>Two studies used caffeine as an intervention to prevent PDPH. <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK> compared oral caffeine 300 mg to placebo. <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK> assessed oral caffeine 75 mg and 125 mg, combined with paracetamol, compared to placebo.</P>
<P>Two studies used intravenous dexamethasone compared to placebo to prevent PDPH (<LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>).</P>
<P>One study compared rectal indomethacin, a non-steroidal anti-inflammatory drug, to placebo (<LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>). Intravenous cosyntropin, a synthetic derivative of ACTH, was compared to placebo in one study (<LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>) and intravenous aminophylline, a xanthine derivative, was compared to no intervention in another study (<LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>).</P>
<P>Follow-up was short in general terms and differed between the included trials at 48 hours (<LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>), three days (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>) and three weeks (<LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes of interest</HEADING>
<P>The number of participants affected by PDPH of any severity after a lumbar puncture (primary outcome) was reported in all included studies. Missing data were reported in six studies (<LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>; <LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>; <LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>). Adverse events related to study drugs were reported in five studies (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>).</P>
<P>The number of participants with severe PDPH was reported in five studies (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>; <LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>).</P>
<P>The number of participants with any headache was detailed in two studies (<LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>).</P>
<P>The number of days that participants stayed in hospital was the only outcome not reported in the included studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Conflict of interest</HEADING>
<P>Only three studies reported any conflict of interest. <LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK> stated that Dumex-Norway supplied the intervention drugs and placebo, <LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK> stated that support was provided solely from institutional or departmental (or both) sources and <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK> stated no conflict of interest.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<P>A total of 127 studies did not fulfil the inclusion criteria and were excluded.</P>
<P>The most frequent reasons for exclusion were that the study did not focus on PDPH (45% of studies) or describe the orthostatic component of headache (35% studies). Other less frequent reasons(20% of the excluded studies) were: was not a RCT, intervention did not aim to prevent PDPH, allocation was not randomised or did not assess an individual drug.</P>
<P>For a summary of the reasons for exclusion see the '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>' table.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JRT 140612: Figure 1 isn't risk of bias, should be deleted?&lt;/p&gt;&lt;p&gt;XB: modified&lt;/p&gt;" NOTES_MODIFIED="2013-01-28 12:10:15 +0000" NOTES_MODIFIED_BY="[Empty name]">
<P>Risk of bias in the included studies is summarised in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
<ALLOCATION MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Sequence generation</HEADING>
<P>Allocation sequence was adequately generated in three studies (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>) that reported a computer-generated random number sequence explicitly.</P>
<P>The other seven included studies were described as randomised but no information was provided, so we judged them as having an unclear risk of selection bias (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>; <LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>; <LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>).<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<P>Two studies reported the method used to conceal the randomisation sequences (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>) and we judged them as having a low risk of selection bias.</P>
<P>The other eight studies did not provide information regarding allocation concealment (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>; <LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>; <LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>) and we judged them as having an unclear risk of selection bias.<BR/>
</P>
</SUBSECTION>
</ALLOCATION>
<BLINDING MODIFIED="2012-08-22 18:12:13 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Blinding of participants and personnel (performance bias)</HEADING>
<P>The blinding method was adequate in five of the studies (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>; <LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>). The rest of the studies (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>; <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>) did not report detailed data to allow assessment of performance bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Blinding of outcome assessment (detection bias)</HEADING>
<P>Blinding of outcome assessment was adequate in four of the included studies (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>; <LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>). The six remaining studies (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>; <LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>) did not report information to allow assessment of detection bias.</P>
</SUBSECTION>
</BLINDING>
<EXCLUSIONS MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<P>Seven studies presented results for all randomised patients or reported the number of participants lost in follow-up with reasons explicitly stated and we judged them as having a low risk of attrition bias (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>; <LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>).</P>
<P>The remainder of the studies stated explicitly the number of participants lost to follow-up without detailed data to allow assessment of attrition bias; <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK> with six participants lost out of 194, <LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK> with three out of 250 and <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK> with two out of 60. Gender of participants lost to follow-up in <LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK> and <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK> was not reported.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<P>Four studies presented outcomes according to objectives stated in the methods section and we judged them as having a low risk of reporting bias (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>). We judged three studies as having an unclear risk of bias because no information was provided (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>). We judged <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>, <LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK> and <LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK> as having a high risk as they did not report outcomes about adverse effects.</P>
</SELECTIVE_REPORTING>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;(Checklist 1.10) Forest plots not linked in same order as &amp;#8216;Data and Analysis&amp;#8217; but I think this is unavoidable, given the structure.&lt;/p&gt;" NOTES_MODIFIED="2013-01-28 12:10:15 +0000" NOTES_MODIFIED_BY="[Empty name]">
<P>We present in this section a narrative synthesis of the results for the different outcomes of interest.</P>
<SUBSECTION>
<HEADING LEVEL="3">Number of participants affected by post-dural puncture headache (PDPH) of any severity</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Opioids</HEADING>
<P>Opioids were assessed in three studies for this primary outcome. Epidural morphine (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>) showed a significant risk reduction of the number of participants affected by PDPH of any severity compared to placebo (15 events in 50 participants; risk ratio (RR) 0.25; 95% confidence interval (CI) 0.08 to 0.78; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
<P>In contrast, spinal morphine and spinal fentanyl showed no differences compared to placebo in <LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK> (17 events in 82 participants; RR 1.18; 95% CI 0.51 to 2.76; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>) or no intervention in <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK> (11 events in 194 participants; RR 1.79; 95% CI 0.54 to 5.91; <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>) respectively, in the number of participants affected by PDPH of any severity.</P>
<P>We did not undertake meta-analysis of these three studies (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>). The <LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK> results were not combined with other studies because baseline incidence of PDPH was much higher in obstetric patients with inadvertent dural puncture during active labour than following spinal anaesthesia for caesarean section. We did not combine the results from <LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK> and <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK> because opioid interventions were not dose equivalent; <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK> assessed 20 &#956;g of fentanyl, which is dose equivalent of morphine 2 mg, which is 10 times higher than the morphine 0.2 mg used in <LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intravenous cosyntropin</HEADING>
<P>Intravenous cosyntropin (<LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>) showed a significant risk reduction of the number of participants affected by PDPH of any severity (46 events in 95 participants; RR 0.49; 95% CI 0.31 to 0.79; <LINK REF="CMP-008.01" TYPE="ANALYSIS">Analysis 8.1</LINK>) compared to placebo.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Oral caffeine</HEADING>
<P>Oral caffeine plus paracetamol was assessed by <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK> with two different doses of caffeine, 75 mg and 125 mg, and compared to placebo. The combined analysis from these two doses of caffeine, compared to placebo, showed no significant risk reduction (42 events in 280 participants; RR 0.91; 95% CI 0.52 to 1.59; <LINK REF="CMP-011.01" TYPE="ANALYSIS">Analysis 11.1</LINK>). Neither comparison showed a significant result: caffeine 75 mg versus placebo (21 events in 140 participants; RR 0.91; 95% CI 0.41 to 2.00; <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>), caffeine 125 mg versus placebo (21 events in 140 participants; RR 0.91; 95% CI 0.41 to 2.00; <LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>) or 75 mg caffeine versus caffeine 125 mg (20 events in 140 participants; RR 1.00; 95% CI 0.44 to 2.25; <LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>). <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK> also showed no significant risk reduction (18 events in 60 participants; RR 2.00; 95% CI 0.86 to 4.63; <LINK REF="CMP-009.01" TYPE="ANALYSIS">Analysis 9.1</LINK>) when comparing oral caffeine 300 mg to placebo.</P>
<P>We did not undertake meta-analysis of these two studies (<LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>) because the caffeine doses used were too different (75 mg/125 mg and 300 mg, respectively) and also because the intervention was different; caffeine plus paracetamol in <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK> while <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK> used caffeine alone.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Rectal indomethacin</HEADING>
<P>Rectal indomethacin (<LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>) showed no significant risk reduction when compared to placebo (51 events in 250 participants; RR 0.70; 95% CI 0.42 to 1.15; <LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intravenous dexamethasone</HEADING>
<P>Intravenous dexamethasone was assessed in two studies for this primary outcome. <LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK> showed no significant risk reduction when compared to placebo (34 events in 178 participants; RR 0.79; 95% CI 0.43 to 1.45; <LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>). <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK> showed a significant risk of increasing the number of participants affected by PDPH of any severity compared to placebo (39 events in 372 participants; RR 2.55; 95% CI 1.31 to 4.96; <LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>).</P>
<P>We did not undertake a meta-analysis of these two studies (<LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>) because participants' characteristics were too different in terms of age, gender, length of gestation and spinal needle size used, and also because of statistical evidence of significant heterogeneity of effect sizes (Chi<SUP>2</SUP> test with P value = 0.01 and I<SUP>2</SUP> statistic value = 85%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intravenous aminophylline</HEADING>
<P>Intravenous aminophylline (<LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>) showed a significant risk reduction of the number of participants affected by PDPH of any severity at 24 and 48 hours after umbilical cord clamping compared to no intervention (at 24 hours: 22 events in 120 participants; RR 0.16; 95% CI 0.05 to 0.51; <LINK REF="CMP-012.01" TYPE="ANALYSIS">Analysis 12.1</LINK>; at 48 hours: 17 events in 120 participants; RR 0.21; 95% CI 0.06 to 0.71; <LINK REF="CMP-012.01" TYPE="ANALYSIS">Analysis 12.1</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Number of participants with severe PDPH (based on the author's definition of severity)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Opioids</HEADING>
<P>Opioids were assessed in two studies for this outcome. Epidural morphine (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>) showed no significant risk reduction compared to placebo (six events in 50 participants; RR 0.08; 95% CI 0.00 to 1.30; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). Spinal fentanyl (<LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>) also showed no significant risk reduction when compared to no intervention (four events in 194 participants; RR 3.06; 95% CI 0.32 to 28.93; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>).</P>
<P>We did not undertake meta-analysis of these two studies (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>) because of the difference between participants' characteristics.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Oral caffeine</HEADING>
<P>Data for oral caffeine doses plus paracetamol assessed in <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK> were analysed in combination, caffeine 75 mg and 125 mg, showing no significant risk reduction compared to placebo (15 events in 280 participants; RR 0.88; 95% CI 0.33 to 2.35; <LINK REF="CMP-011.02" TYPE="ANALYSIS">Analysis 11.2</LINK>). Individual comparisons showed no significant risk reduction in any of the reported comparisons: caffeine 75 mg compared to placebo (10 events in 140 participants; RR 1.50; 95% CI 0.44 to 5.09; <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>), caffeine 125 mg compared to placebo (five events in 140 participants; RR 0.25; 95% CI 0.03 to 2.18; <LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>) or caffeine 75 mg compared to caffeine 125 mg (seven events in 140 participants; RR 6.00; 95% CI 0.74 to 48.55; <LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intravenous dexamethasone</HEADING>
<P>Intravenous dexamethasone was assessed in two studies. <LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK> showed no significant risk reduction compared to placebo (10 events in 178 participants; RR 0.25; 95% CI 0.05 to 1.14; <LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>). <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK> could not estimate this outcome because none of the participants experienced a severe PDPH. For this reason and because of clinical differences these two studies could not be combined.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Number of participants with any headache, not only those explicitly described as PDPH</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Oral caffeine</HEADING>
<P>A combined analysis of caffeine 75 mg with 125 mg in <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK> showed no significant risk reduction compared to placebo (61 events in 280 participants; RR 0.79; 95% CI 0.51 to 1.24; <LINK REF="CMP-011.03" TYPE="ANALYSIS">Analysis 11.3</LINK>). All other comparisons showed no significant risk reduction: 75 mg caffeine compared to placebo (10 events in 140 participants; RR 0.67; 95% CI 0.20 to 2.26; <LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>), 125 mg caffeine compared to placebo (nine events in 140 participants; RR 0.50; 95% CI 0.13 to 1.92; <LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>) or caffeine 75 mg compared to caffeine 125 mg (seven events in 140 participants; RR 1.33; 95% CI 0.31 to 5.74; <LINK REF="CMP-006.03" TYPE="ANALYSIS">Analysis 6.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Dexamethasone</HEADING>
<P>Dexamethasone was assessed in <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK> and showed no significant risk reduction compared to placebo (16 events in 372 participants; RR 2.20; 95% CI 0.78 to 6.21; <LINK REF="CMP-010.03" TYPE="ANALYSIS">Analysis 10.3</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Number of days that patients stayed in hospital</HEADING>
<P>None of the included studies reported this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Any possible adverse events of drugs taken to prevent PDPH</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Opioids</HEADING>
<P>Opioids were assessed in two studies for this outcome. Spinal morphine (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>) showed a significant risk for increasing the number of participants affected by pruritus (28 events in 82 participants; RR 8.75; 95% CI 2.86 to 26.72; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>) compared to placebo, but a non-significant result for the number of participants affected by nausea and vomiting (41 events in 82 participants; RR 0.82; 95% CI 0.53 to 1.27; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>).</P>
<P>Epidural morphine (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>) significantly increased the number of participants affected by nausea and vomiting (15 events in 50 participants; RR 2.75; 95% CI 1.01 to 7.48; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>) compared to placebo. This study (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>) showed three participants affected by pruritus, all of them in the morphine group, with a non-significant result (three events in 50 participants; RR 7.00; 95% CI 0.38 to 128.87; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>).</P>
<P>We did not undertake meta-analysis of these two studies (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>) for this outcome because of the difference between participants' characteristics.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Caffeine</HEADING>
<P>Oral caffeine 300 mg (<LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>) showed a significant risk for increasing the number of participants affected by insomnia (11 events in 60 participants; RR 4.50; 95% CI 1.06 to 19.11; <LINK REF="CMP-009.02" TYPE="ANALYSIS">Analysis 9.2</LINK>) compared to placebo. <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK> reported no adverse events in either the caffeine 75 mg plus paracetamol group or in caffeine 125 mg plus paracetamol group. The study did not report this outcome in the placebo group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intravenous cosyntropin</HEADING>
<P>Intravenous cosyntropin compared to placebo (<LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>) showed two participants affected by mild hypersensitivity reaction (urticaria) in the cosyntropin group, with a non-significant result (two events in 95 participants; RR 5.10; 95% CI 0.25 to 103.57; <LINK REF="CMP-008.02" TYPE="ANALYSIS">Analysis 8.2</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Missing data (withdrawals, drop-outs and participants lost to follow-up)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Opioids</HEADING>
<P>Spinal fentanyl (<LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>) showed no significant risk of losing participants to follow-up (six events in 194 participants; RR 2.04; 95% CI 0.38 to 10.89; <LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>) when compared to no intervention.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Rectal indomethacin</HEADING>
<P>Rectal indomethacin (<LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>) showed no significant risk of losing participants to follow-up (three events in 250 participants; RR 0.14; 95% CI 0.01 to 2.74; <LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>) when compared to placebo.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intravenous cosyntropin</HEADING>
<P>Intravenous cosyntropin (<LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>) show no significant risk of losing participants to follow-up (five events in 95 participants; RR 0.68; 95% CI 0.12 to 3.89; <LINK REF="CMP-008.03" TYPE="ANALYSIS">Analysis 8.3</LINK>) when compared to placebo.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Oral caffeine</HEADING>
<P>Oral caffeine (<LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>) showed no significant risk of losing participants to follow-up when comparing 300 mg oral caffeine to placebo (two events in 60 participants; RR 0.20; 95% CI 0.01 to 4.00; <LINK REF="CMP-009.03" TYPE="ANALYSIS">Analysis 9.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intravenous dexamethasone</HEADING>
<P>Intravenous dexamethasone was assessed in <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK> and showed no significant risk of losing participants to follow-up (12 events in 372 participants; RR 0.50; 95% CI 0.15 to 1.63; <LINK REF="CMP-010.04" TYPE="ANALYSIS">Analysis 10.4</LINK>) compared to placebo. <LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK> could not estimate this outcome because none of the participants were lost to follow-up.</P>
<P>We did not undertake meta-analysis of the six RCTs included in this outcome because of the different intervention drugs assessed.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JRT 140612: I think generally the term 'study' should be used in the place of RCT as per style guide?&lt;/p&gt;&lt;p&gt;XB: modified. Most of RCT have been deleted.&lt;/p&gt;" NOTES_MODIFIED="2013-01-28 12:10:15 +0000" NOTES_MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<P>This systematic review identified three randomised controlled trials (RCTs) assessing opioids for preventing post-dural puncture headache (PDPH): epidural morphine (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>), spinal morphine (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>) and spinal fentanyl (<LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>). Two studies assessed oral caffeine (<LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>) and two studies assessed intravenous dexamethasone (<LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>). Three other studies assessing different drugs for preventing PDPH were identified: rectal indomethacin (<LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>), intravenous cosyntropin (<LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>) and intravenous aminophylline (<LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>).</P>
<P>All the included studies reported data on the primary outcome, the number of participants affected by PDPH of any severity after a lumbar puncture. For this outcome, epidural morphine (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>) and intravenous cosyntropin (<LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>) reduced the number of participants affected by PDPH of any severity after a lumbar puncture when compared to placebo. In both RCTs participants were obstetric patients who had an inadvertent dural puncture. Also intravenous aminophylline (<LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>) reduced the number of participants affected by PDPH of any severity after a lumbar puncture when compared to no intervention in patients undergoing elective caesarean section. Intravenous dexamethasone after caesarean section increased the risk of PDPH in <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK> and showed no significant effect in adults with lower extremity surgery (<LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>). The rest of the interventions assessed for this outcome, spinal morphine (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>) and spinal fentanyl (<LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>), oral caffeine (<LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>) and rectal indomethacin (<LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>), did not show any relevant effect.</P>
<P>When assessing any possible adverse events of drugs taken to prevent PDPH, spinal morphine (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>) increased the number of participants affected by pruritus when compared to placebo and epidural morphine (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>) increased the number of participants affected by nausea and vomiting when compared to placebo. Also three participants in the epidural morphine group experienced pruritus. Two participants in the cosyntropin group and none in the placebo group (<LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>) were affected by a mild self limiting hypersensitivity reaction (urticaria) that required no treatment. Oral caffeine 300 mg every eight hours for three days increased the number of participants affected by insomnia (<LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>); however, <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK> found no relevant adverse effect.</P>
<P>The drugs assessed in the included studies did not show any relevant effect for the rest of the outcomes of interest for this review. The number of participants with severe PDPH was similar between the interventions and their controls in five studies (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>; <LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>). The number of participants with any headache, not just that explicitly described as PDPH, was reported in two studies (<LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>) without relevant effect. Missing data (withdrawals, drop-outs and participants lost to follow-up) were reported in five studies (<LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>; <LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>; <LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>), which showed no significant differences between the interventions and their controls. None of the included studies reported data showing the number of days participants stayed in hospital.</P>
<P>Three studies (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>) compared opioids versus placebo but we did not undertake meta-analysis because of the difference between participants' characteristics or because the opioid doses were not equivalent. The baseline incidence of PDPH was much higher in obstetric patients with inadvertent dural puncture during active labour than following spinal anaesthesia for caesarean section in the <LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK> study. Data from <LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK> and <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK> could not be combined because the opioids used were not dose equivalents. In <LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>, fentanyl 20 &#956;g was the dose equivalent of morphine 2 mg and this was different from the 0.2 mg dose of morphine that was used in <LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>.</P>
<P>Two studies (<LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>) compared caffeine to placebo but we chose not to combine results because the range of caffeine doses used was too wide (75 mg, 125 mg and 300 mg) and also the intervention was different; caffeine plus paracetamol was used in <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK> while <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK> used caffeine alone. The two intervention groups in <LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK> were analysed in combination (i.e. caffeine 75 mg and caffeine 125 mg) compared to placebo, showing no relevant effect.</P>
<P>Two studies (<LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>) compared dexamethasone to placebo but could not be combined because participants' characteristics were too varied in terms of age, gender, length of gestation and spinal needle size used, and also because of statistical evidence of significant heterogeneity of effect sizes.</P>
<P>In future updates of this review, if sufficient data are available, we plan to carry out the subgroup and sensitivity analyses formulated a priori.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JRt 140612: This sentence reads strangely, consider re-writing? &amp;quot;All the opioids used in the included studies are widely commercialised and frequently used, the same happens with indometacin and dexamethasone.&amp;quot;&lt;/p&gt;&lt;p&gt;XB: modified&lt;/p&gt;" NOTES_MODIFIED="2013-01-28 12:10:15 +0000" NOTES_MODIFIED_BY="[Empty name]">
<P>All participants included in this review were recruited from acute care hospitals and their characteristics seemed to be similar to patients seen in usual clinical practice.<BR/>The lumbar punctures were performed during hospital stay, which is the most common setting for this technique. Most of the participants in the included studies underwent lumbar puncture to administer regional anaesthesia (spinal and epidural anaesthesia), which is the most common reason for lumbar puncture. No lumbar puncture in the included studies was done for diagnostic purposes.</P>
<P>The opioids (morphine and fentanyl), indomethacin, aminophylline and dexamethasone, used in the included studies, are widely marketed and frequently used. Caffeine and cosyntropin are also commercialised but for more specific indications and therefore they are less widely available.</P>
<P>Outcomes reported from the included studies were patient-relevant. In fact, all included studies reported on the primary effectiveness outcome, that is the number of participants affected by PDPH of any severity after a lumbar puncture. The second most reported outcome was a safety issue, that is any possible adverse events of drugs taken to prevent PDPH.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<P>The outlined results should be interpreted with caution owing to the diversity of drugs and doses assessed, and outcomes measured, the small sample sizes of the studies included, and the bias presented. There was a lack of data reported to allow a complete appraisal of the risk of bias; review authors' judgements about each 'Risk of bias' item were unclear in around 50% across all included studies (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). We judged three included studies (<LINK REF="STD-Abboud-1992" TYPE="STUDY">Abboud 1992</LINK>; <LINK REF="STD-Flaatten-1987" TYPE="STUDY">Flaatten 1987</LINK>; <LINK REF="STD-Strelec-1994" TYPE="STUDY">Strelec 1994</LINK>) as having an unclear risk of bias in at least five out of the six items evaluated. We judged three other included studies (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>; <LINK REF="STD-Hakim-2010" TYPE="STUDY">Hakim 2010</LINK>; <LINK REF="STD-Yousefshahi-2012" TYPE="STUDY">Yousefshahi 2012</LINK>) as having a low risk of bias in at least five out of the six items evaluated (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). We judged three studies (<LINK REF="STD-Devcic-1993" TYPE="STUDY">Devcic 1993</LINK>; <LINK REF="STD-Doroudian-2011" TYPE="STUDY">Doroudian 2011</LINK>; <LINK REF="STD-Sadeghi-2012" TYPE="STUDY">Sadeghi 2012</LINK>) as having a high risk of bias in only one item each.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2012-08-28 12:43:51 +0100" MODIFIED_BY="[Empty name]">
<P>This review was conducted in accordance with the previously published protocol. We are unaware of any biases in the review process. To minimise bias, the selection, assessment for inclusion eligibility, risk of bias and data extraction were done independently by more than one review author. We also contacted study authors for clarification of study data. None of the review authors have been involved in any of the included studies and none have any commercial or other conflict of interest.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<P>We have found no other systematic review specifically assessing the efficacy of drugs for preventing PDPH. In one systematic review (<LINK REF="REF-Apfel-2010" TYPE="REFERENCE">Apfel 2010</LINK>) analysing any treatment options to prevent PDPH after accidental dural puncture (e.g. prophylactic EBP, epidural morphine, intrathecal catheters, and epidural or intrathecal saline) no strong evidence was found to make a clinical recommendation but, as in this review, epidural morphine was the only drug with proven efficacy, based on a study also included in this review (<LINK REF="STD-Al_x002d_metwalli-2008" TYPE="STUDY">Al-metwalli 2008</LINK>). One narrative review (<LINK REF="REF-Bezov-2010" TYPE="REFERENCE">Bezov 2010</LINK>) about PDPH concluded, as we do, that caffeine was not helpful in preventing PDPH based on a study that we also included (<LINK REF="STD-Esmaoglu-2005" TYPE="STUDY">Esmaoglu 2005</LINK>).</P>
<P>Other Cochrane reviews (<LINK REF="REF-Arevalo_x002d_Rodriguez-2011" TYPE="REFERENCE">Arevalo-Rodriguez 2011</LINK>; <LINK REF="REF-Boonmak-2010" TYPE="REFERENCE">Boonmak 2010</LINK>) have investigated measures other than drugs to prevent PDPH (e.g. posture, fluids and EBP), without reaching strong recommendations. One published guideline (<LINK REF="REF-Verma-2011" TYPE="REFERENCE">Verma 2011</LINK>) only considers the use of smaller gauge (&#8805; 25 G) and pencil-point needles for regional anaesthesia in day-surgery patients.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JRt 140612: This could do with being re-written, also perhaps state what sort of data that's based on ie how many participants/studies? I think the full conclusions need a bit more working on and re-writing to make the data useful and clear to the reader?&lt;/p&gt;&lt;p&gt;XB: modified&lt;/p&gt;" NOTES_MODIFIED="2013-01-28 12:10:15 +0000" NOTES_MODIFIED_BY="[Empty name]">
<P>Available studies show that morphine, cosyntropin and aminophylline could be a first-line drug therapy when trying to prevent post-dural puncture headache (PDPH) after a lumbar puncture.</P>
<P>Epidural morphine and intravenous cosyntropin decreased the number of patients affected by PDPH of any severity after a lumbar puncture compared to placebo, especially in those patients with a high risk of PDPH, such as woman giving birth who have had an inadvertent dural puncture during administration of regional anaesthesia. Pruritus, nausea and vomiting due to morphine and urticaria due to cosyntropin are the adverse events reported but these are less frequent than the benefits, are not severe or life-threatening and, if necessary, efficacious and safe drugs exist to treat them.</P>
<P>Aminophylline also provides the same benefit, reducing the number of participants affected by PDPH of any severity, but in this case when compared to no intervention and in patients undergoing spinal anaesthesia for elective caesarean section.</P>
<P>Dexamethasone increased the risk of PDPH, after spinal anaesthesia for caesarean section, when compared to placebo.</P>
<P>These conclusions should be interpreted with caution, owing to the lack of information to allow a complete appraisal of risk of bias and the small sample sizes of studies.</P>
<P>There is a lack of conclusive results for the other drugs assessed (fentanyl, caffeine, indomethacin and dexamethasone).</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-08-28 12:43:51 +0100" MODIFIED_BY="[Empty name]">
<P>Future research in this field should focus on the design of trials with larger samples (including the reporting of how sample size was determined) in order to provide more sound and accurate information on the effectiveness of drugs in this setting and situation.</P>
<P>The reporting of trials could also be improved by endorsing the CONSORT statement (<LINK REF="REF-Schulz-2010" TYPE="REFERENCE">Schulz 2010</LINK>), which would allow a better appraisal of them for their potential inclusion into systematic reviews.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<P>Xavier Basurto is a PhD student at the Pediatrics, Obstetrics and Gynecology, and Preventive Medicine Department, Universitat Autònoma de Barcelona, Barcelona, Spain.<BR/>We are grateful to Caroline Struthers (former Trials Search Co-ordinator of the Cochrane Pain, Palliative and Supportive Care Review Group) and Jane Hayes for undertaking the searches; to Marta Roqué (Iberoamerican Cochrane Center) for her help in the statistical analysis; to Richard Vanderkleyn for his help in editing the review; and to Cathie Sudlow and Charles Warlow for writing the first draft of the protocol.<BR/>
</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2012-08-28 12:43:51 +0100" MODIFIED_BY="Anne Lawson">
<P>None known.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<P>Conceiving the review (guarantor): Xavier Basurto (XB).</P>
<P>Screening search results: XB, Sonia Uriona (SU).</P>
<P>Screening retrieved papers against inclusion criteria: XB, SU, Laura Martínez (LM), Ivan Solà (IS), Xavier Bonfill Cosp (XBC).</P>
<P>Appraising quality of papers: XB, LM, SU.</P>
<P>Extracting data from papers: XB, LM, SU.</P>
<P>Data management for the review: XB, LM.</P>
<P>Entering data into Review Manager (RevMan 5.1): XB, LM.</P>
<P>Interpretation of data: XB, LM, IS, XBC.</P>
<P>Statistical analysis: XB, LM, IS.</P>
<P>Writing the review: XB, LM, SU, IS.</P>
<P>Comment and editing of review drafts: XB, LM, SU, IS, XBC.</P>
<P>Responsible for reading and checking review before submission: XB, LM, IS, XBC.</P>
<P>Responsible for initiating and running the update of this review: XB.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;JRT 140612: I think the Background text has been revised to be inline with the related review on treatment? State that also if so.&lt;/p&gt;&lt;p&gt;XB: done&lt;/p&gt;" NOTES_MODIFIED="2013-01-28 12:10:15 +0000" NOTES_MODIFIED_BY="[Empty name]">
<UL>
<LI>Types of participants: &#8220;The use of a standardized diagnostic criteria for PDPH was not required, but it should at least be described as orthostatic headache which worsens on standing and improved by lying down.&#8221; The &#8220;it should at least be&#8221; has been added to emphasise the need to include only those studies that have used an orthostatic headache criteria to include participants.</LI>
<LI>PaPaS Review Group Specialised Register electronic search eliminated.</LI>
<LI>CINAHL search strategy included.</LI>
<LI>Background has been adapted with a previous published Cochrane review on treatment drugs for PDPH (<LINK REF="REF-Basurto-2011" TYPE="REFERENCE">Basurto 2011</LINK>).</LI>
</UL>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2016-07-25 11:46:17 +0100" MODIFIED_BY="Anna Erskine">
<P>This protocol was originally published in Issue 1, 2000 by Cathie Sudlow. The review has now been taken over by Xavier Basurto Ona and the title split into one on prevention (this present review) and another on treatment, which is being written alongside this review.</P>
<SUBSECTION>
<HEADING LEVEL="2">Note added July 2016:</HEADING>
<P>A search in July 2015 did not identify any relevant studies likely to change the conclusions. Therefore, this review has now been stabilised following discussion with the authors and editors. If appropriate, we will update the review if new evidence likely to change the conclusions is published, or if standards change substantially which necessitate major revisions.</P>
</SUBSECTION>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-07-25 11:49:30 +0100" MODIFIED_BY="Anna Erskine">
<STUDIES MODIFIED="2013-01-28 12:12:56 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-01-24 12:36:41 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Abboud-1992" MODIFIED="2012-06-14 18:15:57 +0100" MODIFIED_BY="[Empty name]" NAME="Abboud 1992" YEAR="1992">
<REFERENCE MODIFIED="2012-06-14 18:15:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abboud TK, Zhu J, Reyes A</AU>
<TI>Effect of subarachnoid morphine on the incidence of spinal headache</TI>
<SO>Regional Anesthesia</SO>
<YR>1992</YR>
<VL>17</VL>
<NO>1</NO>
<PG>34-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971152"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971151"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Al_x002d_metwalli-2008" MODIFIED="2011-07-12 20:54:23 +0100" MODIFIED_BY="[Empty name]" NAME="Al-metwalli 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-07-12 20:54:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Al-metwalli RR</AU>
<TI>Epidural morphine injections for prevention of post dural puncture headache</TI>
<SO>Anaesthesia</SO>
<YR>2008</YR>
<VL>63</VL>
<NO>8</NO>
<PG>847-50</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971154"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971153"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Devcic-1993" MODIFIED="2012-06-14 18:16:06 +0100" MODIFIED_BY="[Empty name]" NAME="Devcic 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-06-14 18:16:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Devcic A, Sprung J, Patel S, Kettler R, Maitra-D'Cruze A</AU>
<TI>PDPH in obstetric anesthesia: comparison of 24-gauge Sprotte and 25-gauge Quincke needles and effect of subarachnoid administration of fentanyl</TI>
<SO>Regional Anesthesia</SO>
<YR>1993</YR>
<VL>18</VL>
<NO>4</NO>
<PG>222-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971156"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971155"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Doroudian-2011" MODIFIED="2013-01-24 12:08:14 +0000" MODIFIED_BY="[Empty name]" NAME="Doroudian 2011" YEAR="2009">
<REFERENCE MODIFIED="2013-01-24 12:08:14 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Doroudian MR, Norouzi M, Esmailie M, Tanhaeivash R</AU>
<TI>Dexamethasone in preventing post-dural puncture headache: a randomized, double-blind, placebo-controlled trial</TI>
<SO>Acta Neurologica Belgica</SO>
<YR>2011</YR>
<VL>62</VL>
<PG>143-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971158"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971157"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Esmaoglu-2005" MODIFIED="2012-06-14 18:16:25 +0100" MODIFIED_BY="[Empty name]" NAME="Esmaoglu 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-06-14 18:16:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Esmaoglu A, Akpinar H, U&#287;ur F</AU>
<TI>Oral multidose caffeine-paracetamol combination is not effective for the prophylaxis of postdural puncture headache</TI>
<SO>Journal of Clinical Anesthesia</SO>
<YR>2005</YR>
<VL>17</VL>
<NO>1</NO>
<PG>58-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971160"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971159"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flaatten-1987" MODIFIED="2011-07-12 20:27:40 +0100" MODIFIED_BY="[Empty name]" NAME="Flaatten 1987" YEAR="1987">
<REFERENCE MODIFIED="2011-07-12 20:18:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Flaatten H, Rodt S, Rosland J, Vamnes J</AU>
<TI>Postoperative headache in young patients after spinal anaesthesia</TI>
<SO>Anaesthesia</SO>
<YR>1987</YR>
<VL>42</VL>
<NO>2</NO>
<PG>202-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971162"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-07-12 20:27:40 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971161"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hakim-2010" MODIFIED="2012-06-03 20:13:10 +0100" MODIFIED_BY="[Empty name]" NAME="Hakim 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-06-03 20:13:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hakim SM</AU>
<TI>Cosyntropin for prophylaxis against postdural puncture headache after accidental dural puncture</TI>
<SO>Anesthesiology</SO>
<YR>2010</YR>
<VL>113</VL>
<NO>2</NO>
<PG>413-20</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4314500"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971163"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sadeghi-2012" MODIFIED="2012-09-20 22:48:15 +0100" MODIFIED_BY="[Empty name]" NAME="Sadeghi 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-09-20 22:48:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sadeghi SE, Abdollahifard G, Nasabi NA, Mehrabi M, Safarpour AR</AU>
<TI>Effectiveness of single dose intravenous aminophylline administration on prevention of post dural puncture headache in patients who received spinal anesthesia for elective cesarean section</TI>
<SO>World Journal of Medical Sciences</SO>
<YR>2012</YR>
<VL>7</VL>
<NO>1</NO>
<PG>13-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971176"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971175"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Strelec-1994" MODIFIED="2012-09-20 23:31:50 +0100" MODIFIED_BY="[Empty name]" NAME="Strelec 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-09-20 23:31:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Strelec S, Prylinski J, Sakert T, Royal M</AU>
<TI>The efficacy of multi-dose oral caffeine in prevention of post-dural puncture headache</TI>
<SO>Regional Anesthesia</SO>
<YR>1994</YR>
<VL>19</VL>
<NO>2S</NO>
<PG>79</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971178"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971177"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yousefshahi-2012" MODIFIED="2013-01-24 12:36:41 +0000" MODIFIED_BY="[Empty name]" NAME="Yousefshahi 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-01-24 12:36:41 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Yousefshahi F, Dahmardeh AR, Khajavi M, Najafi A, Khashayar P, Barkhordari K</AU>
<TI>Effect of dexamethasone on the frequency of postdural puncture headache after spinal anesthesia for cesarean section: a double-blind randomized clinical trial</TI>
<SO>Acta Neurologica Belgica</SO>
<YR>2012 Apr 20 [Epub ahead of print]</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4314501"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971179"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-01-28 12:12:56 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;YR 28.8.12&lt;/p&gt;&lt;p&gt;&lt;b&gt;[References: Akerman 2004]:&lt;/b&gt; Is this 2004 or 1990 &amp;#8211; I cannot find it on PubMed?&lt;/p&gt;&lt;p&gt;XB: Correct name is Ackerman and published in 1990.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;[References: Excluded studies: Bezarra 1995]:&lt;/b&gt; There is no Bezarra listed in the authors of this reference&lt;/p&gt;&lt;p&gt;XB: Wright. First author is &amp;quot;Nilton Bezarra do Vale&amp;quot;. I've corrected the mistake changing Bezarra for Vale.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;" NOTES_MODIFIED="2013-01-28 12:12:56 +0000" NOTES_MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Ackerman-2004" MODIFIED="2012-09-20 23:31:36 +0100" MODIFIED_BY="[Empty name]" NAME="Ackerman 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-20 23:31:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ackerman WE, Juneja MM, Kaczorowski DM</AU>
<TI>Prophylactic epidural blood patch for the prevention of postdural puncture headache in the parturient</TI>
<SO>Anesthesiology Review</SO>
<YR>1990</YR>
<VL>17</VL>
<NO>2</NO>
<PG>45-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971182"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971181"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Altunkaya-2005" MODIFIED="2012-09-20 23:31:20 +0100" MODIFIED_BY="[Empty name]" NAME="Altunkaya 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-09-20 23:31:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Altunkaya H, Ozer Y, Demirel CB, Ozkocak I, Keser S, Bayar A</AU>
<TI>Preoperative multimodal administration of morphine in arthroscopic surgery</TI>
<SO>Archives of Orthopaedic and Trauma Surgery</SO>
<YR>2005</YR>
<VL>125</VL>
<NO>9</NO>
<PG>609-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971184"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971183"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aziz-1968" MODIFIED="2012-09-20 23:31:04 +0100" MODIFIED_BY="[Empty name]" NAME="Aziz 1968" YEAR="1968">
<REFERENCE MODIFIED="2012-09-20 23:31:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aziz H, Pearce J, Miller E</AU>
<TI>Vasopressin in prevention of lumbar puncture headache</TI>
<SO>British Medical Journal</SO>
<YR>1968</YR>
<VL>4</VL>
<NO>5632</NO>
<PG>677-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971186"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971185"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Balestrieri-2003" MODIFIED="2011-07-12 21:35:27 +0100" MODIFIED_BY="[Empty name]" NAME="Balestrieri 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-07-12 21:35:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Balestrieri PJ</AU>
<TI>The incidence of postdural puncture headache and combined spinal-epidural: some thoughts</TI>
<SO>International Journal of Obstetric Anesthesia</SO>
<YR>2003</YR>
<VL>12</VL>
<NO>4</NO>
<PG>305-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971188"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971187"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beilin-2003" MODIFIED="2011-07-14 10:48:36 +0100" MODIFIED_BY="[Empty name]" NAME="Beilin 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-07-14 10:48:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beilin Y, Zahn J, Abramovitz S, Bernstein H, Hossain S, Bodian C</AU>
<TI>Subarachnoid small-dose bupivacaine versus lidocaine for cervical cerclage</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2003</YR>
<VL>97</VL>
<NO>1</NO>
<PG>56-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971190"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971189"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Breebaart-2003" MODIFIED="2012-09-20 23:30:50 +0100" MODIFIED_BY="[Empty name]" NAME="Breebaart 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-09-20 23:30:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Breebaart MB, Vercauteren MP, Hoffmann VL, Adriaensen HA</AU>
<TI>Urinary bladder scanning after day-case arthroscopy under spinal anaesthesia: comparison between lidocaine, ropivacaine, and levobupivacaine</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2003</YR>
<VL>3</VL>
<PG>309-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971192"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971191"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Caldwell-1994" MODIFIED="2012-09-20 23:30:33 +0100" MODIFIED_BY="[Empty name]" NAME="Caldwell 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-09-20 23:30:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Caldwell LE, Rosen MA, Shnider SM</AU>
<TI>Subarachnoid morphine and fentanyl for labor analgesia. Efficacy and adverse effects</TI>
<SO>Regional Anesthesia</SO>
<YR>1994</YR>
<VL>19</VL>
<NO>1</NO>
<PG>2-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971194"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971193"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Camann-1992" MODIFIED="2011-07-14 11:03:35 +0100" MODIFIED_BY="[Empty name]" NAME="Camann 1992" YEAR="1992">
<REFERENCE MODIFIED="2011-07-14 11:03:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Camann WR, Denney RA, Holby ED, Datta S</AU>
<TI>A comparison of intrathecal, epidural, and intravenous sufentanil for labor analgesia</TI>
<SO>Anesthesiology</SO>
<YR>1992</YR>
<VL>77</VL>
<NO>5</NO>
<PG>884-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971196"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971195"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Camann-1993" MODIFIED="2011-07-14 11:27:14 +0100" MODIFIED_BY="[Empty name]" NAME="Camann 1993" YEAR="1993">
<REFERENCE MODIFIED="2011-07-14 11:27:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Camann WR, Minzter BH, Denney RA, Datta S</AU>
<TI>Intrathecal sufentanil for labor analgesia. Effects of added epinephrine</TI>
<SO>Anesthesiology</SO>
<YR>1993</YR>
<VL>78</VL>
<NO>5</NO>
<PG>870-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971198"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971197"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Campbell-1995" MODIFIED="2012-09-20 23:34:59 +0100" MODIFIED_BY="[Empty name]" NAME="Campbell 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-09-20 23:34:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Campbell DC, Camann WR, Datta S</AU>
<TI>The addition of bupivacaine to intrathecal sufentanil for labor analgesia</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1995</YR>
<VL>81</VL>
<NO>2</NO>
<PG>305-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971200"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971199"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cesur-2009" MODIFIED="2011-07-14 11:32:55 +0100" MODIFIED_BY="[Empty name]" NAME="Cesur 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-07-14 11:32:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cesur M, Alici HA, Erdem AF, Silbir F, Celik M</AU>
<TI>Decreased incidence of headache after unintentional dural puncture in patients with cesarean delivery administered with postoperative epidural analgesia</TI>
<SO>Journal of Anesthesia</SO>
<YR>2009</YR>
<VL>23</VL>
<NO>1</NO>
<PG>31-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971202"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971201"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chalmers-1988" MODIFIED="2012-08-22 19:15:43 +0100" MODIFIED_BY="[Empty name]" NAME="Chalmers 1988" YEAR="1988">
<REFERENCE MODIFIED="2012-08-22 19:15:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chalmers PC, Lang CM, Harte FA, Greenhouse BB</AU>
<TI>Double-blind comparison of intravenous nalbuphine and placebo in the amelioration of side-effects of epidural narcotics</TI>
<SO>Pain Clinic</SO>
<YR>1988</YR>
<VL>2</VL>
<NO>1</NO>
<PG>49-56</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971204"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971203"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chilvers-1997" MODIFIED="2012-09-20 23:34:47 +0100" MODIFIED_BY="[Empty name]" NAME="Chilvers 1997" YEAR="1997">
<REFERENCE MODIFIED="2012-09-20 23:34:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chilvers CR, Vaghadia H, Mitchell GW, Merrick PM</AU>
<TI>Small-dose hypobaric lidocaine-fentanyl spinal anesthesia for short duration outpatient laparoscopy. II. Optimal fentanyl dose</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1997</YR>
<VL>84</VL>
<NO>1</NO>
<PG>65-70</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971206"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971205"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cho-2008" MODIFIED="2012-09-20 23:30:18 +0100" MODIFIED_BY="[Empty name]" NAME="Cho 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-09-20 23:30:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cho JE, Kim JY, Kim JE, Chun DH, Jun NH, Kil HK</AU>
<TI>Epidural sufentanil provides better analgesia from 24 h after surgery compared with epidural fentanyl in children</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>2008</YR>
<VL>52</VL>
<NO>10</NO>
<PG>1360-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971208"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971207"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clarke-2009" MODIFIED="2012-09-20 23:30:03 +0100" MODIFIED_BY="[Empty name]" NAME="Clarke 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-09-20 23:30:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clarke H, Pereira S, Kennedy D, Gilron I, Katz J, Gollish J, et al</AU>
<TI>Gabapentin decreases morphine consumption and improves functional recovery following total knee arthroplasty</TI>
<SO>Pain Research and Management</SO>
<YR>2009</YR>
<VL>14</VL>
<NO>3</NO>
<PG>217-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971210"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971209"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Colonna_x002d_Romano-1989" MODIFIED="2012-09-20 23:29:49 +0100" MODIFIED_BY="[Empty name]" NAME="Colonna-Romano 1989" YEAR="1989">
<REFERENCE MODIFIED="2012-09-20 23:29:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Colonna-Romano P, Shapiro BE</AU>
<TI>Unintentional dural puncture and prophylactic epidural blood patch in obstetrics</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1989</YR>
<VL>69</VL>
<PG>522-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971212"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971211"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cowan-1980" MODIFIED="2012-09-20 23:29:35 +0100" MODIFIED_BY="[Empty name]" NAME="Cowan 1980" YEAR="1980">
<REFERENCE MODIFIED="2012-09-20 23:29:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cowan JM, Durward WF, Harrington H, Johnston JH, Donovan B</AU>
<TI>DDAVP in the prevention of headache after lumbar puncture</TI>
<SO>British Medical Journal</SO>
<YR>1980</YR>
<VL>280</VL>
<NO>6209</NO>
<PG>224</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971214"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971213"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-D_x0027_Angelo-1994" MODIFIED="2011-07-14 12:25:01 +0100" MODIFIED_BY="[Empty name]" NAME="D'Angelo 1994" YEAR="1994">
<REFERENCE MODIFIED="2011-07-14 12:24:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>D'Angelo R, Anderson MT, Philip J, Eisenach JC</AU>
<TI>Intrathecal sufentanil compared to epidural bupivacaine for labor analgesia</TI>
<SO>Anesthesiology</SO>
<YR>1994</YR>
<VL>80</VL>
<NO>6</NO>
<PG>1209-15</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971216"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971215"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Danelli-2004" MODIFIED="2012-09-20 23:29:23 +0100" MODIFIED_BY="[Empty name]" NAME="Danelli 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-20 23:29:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Danelli G, Fanelli G, Berti M, Cornini A, Lacava L, Nuzzi M, et al</AU>
<TI>Spinal ropivacaine or bupivacaine for cesarean delivery: a prospective, randomized, double-blind comparison</TI>
<SO>Regional Anesthesia and Pain Medicine</SO>
<YR>2004</YR>
<VL>29</VL>
<NO>3</NO>
<PG>221-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971218"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971217"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dayioglu-2009" MODIFIED="2011-07-14 12:59:31 +0100" MODIFIED_BY="[Empty name]" NAME="Dayioglu 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-07-14 12:59:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dayioglu H, Baykara ZN, Salbes A, Solak M, Toker K</AU>
<TI>Effects of adding magnesium to bupivacaine and fentanyl for spinal anesthesia in knee arthroscopy</TI>
<SO>Journal of Anesthesia</SO>
<YR>2009</YR>
<VL>23</VL>
<NO>1</NO>
<PG>19-25</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971220"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971219"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Delfino-2001" MODIFIED="2012-06-14 18:24:08 +0100" MODIFIED_BY="[Empty name]" NAME="Delfino 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-06-14 18:24:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Delfino J, Do Vale NB</AU>
<TI>Spinal anesthesia with 0.5% isobaric ropivacaine or levobupivacaine for lower limb surgeries</TI>
<SO>Revista Brasileira de Anestesiologia</SO>
<YR>2001</YR>
<VL>51</VL>
<NO>2</NO>
<PG>91-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971222"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971221"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Pietri-2006" MODIFIED="2012-09-20 23:29:07 +0100" MODIFIED_BY="[Empty name]" NAME="De Pietri 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-09-20 23:29:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Pietri L, Siniscalchi A, Reggiani A, Masetti M, Begliomini B, Gazzi M, et al</AU>
<TI>The use of intrathecal morphine for postoperative pain relief after liver resection: a comparison with epidural analgesia</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2006</YR>
<VL>102</VL>
<NO>4</NO>
<PG>1157-63</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971224"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971223"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dijkstra-2008" MODIFIED="2012-06-14 18:24:43 +0100" MODIFIED_BY="[Empty name]" NAME="Dijkstra 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-06-14 18:24:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dijkstra T, Reesink JA, Verdouw BC, Van der Pol WS, Feberwee T, Vulto AG</AU>
<TI>Spinal anaesthesia with articaine 5% vs bupivacaine 0.5% for day-case lower limb surgery: a double-blind randomized clinical trial</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2008</YR>
<VL>100</VL>
<NO>1</NO>
<PG>104-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971226"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971225"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dilli-2008" MODIFIED="2012-09-20 23:28:55 +0100" MODIFIED_BY="[Empty name]" NAME="Dilli 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-09-20 23:28:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dilli D, Dallar Y, Sorgui NH</AU>
<TI>Intravenous ketamine plus midazolam vs. intravenous ketamine for sedation in lumbar puncture: a randomized controlled trial</TI>
<SO>Indian Pediatrics</SO>
<YR>2008</YR>
<VL>45</VL>
<NO>11</NO>
<PG>899-904</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971228"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971227"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dominguez_x002d_Hervella-1993" MODIFIED="2012-09-20 23:28:41 +0100" MODIFIED_BY="[Empty name]" NAME="Dominguez-Hervella 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-09-20 23:28:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Domínguez-Hervella FD, Rey MS, Guede GR, Martín V, Martínez J, Castro A</AU>
<TI>Combined subarachnoid and epidural block with a single injection, with a modified Tuohy needle and used in hip surgery</TI>
<SO>Revista Española de Anestesiología y Reanimación</SO>
<YR>1993</YR>
<VL>40</VL>
<NO>5</NO>
<PG>279-83</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971230"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971229"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Edstr_x00f6_m-1986" MODIFIED="2012-09-20 23:28:30 +0100" MODIFIED_BY="[Empty name]" NAME="Edström 1986" YEAR="1986">
<REFERENCE MODIFIED="2012-09-20 23:28:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edström HH, Blitt CD, Draper EM, Manny BT, Hameroff SR</AU>
<TI>Hypotension in spinal anesthesia: a comparison of tetracaine and bupivacaine</TI>
<SO>Regional Anesthesia and Pain Medicine</SO>
<YR>1986</YR>
<VL>11</VL>
<PG>139-42</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971232"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971231"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Elkhodair-2010" MODIFIED="2012-09-20 23:28:17 +0100" MODIFIED_BY="[Empty name]" NAME="Elkhodair 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-09-20 23:28:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Elkhodair S</AU>
<TI>Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Bet 1. Caffeine in the prophylaxis of postlumbar puncture headache</TI>
<SO>Emergency Medicine Journal</SO>
<YR>2010</YR>
<VL>27</VL>
<NO>6</NO>
<PG>476-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971234"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971233"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fogarty-1993" MODIFIED="2012-09-20 23:28:06 +0100" MODIFIED_BY="[Empty name]" NAME="Fogarty 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-09-20 23:28:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fogarty DJ, Carabine UA, Milligan KR</AU>
<TI>Comparison of the analgesic effects of intrathecal clonidine and intrathecal morphine after spinal anaesthesia in patients undergoing total hip replacement</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1993</YR>
<VL>71</VL>
<NO>5</NO>
<PG>661-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971236"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971235"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fogarty-1995" MODIFIED="2012-09-20 23:27:49 +0100" MODIFIED_BY="[Empty name]" NAME="Fogarty 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-09-20 23:27:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fogarty DJ, O'Hanlon JJ, Milligan KR</AU>
<TI>Intramuscular ketorolac following total hip replacement with spinal anaesthesia and intrathecal morphine</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1995</YR>
<VL>39</VL>
<NO>2</NO>
<PG>191-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971238"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971237"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-F_x00f6_rster-2006" MODIFIED="2011-07-16 13:17:43 +0100" MODIFIED_BY="[Empty name]" NAME="Förster 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-07-16 13:17:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Förster JG, Rosenberg PH, Niemi TT</AU>
<TI>Continuous spinal microcatheter (28 gauge) technique for arterial bypass surgery of the lower extremities and comparison of ropivacaine with or without morphine for postoperative analgesia</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1996</YR>
<VL>97</VL>
<NO>3</NO>
<PG>393&#8211;400</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971240"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971239"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frey-1998" MODIFIED="2012-09-20 23:27:38 +0100" MODIFIED_BY="[Empty name]" NAME="Frey 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-09-20 23:27:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frey K, Holman S, Mikat-Stevens M, Vazquez J, White L, Pedicini E, et al</AU>
<TI>The recovery profile of hyperbaric spinal anesthesia with lidocaine, tetracaine, and bupivacaine</TI>
<SO>Regional Anesthesia and Pain Medicine</SO>
<YR>1998</YR>
<VL>23</VL>
<NO>2</NO>
<PG>159-63</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971242"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971241"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frizelle-1997" MODIFIED="2012-09-20 23:27:19 +0100" MODIFIED_BY="[Empty name]" NAME="Frizelle 1997" YEAR="1997">
<REFERENCE MODIFIED="2012-09-20 23:27:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frizelle HP, Duranteau J, Samii K</AU>
<TI>A comparison of propofol with a propofol-ketamine combination for sedation during spinal anesthesia</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1997</YR>
<VL>84</VL>
<NO>6</NO>
<PG>1318-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971244"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971243"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fu-2008" MODIFIED="2012-09-20 23:27:06 +0100" MODIFIED_BY="[Empty name]" NAME="Fu 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-09-20 23:27:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fu RQ, Tian YK, Fang WR</AU>
<TI>Combined spinal and epidural anaesthesia with chloroprocaine for hysterectomy</TI>
<SO>Clinical and Experimental Pharmacology &amp; Physiology</SO>
<YR>2008</YR>
<VL>35</VL>
<NO>1</NO>
<PG>60-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971246"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971245"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fujii-1998" MODIFIED="2012-09-20 23:26:52 +0100" MODIFIED_BY="[Empty name]" NAME="Fujii 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-09-20 23:26:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fujii Y, Tanaka H, Toyooka H</AU>
<TI>Prevention of nausea and vomiting with granisetron, droperidol and metoclopramide during and after spinal anaesthesia for caesarean section: a randomized, double-blind, placebo-controlled trial</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1998</YR>
<VL>42</VL>
<NO>8</NO>
<PG>921-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971248"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971247"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gangopadhyay-2010" MODIFIED="2011-07-16 13:28:51 +0100" MODIFIED_BY="[Empty name]" NAME="Gangopadhyay 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-07-16 13:28:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gangopadhyay S, Gupta K, Acharjee S, Nayak SK, Dawn S, Piplai G</AU>
<TI>Ketamine, tramadol and pethidine in prophylaxis of shivering during spinal anaesthesia</TI>
<SO>Journal of Anaesthesiology Clinical Pharmacology</SO>
<YR>2010</YR>
<VL>26</VL>
<NO>1</NO>
<PG>59-63</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971250"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971249"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ganzi-1995" MODIFIED="2012-09-20 23:26:34 +0100" MODIFIED_BY="[Empty name]" NAME="Ganzi 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-09-20 23:26:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ganzi F, Ganzi L, Sabo D, Mandell G, Ramanathan S, Patel R</AU>
<TI>Incidence of spinal headache after spinal anesthesia: a prospective randomized study</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1995</YR>
<VL>80</VL>
<PG>S143</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971252"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971251"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garg-2010" MODIFIED="2012-09-20 23:26:19 +0100" MODIFIED_BY="[Empty name]" NAME="Garg 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-09-20 23:26:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garg A, Ahmed F, Khandelwal M, Chawla V, Verma AP</AU>
<TI>The effect of transdermal nitroglycerine on intrathecal fentanyl with bupivacaine for postoperative analgesia following gynaecological surgery</TI>
<SO>Anaesthesia and Intensive Care</SO>
<YR>2010</YR>
<VL>38</VL>
<NO>2</NO>
<PG>285-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971254"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971253"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gielen-1986" MODIFIED="2012-09-20 23:26:00 +0100" MODIFIED_BY="[Empty name]" NAME="Gielen 1986" YEAR="1986">
<REFERENCE MODIFIED="2012-09-20 23:26:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gielen M, Huho J, DeGrood PM, Edström HH</AU>
<TI>A double-blind evaluation of hyperbaric solutions of bupivacaine 0.5% and lidocaine 5% in spinal anesthesia</TI>
<SO>Regional Anesthesia</SO>
<YR>1986</YR>
<VL>11</VL>
<PG>176-81</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971256"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971255"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ginsberg-1996" MODIFIED="2012-09-20 23:25:46 +0100" MODIFIED_BY="[Empty name]" NAME="Ginsberg 1996" YEAR="1996">
<REFERENCE MODIFIED="2012-09-20 23:25:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ginsberg L, Caine SE, Valentine AR</AU>
<TI>Corticosteroids and the prevention of adverse reactions to myelography</TI>
<SO>British Journal of Neurosurgery</SO>
<YR>1996</YR>
<VL>10</VL>
<NO>3</NO>
<PG>285-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971258"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971257"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Girgin-2008" MODIFIED="2012-09-20 23:25:34 +0100" MODIFIED_BY="[Empty name]" NAME="Girgin 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-09-20 23:25:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Girgin NK, Gurbet A, Turker G, Bulut T, Demir S, Kilic N, et al</AU>
<TI>The combination of low-dose levobupivacaine and fentanyl for spinal anaesthesia in ambulatory inguinal herniorrhaphy</TI>
<SO>Journal of International Medical Research</SO>
<YR>2008</YR>
<VL>36</VL>
<NO>6</NO>
<PG>1287-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971260"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971259"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gogarten-2004" MODIFIED="2012-06-14 18:26:21 +0100" MODIFIED_BY="[Empty name]" NAME="Gogarten 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-06-14 18:26:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gogarten W, Van de Velde M, Soetens F, Van Aken H, Brodner G, Gramke HF, et al</AU>
<TI>A multicentre trial comparing different concentrations of ropivacaine plus sufentanil with bupivacaine plus sufentanil for patient-controlled epidural analgesia in labour</TI>
<SO>European Journal of Anaesthesiology</SO>
<YR>2004</YR>
<VL>21</VL>
<NO>1</NO>
<PG>38-45</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971262"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971261"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gurbet-2008" MODIFIED="2012-09-20 23:25:20 +0100" MODIFIED_BY="[Empty name]" NAME="Gurbet 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-09-20 23:25:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gurbet A, Turker G, Girgin NK, Aksu H, Bahtiyar NH</AU>
<TI>Combination of ultra-low dose bupivacaine and fentanyl for spinal anaesthesia in out-patient anorectal surgery</TI>
<SO>Journal of International Medical Research</SO>
<YR>2008</YR>
<VL>365</VL>
<PG>964-70</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971264"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971263"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hansen-1979" MODIFIED="2012-09-20 23:25:05 +0100" MODIFIED_BY="[Empty name]" NAME="Hansen 1979" YEAR="1979">
<REFERENCE MODIFIED="2012-09-20 23:25:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hansen PE, Hansen JH</AU>
<TI>DDAVP, a synthetic analogue of vasopressin, in prevention of headache after lumbar puncture and lumbar pneumoencephalography</TI>
<SO>Acta Neurologica Scandinavica</SO>
<YR>1979</YR>
<VL>60</VL>
<NO>3</NO>
<PG>183-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971266"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971265"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hansen-1980" MODIFIED="2012-09-20 23:24:54 +0100" MODIFIED_BY="[Empty name]" NAME="Hansen 1980" YEAR="1980">
<REFERENCE MODIFIED="2012-09-20 23:24:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hansen PE, Hansen JH</AU>
<TI>Desmopressin (DDAVP) in lumbar puncture</TI>
<SO>British Medical Journal</SO>
<YR>1980</YR>
<VL>280</VL>
<NO>6223</NO>
<PG>1146</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971268"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971267"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harsten-1997" MODIFIED="2012-09-20 23:24:41 +0100" MODIFIED_BY="[Empty name]" NAME="Harsten 1997" YEAR="1997">
<REFERENCE MODIFIED="2012-09-20 23:24:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harsten A, Gillberg L, Håkansson L, Olsson M</AU>
<TI>Intrathecal sufentanil compared with epidural bupivacaine analgesia in labour</TI>
<SO>European Journal of Anaesthesiology</SO>
<YR>1997</YR>
<VL>14</VL>
<NO>6</NO>
<PG>642-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971270"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971269"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hein-2010" MODIFIED="2012-09-20 23:24:30 +0100" MODIFIED_BY="[Empty name]" NAME="Hein 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-09-20 23:24:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hein A, Rosblad P, Norman M, Ryniak S, Tingaker B, Jakobsson J, et al</AU>
<TI>Addition of low-dose morphine to intrathecal bupivacaine/sufentanil labour analgesia: a randomised controlled study</TI>
<SO>International Journal of Obstetric Anesthesia</SO>
<YR>2010</YR>
<VL>19</VL>
<NO>4</NO>
<PG>384-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971272"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971271"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hendriks-2009" MODIFIED="2012-09-20 23:24:19 +0100" MODIFIED_BY="[Empty name]" NAME="Hendriks 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-09-20 23:24:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hendriks MP, De Weert CJM, Snoeck MMJ, Hu HP, Pluim MAL, Gielen MJM</AU>
<TI>Plain articaine or prilocaine for spinal anaesthesia in day-case knee arthroscopy: a double-blind randomized trial</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2009</YR>
<VL>102</VL>
<NO>2</NO>
<PG>259-63</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971274"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971273"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ilioff-1990" MODIFIED="2012-09-20 23:24:07 +0100" MODIFIED_BY="[Empty name]" NAME="Ilioff 1990" YEAR="1990">
<REFERENCE MODIFIED="2012-09-20 23:24:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ilioff G, Strelec SR, Rothfus W, Teeple E</AU>
<TI>Does prophylactic intramuscular caffeine sodium benzoate decrease incidence of post dural puncture headache</TI>
<SO>Regional Anesthesia</SO>
<YR>1990</YR>
<VL>15</VL>
<NO>1S</NO>
<PG>65</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971276"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971275"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Imbelloni-2003" MODIFIED="2012-09-20 23:23:40 +0100" MODIFIED_BY="[Empty name]" NAME="Imbelloni 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-09-20 23:23:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Imbelloni LE, Vieira EM, Rocha A, Gouveia MA, Cordeiro JA</AU>
<TI>Spinal anesthesia for cesarean section with 0.5% isobaric bupivacaine plus fentanyl and morphine. Prospective study with different volumes</TI>
<SO>Revista Brasileira de Anestesiologia</SO>
<YR>2003</YR>
<VL>53</VL>
<NO>3</NO>
<PG>322-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971278"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971277"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Imbelloni-2009" MODIFIED="2012-09-20 23:23:26 +0100" MODIFIED_BY="[Empty name]" NAME="Imbelloni 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-09-20 23:23:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Imbelloni LE, Gouveia MA, Vieira EM, Cordeiro JA</AU>
<TI>A randomised, double-blind comparison of three different volumes of hypobaric intrathecal bupivacaine for orthopaedic surgery</TI>
<SO>Anaesthesia and Intensive Care</SO>
<YR>2009</YR>
<VL>37</VL>
<NO>2</NO>
<PG>242-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971280"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971279"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Imbelloni-2010" MODIFIED="2012-09-20 23:23:50 +0100" MODIFIED_BY="[Empty name]" NAME="Imbelloni 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-09-20 23:23:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Imbelloni LE, Gouveia MA, Cordeiro JA</AU>
<TI>Hypobaric 0.15% bupivacaine versus hypobaric 0.6% lidocaine for posterior spinal anesthesia in outpatient anorectal surgery</TI>
<SO>Revista Brasileira de Anestesiologia</SO>
<YR>2010</YR>
<VL>60</VL>
<NO>2</NO>
<PG>113-20</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971282"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971281"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jacobsohn-2005" MODIFIED="2012-06-14 18:26:55 +0100" MODIFIED_BY="[Empty name]" NAME="Jacobsohn 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-06-14 18:26:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jacobsohn E, Lee TWR, Amadeo RJ, Syslak PH, Debrouwere RG, Bell D, et al</AU>
<TI>Low-dose intrathecal morphine does not delay early extubation after cardiac surgery</TI>
<SO>Canadian Journal of Anesthesia</SO>
<YR>2005</YR>
<VL>52</VL>
<NO>8</NO>
<PG>848-57</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971284"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971283"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kallio-2004" MODIFIED="2012-06-14 18:27:04 +0100" MODIFIED_BY="[Empty name]" NAME="Kallio 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-06-14 18:27:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kallio H, Snall EVT, Kero MP, Rosenberg PH</AU>
<TI>A comparison of intrathecal plain solutions containing ropivacaine 20 or 15 mg versus bupivacaine 10 mg</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2004</YR>
<VL>99</VL>
<NO>3</NO>
<PG>713-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971286"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971285"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kallio-2005" MODIFIED="2012-09-20 23:23:11 +0100" MODIFIED_BY="[Empty name]" NAME="Kallio 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-09-20 23:23:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kallio H, Snall EVT, Suvanto SJ, Tuomas CA, Iivonen MK, Pokki JP, et al</AU>
<TI>Spinal hyperbaric ropivacaine-fentanyl for day-surgery</TI>
<SO>Regional Anesthesia and Pain Medicine</SO>
<YR>2005</YR>
<VL>30</VL>
<NO>1</NO>
<PG>48-54</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971288"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971287"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kaukinen-1981" MODIFIED="2012-09-20 23:22:53 +0100" MODIFIED_BY="[Empty name]" NAME="Kaukinen 1981" YEAR="1981">
<REFERENCE MODIFIED="2012-09-20 23:22:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kaukinen S, Kaukinen L, Kannisto K, Kataja M</AU>
<TI>The prevention of headache following spinal anaesthesia</TI>
<SO>Annales Chirurgiae et Gynaecologiae</SO>
<YR>1981</YR>
<VL>70</VL>
<NO>3</NO>
<PG>107-11</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971290"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971289"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kouri-2004" MODIFIED="2012-09-20 23:22:41 +0100" MODIFIED_BY="[Empty name]" NAME="Kouri 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-20 23:22:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kouri ME, Kopacz DJ</AU>
<TI>Spinal 2-chloroprocaine: a comparison with lidocaine in volunteers</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2004</YR>
<VL>98</VL>
<NO>1</NO>
<PG>75-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971292"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971291"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lanz-1982" MODIFIED="2013-01-28 12:12:56 +0000" MODIFIED_BY="[Empty name]" NAME="Lanz 1982" YEAR="1982">
<REFERENCE MODIFIED="2013-01-28 12:12:56 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lanz, E, Theiss D, Riess W, Sommer U</AU>
<TI>Epidural morphine for postoperative analgesia: a double-blind study</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1982</YR>
<VL>61</VL>
<NO>3</NO>
<PG>236-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971294"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971293"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lauretti-1999" MODIFIED="2012-06-14 18:27:15 +0100" MODIFIED_BY="[Empty name]" NAME="Lauretti 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-06-14 18:27:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lauretti GR, de Oliveira R, Reis MP, Mattos AL, Pereira NL</AU>
<TI>Transdermal nitroglycerine enhances spinal sufentanil postoperative analgesia following orthopedic surgery</TI>
<SO>Anesthesiology</SO>
<YR>1999</YR>
<VL>90</VL>
<NO>3</NO>
<PG>734-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971296"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971295"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lauretti-1999b" MODIFIED="2012-09-20 23:22:29 +0100" MODIFIED_BY="[Empty name]" NAME="Lauretti 1999b" YEAR="1999">
<REFERENCE MODIFIED="2012-09-20 23:22:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lauretti GR, de Oliveira R, Julião MCC, Reis MP, Paccola CAJ</AU>
<TI>Postoperative analgesia by intra-articular and epidural neostigmine following knee surgery</TI>
<SO>Regional Anesthesia and Pain Medicine</SO>
<YR>1999</YR>
<VL>24</VL>
<NO>3</NO>
<PG>17</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971298"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971297"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lauretti-2000" MODIFIED="2012-06-14 18:27:22 +0100" MODIFIED_BY="[Empty name]" NAME="Lauretti 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-06-14 18:27:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lauretti GR, de Oliveira R, Perez MV, Paccola CAJ</AU>
<TI>Postoperative analgesia by intraarticular and epidural neostigmine following knee surgery</TI>
<SO>Journal of Clinical Anesthesia</SO>
<YR>2000</YR>
<VL>12</VL>
<NO>6</NO>
<PG>444-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971300"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971299"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lauretti-2000b" MODIFIED="2011-08-01 17:20:08 +0100" MODIFIED_BY="[Empty name]" NAME="Lauretti 2000b" YEAR="2000">
<REFERENCE MODIFIED="2011-08-01 17:20:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lauretti GR, Oliveira AP, Julião MC, Reis MP, Pereira NL</AU>
<TI>Transdermal nitroglycerine enhances spinal neostigmine postoperative analgesia following gynecological surgery</TI>
<SO>Anesthesiology</SO>
<YR>2000</YR>
<VL>93</VL>
<NO>4</NO>
<PG>943-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971302"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971301"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2005" MODIFIED="2012-09-20 23:22:18 +0100" MODIFIED_BY="[Empty name]" NAME="Lee 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-09-20 23:22:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee YY, Ngan Kee WD, Muchhal K, Chan CK</AU>
<TI>Randomized double-blind comparison of ropivacaine-fentanyl and bupivacaine-fentanyl for spinal anaesthesia for urological surgery</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>2005</YR>
<VL>49</VL>
<NO>10</NO>
<PG>1477-82</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971304"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971303"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lewis-1992" MODIFIED="2012-09-20 23:22:03 +0100" MODIFIED_BY="[Empty name]" NAME="Lewis 1992" YEAR="1992">
<REFERENCE MODIFIED="2012-09-20 23:22:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lewis RP, Spiers SP, McLaren IM, Hunt PC, Smith HS</AU>
<TI>Pethidine as a spinal anaesthetic agent - a comparison with plain bupivacaine in patients undergoing transurethral resection of the prostate</TI>
<SO>European Journal of Anaesthesiology</SO>
<YR>1992</YR>
<VL>9</VL>
<NO>2</NO>
<PG>105-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971306"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971305"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lierz-2004" MODIFIED="2012-06-14 18:27:33 +0100" MODIFIED_BY="[Empty name]" NAME="Lierz 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-06-14 18:27:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lierz P, Gustorff B, Markow G, Felleiter P</AU>
<TI>Comparison between bupivacaine 0.125% and ropivacaine 0.2% for epidural administration to outpatients with chronic low back pain</TI>
<SO>European Journal of Anaesthesiology</SO>
<YR>2004</YR>
<VL>21</VL>
<PG>32-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971308"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971307"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-L_x00f3_pez_x002d_Soriano-2002" MODIFIED="2012-09-20 23:21:40 +0100" MODIFIED_BY="[Empty name]" NAME="López-Soriano 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-09-20 23:21:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>López-Soriano F, Lajarín B, Rivas F, Verdú JM, López-Robles J</AU>
<TI>Hyperbaric subarachnoid ropivacaine in ambulatory surgery: comparative study with hyperbaric bupivacaine</TI>
<SO>Revista Española de Anestesiología y Reanimación</SO>
<YR>2002</YR>
<VL>49</VL>
<PG>71-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971310"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971309"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luck-2008" MODIFIED="2011-07-18 19:15:58 +0100" MODIFIED_BY="[Empty name]" NAME="Luck 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-07-18 19:15:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Luck JF, Fettes PDW, Wildsmith JAW</AU>
<TI>Spinal anaesthesia for elective surgery: a comparison of hyperbaric solutions of racemic bupivacaine, levobupivacaine, and ropivacaine</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2008</YR>
<VL>101</VL>
<NO>5</NO>
<PG>705-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971312"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971311"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Manaa-2005" MODIFIED="2012-09-20 23:21:30 +0100" MODIFIED_BY="[Empty name]" NAME="Manaa 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-09-20 23:21:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Manaa EM, El-Faroug O</AU>
<TI>Comparative study between intrathecal low-dose bupivacaine versus lidocaine for anorectal surgery</TI>
<SO>Egyptian Journal of Anaesthesia</SO>
<YR>2005</YR>
<VL>21</VL>
<PG>75-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971314"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971313"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martlew-2009" MODIFIED="2011-07-19 08:04:04 +0100" MODIFIED_BY="[Empty name]" NAME="Martlew 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-07-19 08:03:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martlew RA</AU>
<TI>Spinal opioids and the prevention of postdural puncture headache</TI>
<SO>Anaesthesia</SO>
<YR>2009</YR>
<VL>64</VL>
<PG>97</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971316"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971315"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Massou-2008" MODIFIED="2011-09-19 20:11:25 +0100" MODIFIED_BY="[Empty name]" NAME="Massou 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-09-19 20:11:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Massou S, Drissi M, Hatim G, Ibat D, Drissi Kamili N, Atmani M</AU>
<TI>Does propofol have effect on postdural puncture headache?</TI>
<SO>Annales Francaises d Anesthesie et de Reanimation</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>10</NO>
<PG>861-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971318"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971317"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meininger-2003" MODIFIED="2012-09-20 23:20:57 +0100" MODIFIED_BY="[Empty name]" NAME="Meininger 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-09-20 23:20:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meininger D, Byhahn C, Kessler P, Nordmeyer J, Alparslan Y, Hall BA, et al</AU>
<TI>Intrathecal fentanyl, sufentanil, or placebo combined with hyperbaric mepivacaine 2% for parturients undergoing elective cesarean delivery</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2003</YR>
<VL>96</VL>
<PG>852&#8211;8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971320"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971319"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Michalek_x002d_Sauberer-2008" MODIFIED="2012-09-20 23:20:43 +0100" MODIFIED_BY="[Empty name]" NAME="Michalek-Sauberer 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-09-20 23:20:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Michalek-Sauberer A, Kozek-Langenecker SA, Heinzl H, Deusch E, Chiari A</AU>
<TI>Median effective local anesthetic doses of plain bupivacaine and ropivacaine for spinal anesthesia administered via a spinal catheter for brachytherapy of the lower abdomen</TI>
<SO>Regional Anesthesia and Pain Medicine</SO>
<YR>2008</YR>
<VL>33</VL>
<NO>1</NO>
<PG>4-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971322"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971321"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morrison-1994" MODIFIED="2012-09-20 23:20:32 +0100" MODIFIED_BY="[Empty name]" NAME="Morrison 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-09-20 23:20:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morrison LM, Emanuelsson BM, McClure JH, Pollok AJ, McKeown DW, Brockway M, et al</AU>
<TI>Efficacy and kinetics of extradural ropivacaine: comparison with bupivacaine</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1994</YR>
<VL>72</VL>
<NO>2</NO>
<PG>164-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971324"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971323"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mosavy-1975" MODIFIED="2011-07-19 08:17:34 +0100" MODIFIED_BY="[Empty name]" NAME="Mosavy 1975" YEAR="1975">
<REFERENCE MODIFIED="2011-07-19 08:17:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mosavy SH, Shafei M</AU>
<TI>Prevention of headache consequent upon dural puncture in obstetric patient</TI>
<SO>Anaesthesia</SO>
<YR>1975</YR>
<VL>30</VL>
<NO>6</NO>
<PG>807-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971326"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971325"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Murto-1999" MODIFIED="2012-09-20 23:21:12 +0100" MODIFIED_BY="[Empty name]" NAME="Murto 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-09-20 23:21:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Murto K, Lui ACP, Cicutti N</AU>
<TI>Adding low dose meperidine to spinal lidocaine prolongs postoperative analgesia</TI>
<SO>Canadian Journal of Anaesthesia</SO>
<YR>1999</YR>
<VL>46</VL>
<NO>4</NO>
<PG>327-34</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971328"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971327"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-M_x00f8_ller-1984" MODIFIED="2012-09-20 23:20:14 +0100" MODIFIED_BY="[Empty name]" NAME="Møller 1984" YEAR="1984">
<REFERENCE MODIFIED="2012-09-20 23:20:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Møller IW, Fernandes A, Edström HH</AU>
<TI>Subarachnoid anaesthesia with 0.5% bupivacaine: effects of density</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1984</YR>
<VL>56</VL>
<NO>11</NO>
<PG>1191-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971330"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971329"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Neilson-2008" MODIFIED="2013-01-28 12:12:28 +0000" MODIFIED_BY="[Empty name]" NAME="Neilson 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-01-28 12:12:28 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Neilson G, Lennox P, Vaghadia H</AU>
<TI>Selective spinal anesthesia: a comparison of 2-chloroprocaine with lidocaine for ambulatory TUPR surgery</TI>
<SO>Canadian Journal of Anaesthesia</SO>
<YR>2008</YR>
<VL>55</VL>
<NO>S1</NO>
<PG>4752021-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971332"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971331"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ogun-2003" MODIFIED="2012-09-20 23:19:47 +0100" MODIFIED_BY="[Empty name]" NAME="Ogun 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-09-20 23:19:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ogun CO, Kirgiz EN, Duman A, Okesli S, Akyurek C</AU>
<TI>Comparison of intrathecal isobaric bupivacaine-morphine and ropivacaine-morphine for Caesarean delivery</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2003</YR>
<VL>90</VL>
<NO>5</NO>
<PG>659-64</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971334"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971333"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Paech-1993" MODIFIED="2012-09-20 23:19:33 +0100" MODIFIED_BY="[Empty name]" NAME="Paech 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-09-20 23:19:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Paech MJ</AU>
<TI>The influence of adrenaline on postoperative analgesia after subarachnoid morphine</TI>
<SO>Anaesthesia and Intensive Care</SO>
<YR>1993</YR>
<VL>21</VL>
<NO>1</NO>
<PG>79-84</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971336"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971335"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Palahniuk-1979" MODIFIED="2012-09-20 23:19:20 +0100" MODIFIED_BY="[Empty name]" NAME="Palahniuk 1979" YEAR="1979">
<REFERENCE MODIFIED="2012-09-20 23:19:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Palahniuk R, Cumming M</AU>
<TI>Prophylactic blood patch does not prevent post lumbar puncture headache</TI>
<SO>Canadian Journal of Anesthesia</SO>
<YR>1979</YR>
<VL>26</VL>
<NO>2</NO>
<PG>132-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971338"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971337"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pan-2001" MODIFIED="2012-09-20 23:19:09 +0100" MODIFIED_BY="[Empty name]" NAME="Pan 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-09-20 23:19:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pan PH, Moore CH</AU>
<TI>Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia</TI>
<SO>Journal of Clinical Anesthesia</SO>
<YR>2001</YR>
<VL>13</VL>
<NO>6</NO>
<PG>430-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971340"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971339"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Patra-2005" MODIFIED="2011-07-19 08:40:46 +0100" MODIFIED_BY="[Empty name]" NAME="Patra 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-07-19 08:40:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Patra P, Kapoor MC, Nair TGM</AU>
<TI>Spinal anaesthesia with low dose bupivacaine and fentanyl for endoscopic urological surgeries</TI>
<SO>Journal of Anaesthesiology Clinical Pharmacology</SO>
<YR>2005</YR>
<VL>21</VL>
<NO>2</NO>
<PG>147-54</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971342"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971341"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Phero-1987" MODIFIED="2012-09-20 23:18:48 +0100" MODIFIED_BY="[Empty name]" NAME="Phero 1987" YEAR="1987">
<REFERENCE MODIFIED="2012-09-20 23:18:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Phero JC, Bridenbaugh PO, Edström HH, Hagenouw RR, Knarr D, Mukkada TA, et al</AU>
<TI>Hypotension in spinal anesthesia: a comparison of isobaric tetracaine with epinephrine and isobaric bupivacaine without epinephrine</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1987</YR>
<VL>66</VL>
<NO>6</NO>
<PG>549-52</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971344"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971343"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Plaja-2000" MODIFIED="2012-09-20 23:18:36 +0100" MODIFIED_BY="[Empty name]" NAME="Plaja 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-09-20 23:18:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Plaja I, Arxer A, Metje M, Santiveri X, Villalonga A, Fernandez MA, et al</AU>
<TI>Comparison of 5% prilocaine and 2% mepivacaine in spinal anesthesia for transurethral resection</TI>
<SO>Revista Espanola de Anestesiologia y Reanimacion</SO>
<YR>2000</YR>
<VL>47</VL>
<NO>5</NO>
<PG>194-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971346"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971345"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Prusinski-1974" MODIFIED="2012-09-20 23:18:23 +0100" MODIFIED_BY="[Empty name]" NAME="Prusinski 1974" YEAR="1974">
<REFERENCE MODIFIED="2012-09-20 23:18:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Prusinski A, Klimek A</AU>
<TI>Sandomigran in the prevention of headaches following lumbar puncture</TI>
<SO>Neurologia i Neurochirurgia Polska</SO>
<YR>1974</YR>
<VL>8</VL>
<NO>4</NO>
<PG>565-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971348"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971347"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Radpay-2003" MODIFIED="2012-09-20 23:18:10 +0100" MODIFIED_BY="[Empty name]" NAME="Radpay 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-09-20 23:18:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Radpay B, Karimi-Zandi S, Dabir S, Parsa T</AU>
<TI>Comparison between epidural morphine versus morphine + fentanyl in lung resection surgery</TI>
<SO>Archives of Iranian Medicine</SO>
<YR>2003</YR>
<VL>6</VL>
<NO>2</NO>
<PG>81-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971350"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971349"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reinhart-1985" MODIFIED="2012-09-20 23:17:54 +0100" MODIFIED_BY="[Empty name]" NAME="Reinhart 1985" YEAR="1985">
<REFERENCE MODIFIED="2012-09-20 23:17:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reinhart K, Dallinger-Stiller G, Dennhardt R, Heinemeyer G, Eyrich K</AU>
<TI>Comparison of midazolam, diazepam and placebo i.m. as premedication for regional anaesthesia. A randomized double-blind study</TI>
<SO>British Journal of Anaesthesiology</SO>
<YR>1985</YR>
<VL>57</VL>
<NO>3</NO>
<PG>294-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971352"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971351"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rivera_x002d_Ordonez-2005" MODIFIED="2012-09-20 23:17:27 +0100" MODIFIED_BY="[Empty name]" NAME="Rivera-Ordonez 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-09-20 23:17:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rivera-Ordonez A, Rivera-Flores J</AU>
<TI>Postoperative epidural analgesia: ketamine plus bupivacaine vs bupivacaine alone in hip and femur surgery</TI>
<SO>Revista Mexicana de Anestesiologia</SO>
<YR>2005</YR>
<VL>28</VL>
<NO>1</NO>
<PG>14-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971354"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971353"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roux-1983" MODIFIED="2012-09-20 23:16:58 +0100" MODIFIED_BY="[Empty name]" NAME="Roux 1983" YEAR="1983">
<REFERENCE MODIFIED="2012-09-20 23:16:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roux FX, Mallet A, Meresse S</AU>
<TI>Prevention of cephalalgia following rachiocentesis. A controlled double blind trial of intravenous tiapride</TI>
<SO>Semaine des Hopitaux</SO>
<YR>1983</YR>
<VL>59</VL>
<NO>5</NO>
<PG>319-21</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971356"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971355"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rucci-1985" MODIFIED="2012-09-20 23:17:13 +0100" MODIFIED_BY="[Empty name]" NAME="Rucci 1985" YEAR="1985">
<REFERENCE MODIFIED="2012-09-20 23:17:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rucci FS, Cardamone M, Migliori P</AU>
<TI>Fentanyl and bupivacaine mixtures for extradural blockade</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1985</YR>
<VL>57</VL>
<NO>3</NO>
<PG>275-84</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971358"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971357"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ryan-1983" MODIFIED="2011-07-19 09:05:51 +0100" MODIFIED_BY="[Empty name]" NAME="Ryan 1983" YEAR="1983">
<REFERENCE MODIFIED="2011-07-19 09:05:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ryan DW, Pridie AK, Copeland PF</AU>
<TI>Plain bupivacaine 0.5%: a preliminary evaluation as a spinal anaesthetic agent</TI>
<SO>Annals of the Royal College of Surgeons of England</SO>
<YR>1983</YR>
<VL>65</VL>
<NO>1</NO>
<PG>40-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971360"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971359"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sakaguchi-2000" MODIFIED="2012-09-20 23:16:44 +0100" MODIFIED_BY="[Empty name]" NAME="Sakaguchi 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-09-20 23:16:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sakaguchi Y, Sakura S, Shinzawa M, Saito Y</AU>
<TI>Does adrenaline improve epidural bupivacaine and fentanyl analgesia after abdominal surgery?</TI>
<SO>Anaesthesia and Intensive Care</SO>
<YR>2000</YR>
<VL>28</VL>
<NO>5</NO>
<PG>522-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971362"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971361"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sangarlangkarn-1987" MODIFIED="2012-09-20 23:16:29 +0100" MODIFIED_BY="[Empty name]" NAME="Sangarlangkarn 1987" YEAR="1987">
<REFERENCE MODIFIED="2012-09-20 23:16:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sangarlangkarn S, Klaewtanong V, Jonglerttrakool P, Khankaew V</AU>
<TI>Meperidine as a spinal anesthetic agent: a comparison with lidocaine-glucose</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1987</YR>
<VL>66</VL>
<NO>3</NO>
<PG>235-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971364"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971363"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sanli-2005" MODIFIED="2012-09-20 23:16:14 +0100" MODIFIED_BY="[Empty name]" NAME="Sanli 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-09-20 23:16:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sanli S, Yegin A, Kayacan N, Yilmaz M, Coskunfirat N, Karsli B</AU>
<TI>Effects of hyperbaric spinal ropivacaine for caesarean section: with or without fentanyl</TI>
<SO>European Journal of Anaesthesiology</SO>
<YR>2005</YR>
<VL>22</VL>
<NO>6</NO>
<PG>457-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971366"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971365"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Santos-1986" MODIFIED="2012-08-22 21:31:38 +0100" MODIFIED_BY="[Empty name]" NAME="Santos 1986" YEAR="1986">
<REFERENCE MODIFIED="2012-08-22 21:31:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Santos DJ, Barett T, Lachica R, Coyle D</AU>
<TI>Efficacy of epidural saline patch in preventing post-dural puncture headache</TI>
<SO>Regional Anesthesia</SO>
<YR>1986</YR>
<VL>11</VL>
<NO>1</NO>
<PG>42-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971368"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971367"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sawhney-2004" MODIFIED="2012-09-20 23:16:01 +0100" MODIFIED_BY="[Empty name]" NAME="Sawhney 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-20 23:16:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sawhney S, Gupta RC, Shukla RN, Chakravorty S, Kulkarni SN</AU>
<TI>Post-operative analgesia with epidural ketamine and morphine</TI>
<SO>Journal of Anaesthesiology Clinical Pharmacology</SO>
<YR>2004</YR>
<VL>20</VL>
<NO>4</NO>
<PG>401-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971370"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971369"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sengupta-1989" MODIFIED="2012-08-22 21:32:05 +0100" MODIFIED_BY="[Empty name]" NAME="Sengupta 1989" YEAR="1989">
<REFERENCE MODIFIED="2012-08-22 21:32:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sengupta P, Bagley G, Lim M</AU>
<TI>Prevention of postdural puncture headache after spinal anaesthesia for extracorporeal shockwave lithotripsy. An assessment of prophylactic epidural blood patching</TI>
<SO>Anaesthesia</SO>
<YR>1989</YR>
<VL>44</VL>
<NO>1</NO>
<PG>54-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971372"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971371"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seyhan-2005" MODIFIED="2011-09-19 17:51:39 +0100" MODIFIED_BY="[Empty name]" NAME="Seyhan 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-09-19 17:51:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Seyhan TO, Baskan I, Karadeniz M, Senturk M</AU>
<TI>Epidural saline infusion for prophylaxis of postdural puncture headache a preliminary report</TI>
<SO>Regional Anesthesia and Pain Medicine</SO>
<YR>2005</YR>
<VL>30</VL>
<NO>5S1</NO>
<PG>75</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971374"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971373"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shah-2003" MODIFIED="2012-09-20 23:15:44 +0100" MODIFIED_BY="[Empty name]" NAME="Shah 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-09-20 23:15:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shah FR, Halbe AR, Panchal ID, Goodchild CS</AU>
<TI>Improvement in postoperative pain relief by the addition of midazolam to an intrathecal injection of buprenorphine and bupivacaine</TI>
<SO>European Journal of Anaesthesiology</SO>
<YR>2003</YR>
<VL>20</VL>
<NO>11</NO>
<PG>904-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971376"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971375"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Singh-2006" MODIFIED="2011-07-19 13:46:52 +0100" MODIFIED_BY="[Empty name]" NAME="Singh 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-07-19 13:46:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Singh V, Gupta LK, Singh GP</AU>
<TI>Comparison among intrathecal fentanyl and butorphanol in combination with bupivacaine for lower limb surgeries</TI>
<SO>Journal of Anaesthesiology Clinical Pharmacology</SO>
<YR>2006</YR>
<VL>22</VL>
<NO>4</NO>
<PG>371-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971378"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971377"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-2004" MODIFIED="2012-09-20 23:15:27 +0100" MODIFIED_BY="[Empty name]" NAME="Smith 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-20 23:15:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith KN, Kopacz DJ, McDonald SB</AU>
<TI>Spinal 2 - chloroprocaine: a dose-ranging study and the effect of added epinephrine</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2004</YR>
<VL>98</VL>
<NO>1</NO>
<PG>81-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971380"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971379"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Soni-2001" MODIFIED="2013-01-24 12:23:48 +0000" MODIFIED_BY="[Empty name]" NAME="Soni 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-01-24 12:23:48 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Soni AK, Miller CG, Pratt SD, Hess PE, Oriol NE, Sarna MC</AU>
<TI>Low dose intrathecal ropivacaine with or without sufentanil provides effective analgesia and does not impair motor strength during labour: a pilot study</TI>
<SO>Canadian Journal of Anaesthesia</SO>
<YR>2001</YR>
<VL>48</VL>
<NO>7</NO>
<PG>677-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971382"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971381"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sudarshan-1995" MODIFIED="2011-07-19 14:02:45 +0100" MODIFIED_BY="[Empty name]" NAME="Sudarshan 1995" YEAR="1995">
<REFERENCE MODIFIED="2011-07-19 14:02:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sudarshan G, Browne BL, Matthews JNS, Conacher ID</AU>
<TI>Intrathecal fentanyl for post-thoracotomy pain</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1995</YR>
<VL>75</VL>
<NO>1</NO>
<PG>19-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971384"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971383"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tekin-2007" MODIFIED="2012-09-20 23:15:11 +0100" MODIFIED_BY="[Empty name]" NAME="Tekin 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-09-20 23:15:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tekin M, Kati I, Tomak Y, Kisli E</AU>
<TI>Effect of dexmedetomidine IV on the duration of spinal anesthesia with prilocaine: a double-blind, prospective study in adult surgical patients</TI>
<SO>Current Therapeutic Research - Clinical and Experimental</SO>
<YR>2007</YR>
<VL>68</VL>
<NO>5</NO>
<PG>313-24</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971386"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971385"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thomas-2006" MODIFIED="2011-07-19 14:07:44 +0100" MODIFIED_BY="[Empty name]" NAME="Thomas 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-07-19 14:07:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thomas S, Beevi S</AU>
<TI>Epidural dexamethasone reduces postoperative pain and analgesic requirements</TI>
<SO>Canadian Journal of Anesthesia</SO>
<YR>2006</YR>
<VL>53</VL>
<NO>9</NO>
<PG>899-905</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971388"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971387"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trivedi-1993" MODIFIED="2012-09-20 23:14:57 +0100" MODIFIED_BY="[Empty name]" NAME="Trivedi 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-09-20 23:14:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Trivedi NS, Eddi D, Shevde, K</AU>
<TI>Headache prevention following accidental dural puncture in obstetric patients</TI>
<SO>Journal of Clinical Anesthesia</SO>
<YR>1993</YR>
<VL>5</VL>
<NO>1</NO>
<PG>42-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971390"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971389"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tsen-2001" MODIFIED="2012-09-20 23:14:41 +0100" MODIFIED_BY="[Empty name]" NAME="Tsen 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-09-20 23:14:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tsen LC, Schultz R, Martin R, Datta S, Bader AM</AU>
<TI>Intrathecal low-dose bupivacaine versus lidocaine for in vitro fertilization procedures</TI>
<SO>Regional Anesthesia and Pain Medicine</SO>
<YR>2001</YR>
<VL>26</VL>
<NO>1</NO>
<PG>52-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971392"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971391"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tucker-2004" MODIFIED="2012-09-20 23:14:26 +0100" MODIFIED_BY="[Empty name]" NAME="Tucker 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-20 23:14:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tucker AP, Mezzatesta J, Nadeson R, Goodchild CS</AU>
<TI>Intrathecal midazolam II: combination with intrathecal fentanyl for labor pain</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2004</YR>
<VL>98</VL>
<NO>6</NO>
<PG>1521-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971394"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971393"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tuncer-2005" MODIFIED="2011-09-19 20:26:04 +0100" MODIFIED_BY="[Empty name]" NAME="Tuncer 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-09-19 20:26:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tuncer S, Bariskaner H, Reisli R, Sarkilar G, Cicekci F, Otelcioglu S</AU>
<TI>Effect of gabapentin on postoperative pain: a randomized, placebo-controlled clinical study</TI>
<SO>The Pain Clinic</SO>
<YR>2005</YR>
<VL>17</VL>
<NO>1</NO>
<PG>95-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971396"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971395"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Turan-2006" MODIFIED="2012-09-20 23:14:09 +0100" MODIFIED_BY="[Empty name]" NAME="Turan 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-09-20 23:14:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Turan A, Kaya G, Karamanlioglu B, Pamukcu Z, Apfel CC</AU>
<TI>Effect of oral gabapentin on postoperative epidural analgesia</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2006</YR>
<VL>96</VL>
<NO>2</NO>
<PG>242-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971398"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971397"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Turker-2003" MODIFIED="2012-09-20 23:13:56 +0100" MODIFIED_BY="[Empty name]" NAME="Turker 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-09-20 23:13:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Turker G, Uckunkaya N, Yilmazlar A, Demirag B, Tokat O</AU>
<TI>Effects of adding epinephrine plus fentanyl to low-dose lidocaine for spinal anesthesia in outpatient knee arthroscopy</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>2003</YR>
<VL>47</VL>
<NO>8</NO>
<PG>986-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971400"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971399"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Unlugenc-2006" MODIFIED="2012-09-20 23:13:42 +0100" MODIFIED_BY="[Empty name]" NAME="Unlugenc 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-09-20 23:13:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Unlugenc H, Ozalevli M, Gunes Y, Olguner S, Evruke C, Ozcengiz D, et al</AU>
<TI>A double-blind comparison of intrathecal S(+) ketamine and fentanyl combined with bupivacaine 0.5% for Caesarean delivery</TI>
<SO>European Journal of Anaesthesiology</SO>
<YR>2006</YR>
<VL>23</VL>
<NO>12</NO>
<PG>1018-24</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971402"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971401"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Unlugenc-2009" MODIFIED="2012-09-20 23:13:22 +0100" MODIFIED_BY="[Empty name]" NAME="Unlugenc 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-09-20 23:13:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Unlugenc H, Ozalevli M, Gunduz M, Gunasti S, Urunsak I F, Guler T, et al</AU>
<TI>Comparison of intrathecal magnesium, fentanyl, or placebo combined with bupivacaine 0.5% for parturients undergoing elective cesarean delivery</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>2009</YR>
<VL>53</VL>
<NO>3</NO>
<PG>346-53</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971404"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971403"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Usubiaga-1967" MODIFIED="2012-09-20 23:13:04 +0100" MODIFIED_BY="[Empty name]" NAME="Usubiaga 1967" YEAR="1967">
<REFERENCE MODIFIED="2012-09-20 23:13:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Usubiaga JE, Usubiaga LE, Brea LM, Goyena R</AU>
<TI>Effect of saline injections on epidural and subarachnoid space pressures and relation to postspinal anesthesia headache</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1967</YR>
<VL>46</VL>
<NO>3</NO>
<PG>293-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971406"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971405"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vaghadia-1997" MODIFIED="2012-09-20 23:12:53 +0100" MODIFIED_BY="[Empty name]" NAME="Vaghadia 1997" YEAR="1997">
<REFERENCE MODIFIED="2012-09-20 23:12:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vaghadia H, McLeod DH, Mitchell GW, Merrick PM, Chilvers CR</AU>
<TI>Small-dose hypobaric lidocaine-fentanyl spinal anesthesia for short duration outpatient laparoscopy. I. A randomized comparison with conventional dose hyperbaric lidocaine</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1997</YR>
<VL>84</VL>
<NO>1</NO>
<PG>59-64</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971408"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971407"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vale-1995" MODIFIED="2012-09-20 23:12:40 +0100" MODIFIED_BY="[Empty name]" NAME="Vale 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-09-20 23:12:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vale NB, Silva Neto JD, Magalhães Filho EB, Nascimento W, Pereira F, França A</AU>
<TI>Spinal anesthesia with 0.5% bupivacaine and 2% lidocaine without glucose in a fixed dose - efficacy/toxicity in the morning and in the afternoon</TI>
<SO>Revista Brasileira De Anestesiologia</SO>
<YR>1995</YR>
<VL>45</VL>
<NO>5</NO>
<PG>301-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971410"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971409"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vichitvejpaisal-1992" MODIFIED="2012-09-20 23:12:24 +0100" MODIFIED_BY="[Empty name]" NAME="Vichitvejpaisal 1992" YEAR="1992">
<REFERENCE MODIFIED="2012-09-20 23:12:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vichitvejpaisal P, Svastdi-Xuto O, Udompunturux S</AU>
<TI>A comparative study of isobaric and hyperbaric solution of bupivacaine for spinal anaesthesia in caesarean section</TI>
<SO>Journal of the Medical Association of Thailand</SO>
<YR>1992</YR>
<VL>75</VL>
<NO>5</NO>
<PG>278-82</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971412"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971411"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Viscusi-2005" MODIFIED="2012-09-20 23:12:09 +0100" MODIFIED_BY="[Empty name]" NAME="Viscusi 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-09-20 23:12:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Viscusi ER, Martin G, Hartrick CT, Singla N, Manvelian G</AU>
<TI>Forty-eight hours of postoperative pain relief after total hip arthroplasty with a novel, extended-release epidural morphine formulation</TI>
<SO>Anesthesiology</SO>
<YR>2005</YR>
<VL>102</VL>
<NO>5</NO>
<PG>1014-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971414"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971413"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Waxler-2004" MODIFIED="2012-09-20 23:11:58 +0100" MODIFIED_BY="[Empty name]" NAME="Waxler 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-20 23:11:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Waxler B, Mondragon SA, Patel SN, Nedumgottil K</AU>
<TI>Intrathecal lidocaine and sufentanil shorten post-operative recovery after outpatient rectal surgery</TI>
<SO>Canadian Journal of Anesthesia</SO>
<YR>2004</YR>
<VL>51</VL>
<NO>7</NO>
<PG>680-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971416"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971415"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wells-2004" MODIFIED="2012-09-20 23:11:42 +0100" MODIFIED_BY="[Empty name]" NAME="Wells 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-20 23:11:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wells J, Paech MJ, Evans SF</AU>
<TI>Intrathecal fentanyl-induced pruritus during labour: the effect of prophylactic ondansetron</TI>
<SO>International Journal of Obstetric Anesthesia</SO>
<YR>2004</YR>
<VL>13</VL>
<NO>1</NO>
<PG>35-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971418"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971417"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Whiteside-2003" MODIFIED="2012-09-20 23:11:24 +0100" MODIFIED_BY="[Empty name]" NAME="Whiteside 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-09-20 23:11:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Whiteside JB, Burke D, Wildsmith JAW</AU>
<TI>Comparison of ropivacaine 0.5% (in glucose 5%) with bupivacaine 0.5% (in glucose 8%) for spinal anaesthesia for elective surgery</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2003</YR>
<VL>90</VL>
<NO>3</NO>
<PG>304-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971420"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971419"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Widerl_x00f6_v-1979" MODIFIED="2012-09-20 23:11:12 +0100" MODIFIED_BY="[Empty name]" NAME="Widerlöv 1979" YEAR="1979">
<REFERENCE MODIFIED="2012-09-20 23:11:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Widerlöv E, Lindström L</AU>
<TI>D.D.A.V.P. and headache after lumbar puncture</TI>
<SO>Lancet</SO>
<YR>1979</YR>
<VL>1</VL>
<NO>8115</NO>
<PG>548</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971422"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971421"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilder_x002d_Smith-1998" MODIFIED="2012-09-20 23:11:01 +0100" MODIFIED_BY="[Empty name]" NAME="Wilder-Smith 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-09-20 23:11:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilder-Smith CH, Wilder-Smith OHG, Farschtschian M, Naji P</AU>
<TI>Preoperative adjuvant epidural tramadol: the effect of different doses on postoperative analgesia and pain processing</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1998</YR>
<VL>42</VL>
<NO>3</NO>
<PG>299-305</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971424"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971423"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wood-1993" MODIFIED="2012-12-03 15:32:37 +0000" MODIFIED_BY="[Empty name]" NAME="Wood 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-12-03 15:32:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wood MB, Rubin AP</AU>
<TI>A comparison of epidural 1% ropivacaine and 0.75% bupivacaine for lower abdominal gynecologic surgery</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1993</YR>
<VL>76</VL>
<NO>6</NO>
<PG>1274-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971426"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971425"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yanagidate-2004" MODIFIED="2012-09-20 23:10:29 +0100" MODIFIED_BY="[Empty name]" NAME="Yanagidate 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-20 23:10:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yanagidate F, Dohi S</AU>
<TI>Epidural oxycodone or morphine following gynaecological surgery</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2004</YR>
<VL>93</VL>
<NO>3</NO>
<PG>362-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971428"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971427"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yeh-2000" MODIFIED="2012-09-20 23:10:08 +0100" MODIFIED_BY="[Empty name]" NAME="Yeh 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-09-20 23:10:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yeh HM, Chen LK, Lin CJ, Chan WH, Chen YP, Lin CS, et al</AU>
<TI>Prophylactic intravenous ondansetron reduces the incidence of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2000</YR>
<VL>91</VL>
<NO>1</NO>
<PG>172-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971430"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971429"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Y_x00fc_cel-1999" MODIFIED="2012-09-20 23:09:48 +0100" MODIFIED_BY="[Empty name]" NAME="Yücel 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-09-20 23:09:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yücel A, Ozyalçin S, Talu GK, Yücel EC, Erdine S</AU>
<TI>Intravenous administration of caffeine sodium benzoate for postdural puncture headache</TI>
<SO>Regional Anesthesia and Pain Medicine</SO>
<YR>1999</YR>
<VL>24</VL>
<NO>1</NO>
<PG>51-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971432"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971431"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zackova-2000" MODIFIED="2012-09-20 23:09:30 +0100" MODIFIED_BY="[Empty name]" NAME="Zackova 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-09-20 23:09:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zackova M, Manfredini P, Strali W, Baravelli A, Furnari G, Accorsi A</AU>
<TI>Comparison of 0.125% bupivacaine and 0.2% ropivacaine in obstetric analgesia</TI>
<SO>Minerva Anestesiologica</SO>
<YR>2000</YR>
<VL>66</VL>
<NO>9</NO>
<PG>643-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971434"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971433"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2012-01-24 07:16:58 +0000" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2012-04-27 20:44:29 +0100" MODIFIED_BY="[Empty name]"/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-01-24 12:28:47 +0000" MODIFIED_BY="Jessica R Thomas">
<ADDITIONAL_REFERENCES MODIFIED="2013-01-24 12:28:47 +0000" MODIFIED_BY="Jessica R Thomas">
<REFERENCE ID="REF-Ahmed-2006" MODIFIED="2012-02-28 17:03:10 +0000" MODIFIED_BY="[Empty name]" NAME="Ahmed 2006" TYPE="JOURNAL_ARTICLE">
<AU>Ahmed SV, Jayawarna C, Jude E</AU>
<TI>Post lumbar puncture headache: diagnosis and management</TI>
<SO>Postgraduate Medicine</SO>
<YR>2006</YR>
<VL>82</VL>
<NO>973</NO>
<PG>713&#8211;6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Angle-2005" MODIFIED="2012-02-28 17:35:52 +0000" MODIFIED_BY="[Empty name]" NAME="Angle 2005" TYPE="JOURNAL_ARTICLE">
<AU>Angle P, Tang SL, Thompson D, Szalai JP</AU>
<TI>Expectant management of postdural puncture headache increases hospital length of stay and emergency room visits</TI>
<SO>Canadian Journal of Anaesthesia</SO>
<YR>2005</YR>
<VL>52</VL>
<NO>4</NO>
<PG>397&#8211;402</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Apfel-2010" MODIFIED="2012-09-20 23:09:06 +0100" MODIFIED_BY="[Empty name]" NAME="Apfel 2010" TYPE="JOURNAL_ARTICLE">
<AU>Apfel CC, Saxena A, Cakmakkaya OS, Gaiser R, George E, Radke O</AU>
<TI>Prevention of postdural puncture headache after accidental dural puncture: a quantitative systematic review</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2010</YR>
<VL>105</VL>
<NO>3</NO>
<PG>255-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Arevalo_x002d_Rodriguez-2011" MODIFIED="2012-06-03 23:26:06 +0100" MODIFIED_BY="[Empty name]" NAME="Arevalo-Rodriguez 2011" TYPE="COCHRANE_PROTOCOL">
<AU>Arevalo-Rodriguez I, Ciapponi A, Munoz L, Roqué i Figuls M, Bonfill Cosp X</AU>
<TI>Posture and fluids for preventing post-dural puncture headache</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>7</NO>
<IDENTIFIERS MODIFIED="2012-06-03 23:26:06 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2012-06-03 23:25:33 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD009199"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Banks-2001" MODIFIED="2009-05-07 10:50:28 +0100" MODIFIED_BY="Jessica R Thomas" NAME="Banks 2001" TYPE="JOURNAL_ARTICLE">
<AU>Banks S, Paech M, Gurrin L</AU>
<TI>An audit of epidural blood patch after accidental dural puncture with a Tuohy needle in obstetric patients</TI>
<SO>International Journal of Obstetric Anesthesia</SO>
<YR>2001</YR>
<VL>10</VL>
<NO>3</NO>
<PG>172-6</PG>
<IDENTIFIERS MODIFIED="2009-05-07 10:50:28 +0100" MODIFIED_BY="Jessica R Thomas"/>
</REFERENCE>
<REFERENCE ID="REF-Basurto-2011" MODIFIED="2012-06-03 23:24:11 +0100" MODIFIED_BY="Jessica R Thomas" NAME="Basurto 2011" TYPE="COCHRANE_REVIEW">
<AU>Basurto Ona X, Marti&#769;nez Garci&#769;a L, Sola&#768; I, Bonfill Cosp X</AU>
<TI>Drug therapy for treating post-dural puncture headache</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>8</NO>
<IDENTIFIERS MODIFIED="2012-06-03 23:24:11 +0100" MODIFIED_BY="Jessica R Thomas"><IDENTIFIER MODIFIED="2012-06-03 23:22:38 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD007887.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Baumgarten-1987" MODIFIED="2012-02-28 17:06:37 +0000" MODIFIED_BY="[Empty name]" NAME="Baumgarten 1987" TYPE="JOURNAL_ARTICLE">
<AU>Baumgarten RK</AU>
<TI>Should caffeine become the first-line treatment for postdural puncture headache?</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1987</YR>
<VL>66</VL>
<NO>9</NO>
<PG>913&#8211;4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Berger-1998" MODIFIED="2009-04-29 10:05:55 +0100" MODIFIED_BY="Laila Tyrrell" NAME="Berger 1998" TYPE="JOURNAL_ARTICLE">
<AU>Berger CW, Crosby ET, Grodecki W</AU>
<TI>North American survey of the management of dural puncture occurring during labour epidural analgesia</TI>
<SO>Canadian Journal of Anesthesia</SO>
<YR>1998</YR>
<VL>45</VL>
<NO>2</NO>
<PG>110-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bezov-2010" MODIFIED="2012-08-22 21:48:37 +0100" MODIFIED_BY="[Empty name]" NAME="Bezov 2010" TYPE="JOURNAL_ARTICLE">
<AU>Bezov D, Ashina S, Lipton R</AU>
<TI>Post-dural puncture headache: part II - prevention, management, and prognosis</TI>
<SO>Headache</SO>
<YR>2010</YR>
<VL>50</VL>
<NO>9</NO>
<PG>1482-98</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boonmak-2010" MODIFIED="2012-06-03 23:27:19 +0100" MODIFIED_BY="[Empty name]" NAME="Boonmak 2010" TYPE="COCHRANE_REVIEW">
<AU>Boonmak P, Boonmak S</AU>
<TI>Epidural blood patching for preventing and treating post-dural puncture headache</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2012-06-03 23:27:19 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2012-06-03 23:27:19 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001791.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Choi-2003" MODIFIED="2012-09-20 23:08:48 +0100" MODIFIED_BY="Laila Tyrrell" NAME="Choi 2003" TYPE="JOURNAL_ARTICLE">
<AU>Choi PT, Galinski SE, Takeuchi L, Lucas S, Tamayo C, Jadad AR</AU>
<TI>PDPH is a common complication of neuraxial blockade in parturients: a meta-analysis of obstetrical studies</TI>
<SO>Canadian Journal of Anaesthesia</SO>
<YR>2003</YR>
<VL>50</VL>
<NO>5</NO>
<PG>460-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Clark-1996" MODIFIED="2012-08-22 21:49:19 +0100" MODIFIED_BY="[Empty name]" NAME="Clark 1996" TYPE="JOURNAL_ARTICLE">
<AU>Clark JW, Solomon GD, Senanayake PD, Gallagher C</AU>
<TI>Substance P concentration and history of headache in relation to postlumbar puncture headache: towards prevention</TI>
<SO>Journal of Neurology, Neurosurgery and Psychiatry</SO>
<YR>1996</YR>
<VL>60</VL>
<NO>6</NO>
<PG>681&#8211;3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davignon-2002" MODIFIED="2012-02-28 16:08:15 +0000" MODIFIED_BY="[Empty name]" NAME="Davignon 2002" TYPE="JOURNAL_ARTICLE">
<AU>Davignon KR, Dennehy K</AU>
<TI>Update on postdural puncture headache</TI>
<SO>International Anesthesiology Clinics</SO>
<YR>2002</YR>
<VL>40</VL>
<NO>4</NO>
<PG>89&#8211;102</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Denny-1987" MODIFIED="2012-02-28 17:09:43 +0000" MODIFIED_BY="[Empty name]" NAME="Denny 1987" TYPE="JOURNAL_ARTICLE">
<AU>Denny N, Masters R, Pearson D, Read J, Sihota M, Selander D</AU>
<TI>Postdural puncture headache after continuous spinal anesthesia</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1987</YR>
<VL>66</VL>
<NO>8</NO>
<PG>791&#8211;4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grande-2005" MODIFIED="2012-08-22 21:49:47 +0100" MODIFIED_BY="[Empty name]" NAME="Grande 2005" TYPE="JOURNAL_ARTICLE">
<AU>Grande PO</AU>
<TI>Mechanisms behind postspinal headache and brain stem compression following lumbar dural puncture - a physiological approach</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>2005</YR>
<VL>49</VL>
<NO>5</NO>
<PG>619&#8211;26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hafer-1997" MODIFIED="2012-09-20 23:08:27 +0100" MODIFIED_BY="[Empty name]" NAME="Hafer 1997" TYPE="JOURNAL_ARTICLE">
<AU>Hafer J, Rupp D, Wollbrück M, Engel J, Hempelmann G</AU>
<TI>The effect of needle type and immobilization on postspinal headache</TI>
<SO>Anaesthetist</SO>
<YR>1997</YR>
<VL>46</VL>
<NO>10</NO>
<PG>860-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Harrington-2004" MODIFIED="2012-02-28 17:12:07 +0000" MODIFIED_BY="[Empty name]" NAME="Harrington 2004" TYPE="JOURNAL_ARTICLE">
<AU>Harrington BE</AU>
<TI>Postdural puncture headache and the development of the epidural blood patch</TI>
<SO>Regional Anesthesia and Pain Medicine</SO>
<YR>2004</YR>
<VL>29</VL>
<NO>2</NO>
<PG>136&#8211;63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" MODIFIED="2009-05-07 10:52:02 +0100" MODIFIED_BY="Jessica R Thomas" NAME="Higgins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<PG>1539-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2013-01-24 12:28:47 +0000" MODIFIED_BY="Jessica R Thomas" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-08-23 18:36:49 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</TI>
<SO>The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org</SO>
<EN>Available from www.cochrane-handbook.org.</EN>
<IDENTIFIERS MODIFIED="2012-06-03 23:41:30 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-International-Headache-Society-2004" MODIFIED="2012-09-20 23:07:49 +0100" MODIFIED_BY="[Empty name]" NAME="International Headache Society 2004" TYPE="JOURNAL_ARTICLE">
<AU>Headache Classification Subcommittee of the International Headache Society</AU>
<TI>The International Classification of Headache Disorders: 2nd edition</TI>
<SO>Cephalalgia</SO>
<YR>2004</YR>
<VL>24</VL>
<NO>Suppl 1</NO>
<PG>9&#8211;160</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kuczkowski-2006" MODIFIED="2012-02-28 17:27:52 +0000" MODIFIED_BY="[Empty name]" NAME="Kuczkowski 2006" TYPE="JOURNAL_ARTICLE">
<AU>Kuczkowski KM</AU>
<TI>The treatment and prevention of post-dural puncture headache</TI>
<SO>Acta Anaesthesiologica Belgica</SO>
<YR>2006</YR>
<VL>57</VL>
<NO>1</NO>
<PG>55&#8211;6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lavi-2006" MODIFIED="2012-02-28 17:30:23 +0000" MODIFIED_BY="[Empty name]" NAME="Lavi 2006" TYPE="JOURNAL_ARTICLE">
<AU>Lavi R, Yarnitsky D, Rowe JM, Weissman A, Segal D, Avivi I</AU>
<TI>Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: a randomized trial</TI>
<SO>Neurology</SO>
<YR>2006</YR>
<VL>67</VL>
<NO>8</NO>
<PG>1492&#8211;4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lybecker-1995" MODIFIED="2009-05-07 10:54:07 +0100" MODIFIED_BY="Jessica R Thomas" NAME="Lybecker 1995" TYPE="JOURNAL_ARTICLE">
<AU>Lybecker H, Djernes M, Schmidt JF</AU>
<TI>Postdural puncture headache (PDPH): onset, duration, severity, and associated symptoms. An analysis of 75 consecutive patients with PDPH</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1995</YR>
<VL>39</VL>
<NO>5</NO>
<PG>605-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McQuay-1998" MODIFIED="2012-09-20 23:07:25 +0100" MODIFIED_BY="[Empty name]" NAME="McQuay 1998" TYPE="BOOK">
<AU>McQuay HJ, Moore RA</AU>
<SO>An Evidence-Based Resource for Pain Relief</SO>
<YR>1998</YR>
<PB>Oxford University Press</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Morewood-1993" MODIFIED="2012-09-20 23:06:54 +0100" MODIFIED_BY="[Empty name]" NAME="Morewood 1993" TYPE="JOURNAL_ARTICLE">
<AU>Morewood GH</AU>
<TI>A rational approach to the cause, prevention and treatment of postdural puncture headache</TI>
<SO>Canadian Medical Association Journal</SO>
<YR>1993</YR>
<VL>149</VL>
<NO>8</NO>
<PG>1087-93</PG>
<IDENTIFIERS MODIFIED="2008-07-27 19:30:20 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2008-07-27 19:30:20 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8221447"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Newman-2010" MODIFIED="2012-06-04 00:00:20 +0100" MODIFIED_BY="[Empty name]" NAME="Newman 2010" TYPE="COCHRANE_PROTOCOL">
<AU>Newman MJ, Cyna AM, Middleton P</AU>
<TI>Epidural catheter replacement and intrathecal catheter techniques for preventing post-dural puncture headache following an inadvertent dural puncture in labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2012-06-04 00:00:20 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2012-06-04 00:00:20 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD008266"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2011" MODIFIED="2013-01-24 11:14:32 +0000" MODIFIED_BY="[Empty name]" NAME="RevMan 2011" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2011</YR>
<EN>5.1</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-2010" MODIFIED="2012-09-20 23:06:32 +0100" MODIFIED_BY="[Empty name]" NAME="Schulz 2010" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Altman DG, Moher D, for the CONSORT Group</AU>
<TI>CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2010</YR>
<VL>152</VL>
<PG>726&#8211;32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Thew-2008" MODIFIED="2012-02-28 17:25:30 +0000" MODIFIED_BY="[Empty name]" NAME="Thew 2008" TYPE="JOURNAL_ARTICLE">
<AU>Thew M, Paech MJ</AU>
<TI>Management of postdural puncture headache in the obstetric patient</TI>
<SO>Current Opinion in Anesthesiology</SO>
<YR>2008</YR>
<VL>21</VL>
<NO>3</NO>
<PG>288&#8211;92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Turnbull-2003" MODIFIED="2009-04-29 10:08:01 +0100" MODIFIED_BY="Laila Tyrrell" NAME="Turnbull 2003" TYPE="JOURNAL_ARTICLE">
<AU>Turnbull DK, Shepherd DB</AU>
<TI>Post-dural puncture headache: pathogenesis, prevention and treatment</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2003</YR>
<VL>91</VL>
<NO>5</NO>
<PG>718-29</PG>
<IDENTIFIERS MODIFIED="2008-07-27 19:27:42 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2008-07-27 19:27:42 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1093/bja/aeg231"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Vallejo-2000" MODIFIED="2009-04-29 10:08:54 +0100" MODIFIED_BY="Laila Tyrrell" NAME="Vallejo 2000" TYPE="JOURNAL_ARTICLE">
<AU>Vallejo MC, Mandell GL, Sabo DP, Ramanathan S</AU>
<TI>Postdural puncture headache: a randomized comparison of five spinal needles in obstetric patients</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2000</YR>
<VL>91</VL>
<NO>4</NO>
<PG>916-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Verma-2011" MODIFIED="2012-09-20 23:05:57 +0100" MODIFIED_BY="[Empty name]" NAME="Verma 2011" TYPE="JOURNAL_ARTICLE">
<AU>Verma R, Alladi R, Jackson I, Johnston I, Kumar C, Page R, et al</AU>
<TI>Day case and short stay surgery: 2</TI>
<SO>Anaesthesia</SO>
<YR>2011</YR>
<VL>66</VL>
<NO>5</NO>
<PG>417-34</PG>
<IDENTIFIERS MODIFIED="2012-02-26 17:43:19 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;&lt;b&gt;YR - [Characteristics of included studies: Al-metwalli 2008]: &lt;/b&gt;Was it double or triple blinded?&lt;/p&gt;&lt;p&gt;XB: double-blind. Corrected.&lt;/p&gt;&lt;p&gt;&lt;b&gt;[Characteristics of included studies: Al-metwalli 2008]:&lt;/b&gt; Does this make sense?&lt;/p&gt;&lt;p&gt;XB: corrected&lt;/p&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;p&gt;&lt;b&gt;[Characteristics of included studies: Devcic 1993]: &lt;/b&gt;What anaesthesiologist criteria?&lt;/p&gt;&lt;p&gt;Original text says: &amp;quot;The total dose was decided by the anaesthesiologist performing the spinal anaesthesia.&amp;quot;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&amp;#160;&lt;b&gt;[Characteristics of included studies: Sadeghi 2012]:&lt;/b&gt; I have added the text in brackets as there are two &amp;#8216;doses&amp;#8217; given here &amp;#8211; the &amp;#8216;55 mg&amp;#8217; and the &amp;#8216;5%&amp;#8217; is this correct? Having checked the full-text paper this is how it is reported.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;" NOTES_MODIFIED="2013-01-28 12:10:16 +0000" NOTES_MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Abboud-1992">
<CHAR_METHODS MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised, double-blind, controlled trial</P>
<P>Study type: single-centre study</P>
<P>Location: US (Los Angeles)</P>
<P>Setting: hospital</P>
<P>Study design: parallel</P>
<P>Randomisation: not described</P>
<P>Allocation concealment: not described</P>
<P>Blinding: double-blind</P>
<P>Follow-up period: 3 days</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-08-28 12:43:51 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised: 82 (intervention group: 40; control group: 42)</P>
<P>Excluded (post-randomisation): not described</P>
<P>Gender (women): 82 (100%)</P>
<P>Age (years): mean (SD): intervention group: 30.3 (6.3); control group: 29.6 (5.8)</P>
<P>Inclusion criteria: healthy pregnant women at term, ASA I or II with no medical complications, who underwent caesarean delivery with spinal anaesthesia</P>
<P>Exclusion criteria: not described</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-28 12:43:51 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention group: intraspinal administration of morphine 0.2 mg in 0.2 mL solution</P>
<P>Control group: intraspinal administration of 0.2 mL of normal saline</P>
<P>Co-interventions: spinal anaesthesia with 0.75% bupivacaine in 8.25% dextrose plus 0.2 mL of 1:1000 epinephrine. Hydration with 1500 mL lactated Ringer's solution</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-28 12:43:51 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Number of participants affected by PDPH of any severity</LI>
<LI>Number of any possible adverse effects from the drug taken to prevent PDPH</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<P>PDPH defined as: quote: "PDPH if it occurred after the patient became ambulatory, was aggravated by sitting or standing position, was relieved by lying supine, and was mostly occipital or frontal" (Page 34)</P>
<P>Sample size calculation: quote: "Consultation with a statistician determined the sample size of the study. The statistical approach was analysed to ensure that the power of these data was adequate to decrease below the level of statistical probability that a Type II error could have been made" (Page 35)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Al_x002d_metwalli-2008">
<CHAR_METHODS MODIFIED="2012-12-03 15:25:53 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised, double-blind, controlled trial</P>
<P>Study type: single-centre study</P>
<P>Location: Saudi Arabia (Al-Khobar)</P>
<P>Setting: hospital</P>
<P>Study design: parallel</P>
<P>Randomisation: computer-generated random number table</P>
<P>Allocation concealment: opaque envelope labelled with the study subject number</P>
<P>Blinding: double-blind</P>
<P>Follow-up period: minimum 5 days in those without PDPH and 3 days after resolution of the headache in those with PDPH</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised: 50 (intervention group: 25, control group: 25)</P>
<P>Excluded (post-randomisation): not described</P>
<P>Gender (women): 50 (100%)</P>
<P>Age (years): mean (SD): intervention group 28.4 (6.0); control group 29.6 (5.4)</P>
<P>Inclusion criteria: postpartum woman with inadvertent dural puncture during epidural analgesia in labour</P>
<P>Exclusion criteria: temperature &gt; 37.8 ºC, coagulopathy and delivering by caesarean section</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-28 12:43:51 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention group: epidural morphine 3 mg in 10 mL saline and repeated the same treatment after 24 h</P>
<P>Control group: epidural 10 mL saline and repeated the same treatment after 24 h</P>
<P>Co-interventions: 3 mL of lidocaine 2% with fentanyl 15 &#956;g administered to all patients before delivery to test correct epidural placement. Next, 10 mL bupivacaine 0.25% with 50 &#956;g of fentanyl  was injected followed by a continuous infusion of bupivacaine 0.125% with 1 &#956;g/mL of fentanyl at 10 mL/h</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-28 12:43:51 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Number of participants affected by PDPH of any severity</LI>
<LI>Number of participants with severe PDPH</LI>
<LI>Number of any possible adverse effects from the drug taken to prevent PDPH</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-28 12:43:51 +0100" MODIFIED_BY="[Empty name]">
<P>PDPH defined as: quote "PDPH was defined as the presence of a headache or neck ache that improved significantly or completely when the subject assumed the supine position"</P>
<P>Sample size calculation: 24 participants calculated estimating an incidence decrease of PDPH from 75% to 35%. Significance level of 0.05 and power of 80%</P>
<P>VRSP: 0 = no pain and 10 = worst possible pain</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-12-03 15:26:35 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Devcic-1993">
<CHAR_METHODS MODIFIED="2012-12-03 15:26:30 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised, blinded, controlled trial</P>
<P>Study type: single-centre study</P>
<P>Location: US (Milwaukee)</P>
<P>Setting: hospital</P>
<P>Study design: parallel</P>
<P>Randomisation: not described</P>
<P>Allocation concealment: not described</P>
<P>Blinding: blinding of patients and outcome assessors</P>
<P>Follow-up period: 3 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-08-28 12:43:51 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised: 194 (Sprotte needle with fentanyl: 47; Sprotte needle without fentanyl: 49; Quincke needle with fentanyl: 49; Quincke needle without fentanyl: 49)</P>
<P>Excluded (post-randomisation): not described</P>
<P>Gender (women): 194 (100%)</P>
<P>Age (years): mean (SD): Sprotte needle with fentanyl: 28.2 (5.8); Sprotte needle without fentanyl: 29.5 (4.4); Quincke needle with fentanyl: 28.3 (5.6), Quincke needle without fentanyl: 28.7 (5.5)</P>
<P>Inclusion criteria: healthy obstetric patients requiring caesarean delivery who consented to spinal anaesthesia</P>
<P>Exclusion criteria: previously attempted or performed labour epidural analgesia or spinal anaesthesia attempted with other kind of needles</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-03 15:26:35 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention group: subarachnoid  fentanyl 20 &#956;g through a 24-gauge Sprotte needle or through a 25-gauge Quincke needle</P>
<P>Control group: subarachnoid anaesthesia without fentanyl through a 24-gauge Sprotte needle or through a 25-gauge Quincke needle</P>
<P>Co-interventions: all patients received 1000 to 1500 mL of 0.9% normal saline or Ringer's lactate solution before spinal anaesthesia and continued for 48 h</P>
<P>Spinal anaesthesia with hyperbaric bupivacaine 0.75% to all patients. The total dose was decided by the anaesthesiologist performing the spinal anaesthesia</P>
<P>Opioids via patient&#8211;controlled pump during the first 24 h postoperative and followed the next day by oral analgesics as needed</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Number of participants affected by PDPH of any severity</LI>
<LI>Number of participants with severe PDPH</LI>
<LI>Number of missing data (withdrawals, drop-outs and participants lost to follow-up)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>PDPH defined as: quote: "If the headache occurring on mobilization was aggravated by an erect position and was relieved by lying flat, it was considered to be a PDPH" (Page 223)</P>
<P>Sample size calculation: not described</P>
<P>PDPH severity: mild (annoying, but tolerable on ambulation, requiring oral analgesics); moderate (very annoying, very uncomfortable on ambulation, requiring bed rest, scheduled analgesia with intravenous fluids); severe (bedridden requiring EBP)</P>
<P>Email contact</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-24 11:05:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Doroudian-2011">
<CHAR_METHODS MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, blinded, controlled trial</P>
<P>Study type: single-centre study</P>
<P>Location: Iran (Kerman)</P>
<P>Setting: admitted to hospital</P>
<P>Study design: parallel</P>
<P>Randomisation: computer-generated random allocation</P>
<P>Allocation concealment: not described</P>
<P>Blinding: blinding of patients and the spinal anaesthesia staff</P>
<P>Follow-up period: 7 days</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-24 11:05:13 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised: 178 (intervention group: 89; control group: 89)</P>
<P>Excluded (post-randomisation): none</P>
<P>Gender (women): 61 (34.3%)</P>
<P>Age (years): mean (range): intervention group 41.7 (31 to 53); control group 40 (30 to 50)</P>
<P>Inclusion criteria: all adults admitted to hospital for lower-extremity surgery</P>
<P>Exclusion criteria: hypo/hypertension, diabetes, dexamethasone intolerance or past hypersensitivity reaction, intake of any analgesic or anti-inflammatory agent during the week prior to admission, past history of chronic headache, recent-onset acute headache, contraindication for LP, a surgical procedure estimated to last longer than 90 minutes, current pregnancy, past/active peptic ulcer disease, active systemic fungal infection, any kind of addiction, more than 2 attempts at spinal anaesthesia, any history of cardiopulmonary disorder, long-term admission, severe post-spinal haemodynamic changes and strong dependency to tea or caffeine</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention group: intravenous dexamethasone 8 mg (2 mL) of before spinal anaesthesia</P>
<P>Control group: 2 mL of intravenous normal saline before spinal anaesthesia</P>
<P>Co-interventions: all patients received 500 mL of normal saline intravenously before intervention and spinal anaesthesia</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Number of participants affected by PDPH of any severity</LI>
<LI>Number of participants with severe PDPH</LI>
<LI>Number of missing data (withdrawals, drop-outs and participants lost to follow-up)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>PDPH defined as: an exclusion criteria was: quote: "long term admission which does not permit patient to resume the upright position within the first 7 days" (Page 144) and Class I intensity headache was: quote: "Patient suffers from a mild headache while sitting or walking" (Page 144)</P>
<P>Sample size calculation: not described</P>
<P>PDPH severity:</P>
<P>Class I: "Patient suffers from a mild headache while sitting or walking", Class II: "Patient suffers from a moderate to severe headache while sitting or walking" and Class III: "Patient suffers from a moderate to severe headache even in supine position which impedes his/her daily activities"</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Esmaoglu-2005">
<CHAR_METHODS MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, blinded, controlled trial</P>
<P>Study type: single-centre study</P>
<P>Location: Turkey (Kayseri)</P>
<P>Setting: admitted to hospital</P>
<P>Study design: parallel</P>
<P>Randomisation: not described</P>
<P>Allocation concealment: not described</P>
<P>Blinding: outcome assessors and probably patients</P>
<P>Follow-up period: 7 days</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised: 210 (caffeine 75 group: 70; caffeine 125 group: 70; control group: 70)</P>
<P>Excluded (post-randomisation): not described</P>
<P>Gender (women): 83 (39.5%)</P>
<P>Age (years): mean (SD): caffeine 75 group: 38 (12); caffeine 125 group: 38 (11); control group: 37 (14)</P>
<P>Inclusion criteria: patients scheduled for elective lower extremity surgery, ASA I-II</P>
<P>Exclusion criteria: hypertension, diabetes mellitus, caffeine consumption &gt; 250 mg/day, intolerance to caffeine, chronic headache, contraindication to spinal anaesthesia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>Caffeine 75 group: paracetamol 500 mg + caffeine 75 mg orally</P>
<P>Caffeine 125 group: paracetamol 500 mg + caffeine 125 mg orally</P>
<P>Control group: placebo orally</P>
<P>All 3 groups received intervention 1 h before the spinal anaesthesia and the same doses repeated every 6 hours for 3 days. Spinal anaesthesia with 3 mL of hyperbaric bupivacaine 0.5%</P>
<P>Co-interventions: all patients hydrated with at least 0.5 L of intravenous crystalloid solution before the procedure</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Number of participants affected by PDPH of any severity</LI>
<LI>Number of participants with severe PDPH</LI>
<LI>Number of participants with any headache</LI>
<LI>Number of any possible adverse effects from the drug taken to prevent PDPH</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>PDPH defined as: quote: "headache was categorized as a PDPH if it was worse on sitting or standing and relieved or reduced by lying flat" (Page 59)</P>
<P>PDPH severity: quote: "class I, mild headache when sitting or ambulating; class II, moderate to severe headache when sitting or ambulating; and class III, moderate to severe headache when supine" (Page 60)</P>
<P>Sample size calculation: not described</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-24 11:56:10 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Flaatten-1987">
<CHAR_METHODS MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, double-blind, controlled trial</P>
<P>Study type: single-centre study</P>
<P>Location: Norway (Bergen)</P>
<P>Setting: admitted to hospital</P>
<P>Study design: parallel</P>
<P>Randomisation: not described</P>
<P>Allocation concealment: not described</P>
<P>Blinding: double-blind</P>
<P>Follow-up period: 3 days</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised: 250 (intervention group: 125; control group: 125)</P>
<P>Excluded (post-randomisation): not described</P>
<P>Gender (women): 85 (34%)</P>
<P>Age (years): mean: intervention group 34.2; control group 33.0</P>
<P>Inclusion criteria: young (&lt; 55 years old) hospitalised patients of either sex of ASA groups I and II, receiving spinal anaesthesia</P>
<P>Exclusion criteria: not described</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-24 11:56:10 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention group: indomethacin 100 mg per rectum 4 hours post operation</P>
<P>Control group: placebo per rectum 4 hours post operation</P>
<P>Co-interventions: all spinal anaesthesia were performed using a 25-G spinal needle</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Number of participants affected by PDPH of any severity</LI>
<LI>Number of missing data (participants lost to follow-up)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>PDPH defined as: quote "occurred after mobilisation, aggravated by the erect or sitting position, relieved by lying flat, mostly occipital or frontal, accompanied by dizziness, vomiting, rigidity of the neck and visual disturbances" (Page 202)</P>
<P>Sample size calculation: not described</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hakim-2010">
<CHAR_METHODS MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised, double-blind, controlled trial</P>
<P>Study type: single-centre study<BR/>Location: Egypt (Cairo)</P>
<P>Setting: admitted to hospital</P>
<P>Study design: parallel</P>
<P>Randomisation: computer-generated random number list</P>
<P>Allocation concealment: yes</P>
<P>Blinding: blinding of patients, hospital health personnel and outcome assessors</P>
<P>Follow-up period: 14 days</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised: 95 (intervention group: 47; control group: 48)</P>
<P>Excluded (post randomisation): 5 (intervention group: 2; control group: 3)</P>
<P>Gender (women): 95 (100%)</P>
<P>Age (years): mean (SD): intervention group: 31.3 (4.8); control group: 29.7 (4.9)</P>
<P>Inclusion criteria: parturients who had epidural analgesia for normal vaginal delivery and who suffered an inadvertent dural tap</P>
<P>Exclusion criteria: contraindication to steroid or ACTH therapy (e.g. hypertension or diabetes mellitus), pre-eclampsia, or contraindication to EBP (e.g. fever or leukocytosis)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention group: cosyntropin 1 mg (Cortrosy®, Amphastar Pharmaceuticals Inc) in 1 mL solution, intravenously over 5 min</P>
<P>Control group: 1 mL of normal saline intravenously</P>
<P>Co-interventions: epidural analgesia: test with 3 mL of 2% lidocaine with 1:200,000 epinephrine. Loading dose of 8 to 15 mL of bupivacaine 0.125% plus fentanyl 50 &#956;g. Continuous infusion of bupivacaine 0.125% with fentanyl 2 &#956;g/mL at 8 to 15 mL/h. Patients with accidental dural puncture were encouraged to ambulate and to drink plenty of fluids, with prescription of stool softeners</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Number of participants affected by PDPH of any severity</LI>
<LI>Number of any possible adverse effects from the drug taken to prevent PDPH</LI>
<LI>Number of missing data (withdrawals, drop-outs and participants lost to follow-up)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>PDPH defined as: quote: "PDPH if they developed headache within 5 days after dural puncture, which worsened within 15 min of sitting or standing, and improved within 15 min after lying, with at least one of the following criteria: neck stiffness, tinnitus, hypacusia, photophobia, or nausea" (Page 414)</P>
<P>Sample size calculation: estimated 44 patients in each group for detecting at least a 30% difference between the groups the incidence of PDPH, a beta error of 0.2, 2-tailed alfa-error of 0.05 and degree of freedom of 1</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sadeghi-2012">
<CHAR_METHODS MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, double-blind, controlled trial</P>
<P>Study type: single-centre study</P>
<P>Location: Iran (Shiraz)</P>
<P>Setting: admitted to hospital</P>
<P>Study design: parallel</P>
<P>Randomisation: not described</P>
<P>Allocation concealment: not described</P>
<P>Blinding: double-blind (patient and researcher)</P>
<P>Follow-up period: 48 hours after elective caesarean section</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised: 120 (intervention group: 60; control group: 60)</P>
<P>Excluded (post-randomisation): not described</P>
<P>Gender (women): 120 (100%)</P>
<P>Age (years): mean (SD): intervention group 26.11 (4.4); control group 26.35 (5.3)</P>
<P>Inclusion criteria: patients undergoing elective caesarean section</P>
<P>Exclusion criteria: headache, psychiatric problems, back pain, pre-eclampsia, coagulation disorders, convulsion background, spinal anaesthesia history and those who used any kinds of opiates</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention group: after the child birth and umbilical cord clamping, aminophylline 1 mg/kg intravenously</P>
<P>Control group: no intervention</P>
<P>Co-interventions: 2 mL lidocaine 1% used for skin anaesthesia. A combination of 55 mg lidocaine 5% (dose and concentration as cited in the publication) and meperidine 5 mg were used for spinal anaesthesia. Needle nº 23 used for the spinal anaesthesia. In case of hypotension in both groups, ephedrine 5 mg intravenously. In both groups, the patients rested 24 h after the operation and then started walking</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Number of participants affected by PDPH of any severity</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>PDPH defined as: quote "Post dural puncture headache (PDPH) is a kind of headache that worsens by standing up and dwindles with recumbency" (Page 13)</P>
<P>Sample size calculation: not described</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Strelec-1994">
<CHAR_METHODS MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, double-blind, controlled trial</P>
<P>Study type: single-centre study</P>
<P>Location: US (Pittsburgh)</P>
<P>Setting: hospital</P>
<P>Study design: parallel</P>
<P>Randomisation: not described</P>
<P>Allocation concealment: not described</P>
<P>Blinding: described as double-blind</P>
<P>Follow-up period: 4 days</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised: 60 (intervention group: 30; control group: 30)</P>
<P>Excluded (post randomisation): 2 (intervention group: 0; control group: 2)</P>
<P>Gender (women): 18 (31%)</P>
<P>Age (years): mean (SD): intervention group: 40.2 (13.3); control group: 48.5 (13)</P>
<P>Inclusion criteria: participants who have had a lumbar myelography</P>
<P>Exclusion criteria: not described</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention group: oral anhydrous caffeine capsules, 300 mg every 8 hours for 3 days</P>
<P>Control group: placebo capsules every 8 hours for 3 days</P>
<P>Co-interventions: all other caffeinated substances were forbidden</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Number of participants affected by PDPH of any severity</LI>
<LI>Number of any possible adverse effects from the drug taken to prevent PDPH</LI>
<LI>Number of missing data (withdrawals, drop-outs and participants lost to follow-up)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>PDPH defined as: quote: "PDPH criteria included postural headache, associated N/V, photophobia and neck stiffness" (Page 79)</P>
<P>Sample size calculation: not described</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;&lt;b&gt;YR - [References: Yousefshahi 2012]:&lt;/b&gt; Page numbers need adding here&lt;/p&gt;&lt;p&gt;XB: done&lt;/p&gt;" NOTES_MODIFIED="2013-01-28 12:10:16 +0000" NOTES_MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yousefshahi-2012">
<CHAR_METHODS MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, double-blind, controlled trial</P>
<P>Study type: single-centre study</P>
<P>Location: Iran (Tehran)</P>
<P>Setting: admitted to hospital</P>
<P>Study design: parallel</P>
<P>Randomisation: computer-generated random number list</P>
<P>Allocation concealment: not described</P>
<P>Blinding: described as double-blind</P>
<P>Follow-up period: 3 days</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised: 372 (intervention group: 186; control group: 186)</P>
<P>Excluded (post randomisation): 12 (intervention group: 4; control group: 8)</P>
<P>Gender (women): 372 (100%)</P>
<P>Age (years): mean: intervention group: 28.5; control group: 28.9</P>
<P>Inclusion criteria: parturient after spinal anaesthesia for caesarean section</P>
<P>Exclusion criteria: patients ASA class higher than II, sensitive to local anaesthetics, anticoagulant therapy, pre-eclampsia or skin infection at the site of needle insertion</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention group: intravenous dexamethasone 8 mg (2 mL) after clamping the umbilical cord</P>
<P>Control group: 2 mL of intravenous normal saline after clamping the umbilical cord</P>
<P>Co-interventions: all patients received 500 mL of normal saline or Ringer's solution intravenously before spinal anaesthesia. Ondansetron, metoclopramide and H2-blockers as needed</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Number of participants affected by PDPH of any severity</LI>
<LI>Number of participants with severe PDPH</LI>
<LI>Number of participants with any headache</LI>
<LI>Number of missing data (withdrawals, drop-outs and participants lost to follow-up)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>PDPH defined as: quote: "PDPH was defined as a headache located in the occipital and/or frontal areas which was worsened by standing or sitting, and alleviates by lying down" (Page 2)</P>
<P>Sample size calculation: quote: "The study was designed to achieve 80 % power to detect a 15 % difference in the population, in which the prevalence of the condition was 8.9 % based on previous studies. The level of statistical significance was reported to be 5 %" (Page 3)</P>
<P>Email contact with Fardin Yousefshahi MD on April 2012 for clarification about missing data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ACTH: adrenocorticotropic hormone; ASA: American Society of Anesthesiologists; EBP: epidural blood patch; LP: lumbar puncture; PDPH: post-dural puncture headache; SD: standard deviation; VRSP: Verbal Rating Score for Pain.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-01-24 12:06:32 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:46:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ackerman-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:46:13 +0000" MODIFIED_BY="[Empty name]">
<P>No individual drug assessed</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Altunkaya-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:31 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 09:16:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aziz-1968">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 09:16:19 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-24 12:04:00 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Balestrieri-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-24 12:04:00 +0000" MODIFIED_BY="[Empty name]">
<P>The study was not a RCT (letter)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 09:53:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Beilin-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 09:53:16 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Breebaart-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-19 21:12:05 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Caldwell-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-19 21:12:05 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 09:55:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Camann-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 09:55:06 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Camann-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Campbell-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-24 12:04:21 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cesur-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-24 12:04:21 +0000" MODIFIED_BY="[Empty name]">
<P>The study was not a RCT (retrospective observational study)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chalmers-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chilvers-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cho-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Clarke-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Colonna_x002d_Romano-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>No individual drug assessed</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 09:17:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cowan-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 09:17:11 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-D_x0027_Angelo-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Danelli-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 10:10:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dayioglu-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 10:10:45 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 10:11:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-De-Pietri-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 10:11:14 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 08:51:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Delfino-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 08:51:52 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 10:03:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dijkstra-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 10:03:04 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed to prevent PDPH </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dilli-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-19 21:18:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dominguez_x002d_Hervella-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-19 21:18:34 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-19 21:18:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Edstr_x00f6_m-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-19 21:18:44 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-24 12:04:47 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Elkhodair-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-24 12:04:47 +0000" MODIFIED_BY="[Empty name]">
<P>The study was not a RCT (Critically Appraised Topics)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fogarty-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fogarty-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-19 21:20:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Frey-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-19 21:20:11 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 10:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Frizelle-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 10:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fu-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fujii-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-F_x00f6_rster-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:32 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 10:18:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gangopadhyay-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 10:18:38 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ganzi-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]">
<P>No individual drug assessed</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Garg-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gielen-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ginsberg-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Girgin-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gogarten-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gurbet-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 09:11:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hansen-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 09:11:14 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-24 12:05:09 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hansen-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-24 12:05:09 +0000" MODIFIED_BY="[Empty name]">
<P>The study was not a RCT (letter)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-19 21:21:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Harsten-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-19 21:21:29 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 10:22:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hein-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 10:22:14 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 10:22:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hendriks-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 10:22:39 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 08:54:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ilioff-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 08:54:44 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Imbelloni-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 13:49:33 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:13:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Imbelloni-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:13:26 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:13:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Imbelloni-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:13:26 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 12:25:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jacobsohn-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 12:25:51 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:13:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kallio-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:13:26 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:13:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kallio-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:13:26 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-29 19:27:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kaukinen-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-29 19:27:19 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation was not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:30 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kouri-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:30 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:30 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lanz-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:30 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:30 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lauretti-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:30 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lauretti-1999b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lauretti-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lauretti-2000b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lewis-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lierz-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Luck-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 12:44:05 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-L_x00f3_pez_x002d_Soriano-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 12:44:05 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Manaa-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-24 12:05:41 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Martlew-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-24 12:05:41 +0000" MODIFIED_BY="[Empty name]">
<P>The study was not a RCT (letter)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-24 12:05:43 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Massou-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-24 12:05:43 +0000" MODIFIED_BY="[Empty name]">
<P>The study was not a RCT (letter)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meininger-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 12:51:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Michalek_x002d_Sauberer-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 12:51:53 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Morrison-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-29 19:24:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mosavy-1975">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-29 19:24:15 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation was not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Murto-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-M_x00f8_ller-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Neilson-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-23 17:53:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ogun-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-23 17:53:06 +0100" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Paech-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Palahniuk-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation was not randomised</P>
<P>No individual drug assessed</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pan-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Patra-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 12:56:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Phero-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 12:56:34 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Plaja-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-29 19:24:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Prusinski-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-29 19:24:36 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation was not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Radpay-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Reinhart-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rivera_x002d_Ordonez-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-01-24 07:18:44 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Roux-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-01-24 07:18:44 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rucci-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ryan-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sakaguchi-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 12:56:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sangarlangkarn-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 12:56:43 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sanli-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-24 12:06:24 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Santos-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-24 12:06:24 +0000" MODIFIED_BY="[Empty name]">
<P>The study was not a RCT (no control group)</P>
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sawhney-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sengupta-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:17:32 +0000" MODIFIED_BY="[Empty name]">
<P>No individual drug assessed</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-24 12:06:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Seyhan-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-24 12:06:32 +0000" MODIFIED_BY="[Empty name]">
<P>The study was not a RCT (no control group)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:56 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shah-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:56 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:56 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Singh-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:56 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:56 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smith-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:56 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Soni-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sudarshan-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tekin-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Thomas-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Trivedi-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>Epidural saline infusion was not used as a pharmacological agent</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-01 16:58:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tsen-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-01 16:58:07 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tucker-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tuncer-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Turan-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Turker-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Unlugenc-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Unlugenc-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Usubiaga-1967">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation was not randomised</P>
<P>No individual drug assessed</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vaghadia-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vale-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vichitvejpaisal-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:57 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Viscusi-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Waxler-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wells-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Whiteside-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention was not aimed at preventing PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 09:16:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Widerl_x00f6_v-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 09:16:49 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilder_x002d_Smith-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wood-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yanagidate-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yeh-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-30 09:15:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Y_x00fc_cel-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-30 09:15:53 +0100" MODIFIED_BY="[Empty name]">
<P>The orthostatic component of headache not described</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zackova-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-14 15:20:58 +0000" MODIFIED_BY="[Empty name]">
<P>The study did not focus on PDPH</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>PDPH: post-dural puncture headache; RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2012-01-24 07:16:58 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2012-04-27 20:44:29 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2013-01-24 13:46:51 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-28 12:43:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abboud-1992">
<DESCRIPTION>
<P>No information provided. Quote: "Patients were randomly assigned to receive, in a double-blind fashion, either 0.2 mg of morphine (Group 1, n = 40) or saline (Group 2, n = 42)..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-28 12:43:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Al_x002d_metwalli-2008">
<DESCRIPTION>
<P>Quote: "Patients were randomised (via a computer-generated random number table) to treatment (morphine) group or control (saline) group" (Page 848)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-25 12:28:25 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Devcic-1993">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Doroudian-2011">
<DESCRIPTION>
<P>Quote: "The randomization process was performed using Random Allocation Software<SUP>®</SUP>" (Page 143)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Esmaoglu-2005">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-24 13:46:51 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Flaatten-1987">
<DESCRIPTION>
<P>No information provided. Quote: "following this they were randomly allocated in a double-blind manner to receive either indomethacin 100mg or a placebo per rectum 4 hours postoperatively" (Page 202)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-24 09:19:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hakim-2010">
<DESCRIPTION>
<P>Quote: "Patients were randomly assigned to one of two groups using a computer-generated random number list. The list was created using the GraphPad StatMate version 1.01i software" (Page 414)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sadeghi-2012">
<DESCRIPTION>
<P>Quote: "patients were randomly divided into two groups with an accidental allocation" (Page 14)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-25 12:32:38 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Strelec-1994">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yousefshahi-2012">
<DESCRIPTION>
<P>Quote: "patients were divided into two groups based on a computer random number generator" (Page 2)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-24 08:42:45 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abboud-1992">
<DESCRIPTION>
<P>No information available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-28 12:43:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Al_x002d_metwalli-2008">
<DESCRIPTION>
<P>Quote: "Group assignment was determined by opening an opaque envelope labelled with the study subject number" (Page 848)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-26 12:36:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Devcic-1993">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-24 09:05:53 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Doroudian-2011">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 10:38:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Esmaoglu-2005">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-24 09:14:40 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Flaatten-1987">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hakim-2010">
<DESCRIPTION>
<P>Quote: "The list... was accessible to anaesthesiologist attending to patients in labor through the computer database" (Page 414)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-22 09:25:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sadeghi-2012">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-17 19:02:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Strelec-1994">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 21:34:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yousefshahi-2012">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2013-01-24 13:46:21 +0000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-01-24 09:25:03 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abboud-1992">
<DESCRIPTION>
<P>No information available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-01-24 09:26:43 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Al_x002d_metwalli-2008">
<DESCRIPTION>
<P>Quote: "An anaesthetist, who was blind to the study drug, injected 10 ml saline (control group) or 3 mg of morphine in 10 ml saline (morphine group)" (Page 848)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-01-24 09:01:18 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Devcic-1993">
<DESCRIPTION>
<P>Described as blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-01-24 13:46:21 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Doroudian-2011">
<DESCRIPTION>
<P>Quote: "For all injections, the anesthetic staff was blind with respect to the group allocation whereas patients were also unaware regarding the content of the study injectate" (Page 144)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-07-25 10:40:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Esmaoglu-2005">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-01-24 09:33:18 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Flaatten-1987">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hakim-2010">
<DESCRIPTION>
<P>Quote: "Injections were prepared by assistants not participating in the study, and both the patients and those involved in the study were blinded as to the patients' group" (Page 414)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sadeghi-2012">
<DESCRIPTION>
<P>Quote: "double-blind randomised study (patient and researcher)" (Page 14)</P>
<P>Quote: "data collection performed by a trained nurse that did not know anything about the intervention, the other stages of the study were performed by the doctors who knew the whole project and it may cause bias in the study" (Page 15)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-01-24 09:35:27 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Strelec-1994">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yousefshahi-2012">
<DESCRIPTION>
<P>Quote: "Each patient received a specific row number for grouping into the dexamethasone or placebo group, corresponding to a computerized randomization system; grouping was not reflected in the patient&#8217;s data sheet" (Page 2)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2012-12-03 15:29:10 +0000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-01-24 08:42:56 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abboud-1992">
<DESCRIPTION>
<P>No information available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-08-28 12:43:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Al_x002d_metwalli-2008">
<DESCRIPTION>
<P>Quote: "An anaesthetist unaware of the treatment group evaluated the subjects postpartum to ascertain the presence of PDPH" (Page 848)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Devcic-1993">
<DESCRIPTION>
<P>Quote: "All patients were evaluated daily during the first 4 postoperative days by the designated nurse, who was blinded to the type of needle and medication used... Investigators conducting telephone follow-up were blinded to the type of needle and anaesthetic solution used" (Page 223)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-01-24 09:05:53 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Doroudian-2011">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Esmaoglu-2005">
<DESCRIPTION>
<P>Quote: "The interviewer was blinded as to study group assignment" (Page 59)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-01-24 09:14:40 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Flaatten-1987">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hakim-2010">
<DESCRIPTION>
<P>Quote: "Nurses and anaesthesiologists involved in headache assessment were blinded as to the patients' group" (Page 414)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sadeghi-2012">
<DESCRIPTION>
<P>Quote: "data collection performed by a trained nurse that did not know anything about the intervention, the other stages of the study were performed by the doctors who knew the whole project and it may cause bias in the study" (Page 15)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-09-17 19:05:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Strelec-1994">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-12-03 15:29:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yousefshahi-2012">
<DESCRIPTION>
<P>Quote: "Trained nurses, who were unaware of the objectives of the study, asked the patients about any occurrence of headache every 24 h for 72 h. The patients complaining of possible PDPH were then visited by an anesthesiologist, similarly unaware of the study objectives, to rule out other causes of headache" (Page 2)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abboud-1992">
<DESCRIPTION>
<P>Results presented for all 82 randomised patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-28 12:10:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Al_x002d_metwalli-2008">
<DESCRIPTION>
<P>Results presented for all 50 randomised patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Devcic-1993">
<DESCRIPTION>
<P>6 lost to follow-up described (4 in fentanyl group, 2 in control group), but is unlikely that this loss may influence the outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Doroudian-2011">
<DESCRIPTION>
<P>Results presented for all 178 randomised patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-24 09:32:02 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Esmaoglu-2005">
<DESCRIPTION>
<P>No explicit information but it seems that no patients were lost</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Flaatten-1987">
<DESCRIPTION>
<P>Quote: "Three patients were lost to follow-up and their results are not included in the study." (Page 202). All 3 patients from placebo group, and not reasons stated. Unlikely to produce bias, but incomplete information available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-29 20:31:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hakim-2010">
<DESCRIPTION>
<P>Quote: "Flowchart showing incidence of accidental dural puncture, patient recruitment and randomisation, incidence of PDPH and need for EBP and repeat EBP" (Page 415)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-22 09:26:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sadeghi-2012">
<DESCRIPTION>
<P>No explicit information but it seems that no patients were lost</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-08-28 12:43:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Strelec-1994">
<DESCRIPTION>
<P>2 lost. No information provided about the reasons or the moment, but unlikely this is a cause of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yousefshahi-2012">
<DESCRIPTION>
<P>Quote: "Twelve patients were excluded from the study due to missing data" (Page 2). 4 patients from the intervention group and 8 from the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2012-09-13 09:53:59 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-24 09:26:04 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abboud-1992">
<DESCRIPTION>
<P>No information available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-13 09:53:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Al_x002d_metwalli-2008">
<DESCRIPTION>
<P>Results presented according to objectives stated in the introductory section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-24 09:29:56 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Devcic-1993">
<DESCRIPTION>
<P>Adverse events not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-24 09:31:18 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Doroudian-2011">
<DESCRIPTION>
<P>Adverse events not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-24 09:32:32 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Esmaoglu-2005">
<DESCRIPTION>
<P>No information available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-24 09:33:51 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Flaatten-1987">
<DESCRIPTION>
<P>No information available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-24 09:19:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hakim-2010">
<DESCRIPTION>
<P>Results presented according to objectives stated in the introductory section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-22 09:26:34 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sadeghi-2012">
<DESCRIPTION>
<P>Adverse events not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-25 12:33:22 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strelec-1994">
<DESCRIPTION>
<P>Results presented according to objectives stated in the introductory section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-27 21:45:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yousefshahi-2012">
<DESCRIPTION>
<P>Results presented according to objectives stated in the introductory section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2012-05-02 17:54:15 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2012-12-17 09:04:01 +0000" MODIFIED_BY="[Empty name]"/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-01-24 12:32:47 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2012-11-14 14:25:34 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Spinal morphine versus placebo</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:23:56 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="40" TOTAL_2="42" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants affected by PDPH of any severity</NAME>
<GROUP_LABEL_1>Spinal morphine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours spinal morphine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.7588483814802824" CI_START="0.505773195753263" EFFECT_SIZE="1.18125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.4407278335361556" LOG_CI_START="-0.296044190501517" LOG_EFFECT_SIZE="0.07234182151731933" MODIFIED="2011-09-20 11:00:58 +0100" MODIFIED_BY="[Empty name]" ORDER="1" O_E="0.0" SE="0.4327835340000672" STUDY_ID="STD-Abboud-1992" TOTAL_1="40" TOTAL_2="42" VAR="0.1873015873015873" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="43" EVENTS_2="26" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:25:34 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="80" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>Number of any possible adverse effects from the drug taken to prevent PDPH</NAME>
<GROUP_LABEL_1>Favours spinal morphine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours spinal morphine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="25" EVENTS_2="3" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-01-31 14:00:24 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="42" WEIGHT="0.0" Z="0.0">
<NAME>Pruritus</NAME>
<DICH_DATA CI_END="26.72464604517111" CI_START="2.864864884294104" EFFECT_SIZE="8.75" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="3" LOG_CI_END="1.4269119619015078" LOG_CI_START="0.45710414414311884" LOG_EFFECT_SIZE="0.9420080530223133" MODIFIED="2012-01-31 13:54:31 +0000" MODIFIED_BY="[Empty name]" ORDER="2" O_E="0.0" SE="0.5696699127773991" STUDY_ID="STD-Abboud-1992" TOTAL_1="40" TOTAL_2="42" VAR="0.32452380952380944" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="18" EVENTS_2="23" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-01-31 14:00:05 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="42" WEIGHT="0.0" Z="0.0">
<NAME>Nausea and vomiting</NAME>
<DICH_DATA CI_END="1.2749549748864568" CI_START="0.5296306236601404" EFFECT_SIZE="0.8217391304347826" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="23" LOG_CI_END="0.10549484790437949" LOG_CI_START="-0.27602691159307696" LOG_EFFECT_SIZE="-0.08526603184434872" MODIFIED="2012-01-31 14:00:05 +0000" MODIFIED_BY="[Empty name]" ORDER="42" O_E="0.0" SE="0.22410777009197375" STUDY_ID="STD-Abboud-1992" TOTAL_1="40" TOTAL_2="42" VAR="0.050224292615596966" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2012-11-14 14:33:23 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Epidural morphine versus placebo</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:26:18 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants affected by PDPH of any severity</NAME>
<GROUP_LABEL_1>Epidural morphine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours epidural morphine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.779529479356696" CI_START="0.08017657016842764" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="12" LOG_CI_END="-0.10816745651123864" LOG_CI_START="-1.095952526144686" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2011-09-20 11:17:52 +0100" MODIFIED_BY="[Empty name]" ORDER="3" O_E="0.0" SE="0.5802298395176404" STUDY_ID="STD-Al_x002d_metwalli-2008" TOTAL_1="25" TOTAL_2="25" VAR="0.33666666666666667" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:29:48 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants with severe PDPH</NAME>
<GROUP_LABEL_1>Epidural morphine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours epidural morphine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.296488391011581" CI_START="0.0045639897775689026" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.11276863237248712" LOG_CI_START="-2.3406553369861607" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2011-09-20 11:20:32 +0100" MODIFIED_BY="[Empty name]" ORDER="4" O_E="0.0" SE="1.4411533842457842" STUDY_ID="STD-Al_x002d_metwalli-2008" TOTAL_1="25" TOTAL_2="25" VAR="2.076923076923077" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="14" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:33:23 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Number of any possible adverse effects from the drug taken to prevent PDPH</NAME>
<GROUP_LABEL_1>epidural morphine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours epidural morphine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="0" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-01-31 15:57:53 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>Pruritus</NAME>
<DICH_DATA CI_END="128.87064248425733" CI_START="0.3802262412557286" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1101539936976934" LOG_CI_START="-0.4199579136691801" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-01-31 15:57:53 +0000" MODIFIED_BY="[Empty name]" ORDER="25" O_E="0.0" SE="1.4862002586432317" STUDY_ID="STD-Al_x002d_metwalli-2008" TOTAL_1="25" TOTAL_2="25" VAR="2.208791208791209" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="4" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-01-31 15:58:59 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>Nausea and vomiting</NAME>
<DICH_DATA CI_END="7.4837651808640535" CI_START="1.0105207495469353" EFFECT_SIZE="2.75" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" LOG_CI_END="0.8741201521236831" LOG_CI_START="0.004545235536842172" LOG_EFFECT_SIZE="0.43933269383026263" MODIFIED="2012-01-31 15:58:59 +0000" MODIFIED_BY="[Empty name]" ORDER="43" O_E="0.0" SE="0.510792610468369" STUDY_ID="STD-Al_x002d_metwalli-2008" TOTAL_1="25" TOTAL_2="25" VAR="0.260909090909091" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2012-11-14 14:35:29 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Spinal fentanyl versus no intervention</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:34:25 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="96" TOTAL_2="98" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants affected by PDPH of any severity</NAME>
<GROUP_LABEL_1>Spinal fentanyl</GROUP_LABEL_1>
<GROUP_LABEL_2>No intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours spinal fenatanyl</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no intervention</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.906374593823138" CI_START="0.5403371096837811" EFFECT_SIZE="1.7864583333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.771320987307584" LOG_CI_START="-0.2673352046291423" LOG_EFFECT_SIZE="0.25199289133922087" MODIFIED="2011-09-20 11:31:23 +0100" MODIFIED_BY="[Empty name]" ORDER="5" O_E="0.0" SE="0.610111788574703" STUDY_ID="STD-Devcic-1993" TOTAL_1="96" TOTAL_2="98" VAR="0.3722363945578231" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:35:14 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="96" TOTAL_2="98" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants with severe PDPH</NAME>
<GROUP_LABEL_1>Spinal fentanyl</GROUP_LABEL_1>
<GROUP_LABEL_2>No comparison</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours spinal fentanyl</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no comparison</GRAPH_LABEL_2>
<DICH_DATA CI_END="28.928701768068162" CI_START="0.32420764420035414" EFFECT_SIZE="3.0625" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4613289442731061" LOG_CI_START="-0.4891767495279284" LOG_EFFECT_SIZE="0.4860760973725889" MODIFIED="2011-09-20 11:33:41 +0100" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="1.1457366996976284" STUDY_ID="STD-Devcic-1993" TOTAL_1="96" TOTAL_2="98" VAR="1.3127125850340136" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:35:29 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="96" TOTAL_2="98" WEIGHT="0.0" Z="0.0">
<NAME>Number of missing data (withdrawals, drop-outs and participants lost to follow-up)</NAME>
<GROUP_LABEL_1>Spinal fentanyl</GROUP_LABEL_1>
<GROUP_LABEL_2>No intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours spinal fentanyl</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no intervention</GRAPH_LABEL_2>
<DICH_DATA CI_END="10.887858742422901" CI_START="0.3828487195132523" EFFECT_SIZE="2.0416666666666665" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.036942477755141" LOG_CI_START="-0.41697280112132573" LOG_EFFECT_SIZE="0.3099848383169076" MODIFIED="2011-09-20 19:07:03 +0100" MODIFIED_BY="[Empty name]" ORDER="27" O_E="0.0" SE="0.8540370318087386" STUDY_ID="STD-Devcic-1993" TOTAL_1="96" TOTAL_2="98" VAR="0.7293792517006803" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2012-11-14 14:37:34 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Caffeine 75 mg versus placebo</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:36:12 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants affected by PDPH of any severity</NAME>
<GROUP_LABEL_1>Caffeine 75 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine 75 mg</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.00247079162352" CI_START="0.4127132762429395" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.3015661901099615" LOG_CI_START="-0.3843515604264116" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2011-09-20 12:26:27 +0100" MODIFIED_BY="[Empty name]" ORDER="18" O_E="0.0" SE="0.40291148201269017" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="0.16233766233766234" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:36:51 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants with severe PDPH</NAME>
<GROUP_LABEL_1>Caffeine 75 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine 75 mg</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.085887573602296" CI_START="0.44240065621551716" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7063667556226622" LOG_CI_START="-0.3541842375112997" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2011-09-20 12:27:44 +0100" MODIFIED_BY="[Empty name]" ORDER="19" O_E="0.0" SE="0.622972903178973" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="0.38809523809523805" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:37:34 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants with any headache</NAME>
<GROUP_LABEL_1>Caffeine 75 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine 75 mg</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.260394477156576" CI_START="0.1966225138735632" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3541842375112996" LOG_CI_START="-0.7063667556226622" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2011-09-20 12:29:21 +0100" MODIFIED_BY="[Empty name]" ORDER="20" O_E="0.0" SE="0.622972903178973" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="0.38809523809523805" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2012-11-14 14:40:39 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Caffeine 125 mg versus placebo</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:38:40 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants affected by PDPH of any severity</NAME>
<GROUP_LABEL_1>Caffeine 125 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine 125 mg</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.00247079162352" CI_START="0.4127132762429395" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.3015661901099615" LOG_CI_START="-0.3843515604264116" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2011-09-20 12:33:19 +0100" MODIFIED_BY="[Empty name]" ORDER="21" O_E="0.0" SE="0.40291148201269017" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="0.16233766233766234" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:39:09 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants with severe PDPH</NAME>
<GROUP_LABEL_1>Caffeine 125 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine 125 mg</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.181087758626191" CI_START="0.028655426519548714" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.33867314027852674" LOG_CI_START="-1.5427931229344514" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2011-09-20 12:35:02 +0100" MODIFIED_BY="[Empty name]" ORDER="22" O_E="0.0" SE="1.105182596419511" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="1.2214285714285715" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:40:39 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants with any headache</NAME>
<GROUP_LABEL_1>Caffeine 125 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine 125 mg</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9204834537024995" CI_START="0.13017555528428273" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.2834105697690125" LOG_CI_START="-0.885470561096975" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2011-09-20 12:36:46 +0100" MODIFIED_BY="[Empty name]" ORDER="23" O_E="0.0" SE="0.6866065623255951" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="0.4714285714285714" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2012-11-14 14:44:25 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Caffeine 75 mg versus caffeine 125 mg</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:41:51 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants affected by PDPH of any severity</NAME>
<GROUP_LABEL_1>Caffeine 75 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Caffeine 125 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine 75 mg</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours caffeine 125 mg</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.251287300057891" CI_START="0.4441903083512644" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="10" LOG_CI_END="0.3524309214189808" LOG_CI_START="-0.35243092141898075" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-09-20 11:50:12 +0100" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.4140393356054125" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="0.17142857142857143" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:42:49 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants with severe PDPH</NAME>
<GROUP_LABEL_1>Caffeine 75 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Caffeine 125 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine 75 mg</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours caffeine 125 mg</GRAPH_LABEL_2>
<DICH_DATA CI_END="48.55413496751751" CI_START="0.7414404565972359" EFFECT_SIZE="6.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6862262212081194" LOG_CI_START="-0.129923720440832" LOG_EFFECT_SIZE="0.7781512503836436" MODIFIED="2011-09-20 12:17:36 +0100" MODIFIED_BY="[Empty name]" ORDER="14" O_E="0.0" SE="1.0668154658117954" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="1.1380952380952383" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-006.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:43:58 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants with any headache</NAME>
<GROUP_LABEL_1>Caffeine 75 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Caffeine 125 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine 75 mg</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours caffeine 125 mg</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.74028649588045" CI_START="0.30970192499165505" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7589335684389047" LOG_CI_START="-0.5090560952223049" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2011-09-20 12:22:28 +0100" MODIFIED_BY="[Empty name]" ORDER="16" O_E="0.0" SE="0.7448234050846582" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="0.5547619047619048" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-006.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:44:25 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Number of any possible adverse effects from the drug taken to prevent PDPH</NAME>
<GROUP_LABEL_1>Caffeine 75 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Caffeine 125 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine 75 mg</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours caffeine 125 mg</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-09-20 12:23:49 +0100" MODIFIED_BY="[Empty name]" ORDER="17" O_E="0.0" SE="0.0" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2013-01-24 12:32:47 +0000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Indomethacin versus placebo</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="21" EVENTS_2="30" I2="0.0" I2_Q="0.0" ID="CMP-007.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2013-01-24 12:32:47 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="125" TOTAL_2="125" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants affected by PDPH of any severity</NAME>
<GROUP_LABEL_1>Indomethacin</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours indomethacin</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1535414294884119" CI_START="0.424778848400193" EFFECT_SIZE="0.7" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="30" LOG_CI_END="0.062033196841593446" LOG_CI_START="-0.3718371168130798" LOG_EFFECT_SIZE="-0.1549019599857432" MODIFIED="2011-09-20 13:33:36 +0100" MODIFIED_BY="[Empty name]" ORDER="17" O_E="0.0" SE="0.2548575699334452" STUDY_ID="STD-Flaatten-1987" TOTAL_1="125" TOTAL_2="125" VAR="0.06495238095238093" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-007.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:55:57 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="125" TOTAL_2="125" WEIGHT="0.0" Z="0.0">
<NAME>Number of missing data (withdrawals, drop-outs and participants lost to follow-up)</NAME>
<GROUP_LABEL_1>Indometacin</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours indometacin</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.737294709582623" CI_START="0.007455595918796014" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4373215580441088" LOG_CI_START="-2.1275176380726224" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2011-09-20 13:36:13 +0100" MODIFIED_BY="[Empty name]" ORDER="18" O_E="0.0" SE="1.50659923995775" STUDY_ID="STD-Flaatten-1987" TOTAL_1="125" TOTAL_2="125" VAR="2.2698412698412698" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2012-11-14 14:59:03 +0000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Cosyntropin versus placebo</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="15" EVENTS_2="31" I2="0.0" I2_Q="0.0" ID="CMP-008.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:58:19 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="47" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants affected by PDPH of any severity</NAME>
<GROUP_LABEL_1>Cosyntropin</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cosyntropin</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7884317718432833" CI_START="0.30972893012051306" EFFECT_SIZE="0.49416609471516815" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="31" LOG_CI_END="-0.103235883050389" LOG_CI_START="-0.5090182276270543" LOG_EFFECT_SIZE="-0.3061270553387217" MODIFIED="2011-09-20 13:39:38 +0100" MODIFIED_BY="[Empty name]" ORDER="19" O_E="0.0" SE="0.23835855785933407" STUDY_ID="STD-Hakim-2010" TOTAL_1="47" TOTAL_2="48" VAR="0.056814802104781514" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-008.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:58:44 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="47" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>Number of any possible adverse effects from the drug taken to prevent PDPH</NAME>
<GROUP_LABEL_1>Cosyntropin</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cosyntropin</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="103.5670193013528" CI_START="0.25155225608362" EFFECT_SIZE="5.104166666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.015221477264352" LOG_CI_START="-0.5993717832864617" LOG_EFFECT_SIZE="0.7079248469889453" MODIFIED="2011-09-20 13:57:55 +0100" MODIFIED_BY="[Empty name]" ORDER="20" O_E="0.0" SE="1.5358250236929207" STUDY_ID="STD-Hakim-2010" TOTAL_1="47" TOTAL_2="48" VAR="2.3587585034013605" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-008.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:59:03 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="47" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>Number of missing data (withdrawals, drop-outs and participants lost to follow-up)</NAME>
<GROUP_LABEL_1>Cosyntropin</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cosyntropin</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.8922630819780957" CI_START="0.11909733780959306" EFFECT_SIZE="0.6808510638297872" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5902021869894235" LOG_CI_START="-0.9240979462210465" LOG_EFFECT_SIZE="-0.1669478796158115" MODIFIED="2011-09-20 13:59:14 +0100" MODIFIED_BY="[Empty name]" ORDER="21" O_E="0.0" SE="0.889507394154382" STUDY_ID="STD-Hakim-2010" TOTAL_1="47" TOTAL_2="48" VAR="0.791223404255319" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" MODIFIED="2012-11-14 15:00:33 +0000" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Caffeine 300 mg versus placebo</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-009.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 14:59:27 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants affected by PDPH of any severity</NAME>
<GROUP_LABEL_1>Caffeine 300 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine 300 mg</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.629059063724054" CI_START="0.864106494416172" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.6654927221277646" LOG_CI_START="-0.06343273079980219" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2011-09-20 14:02:55 +0100" MODIFIED_BY="[Empty name]" ORDER="22" O_E="0.0" SE="0.42817441928883765" STUDY_ID="STD-Strelec-1994" TOTAL_1="30" TOTAL_2="30" VAR="0.18333333333333335" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-009.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 15:00:07 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>Number of any possible adverse effects from the drug taken to prevent PDPH</NAME>
<GROUP_LABEL_1>Caffeine 300 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine 300 mg</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="19.11103287056746" CI_START="1.0595973612282696" EFFECT_SIZE="4.5" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.281284159470821" LOG_CI_START="0.02514086807986643" LOG_EFFECT_SIZE="0.6532125137753437" MODIFIED="2011-09-20 14:04:23 +0100" MODIFIED_BY="[Empty name]" ORDER="23" O_E="0.0" SE="0.7378647873726218" STUDY_ID="STD-Strelec-1994" TOTAL_1="30" TOTAL_2="30" VAR="0.5444444444444445" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-009.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="IV" MODIFIED="2012-11-14 15:00:33 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>Number of missing data (withdrawals, drop-outs and participants lost to follow-up)</NAME>
<GROUP_LABEL_1>Caffeine 300 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine 300 mg</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2011-09-20 14:08:08 +0100" MODIFIED_BY="[Empty name]" ORDER="24" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Strelec-1994" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" MODIFIED="2012-11-14 15:03:22 +0000" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Dexamethasone versus placebo</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="43" EVENTS_2="30" I2="0.0" I2_Q="0.0" ID="CMP-010.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2012-11-14 15:01:07 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="275" TOTAL_2="275" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants affected by PDPH of any severity</NAME>
<GROUP_LABEL_1>Dexamethasone</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours dexamethasone</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.452798723305204" CI_START="0.42901242137862583" EFFECT_SIZE="0.7894736842105263" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="19" LOG_CI_END="0.1622054495265772" LOG_CI_START="-0.36753013332087264" LOG_EFFECT_SIZE="-0.10266234189714771" MODIFIED="2012-01-25 18:12:03 +0000" MODIFIED_BY="[Empty name]" ORDER="39" O_E="0.0" SE="0.31116930359801803" STUDY_ID="STD-Doroudian-2011" TOTAL_1="89" TOTAL_2="89" VAR="0.09682633550167553" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.960352174998843" CI_START="1.306225569150585" EFFECT_SIZE="2.5454545454545454" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="11" LOG_CI_END="0.6955125116170212" LOG_CI_START="0.11601818075096715" LOG_EFFECT_SIZE="0.4057653461839942" MODIFIED="2012-05-02 09:40:48 +0100" MODIFIED_BY="[Empty name]" ORDER="44" O_E="0.0" SE="0.3403978384939212" STUDY_ID="STD-Yousefshahi-2012" TOTAL_1="186" TOTAL_2="186" VAR="0.11587068845133364" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-010.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2012-11-14 15:01:23 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="275" TOTAL_2="275" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants with severe PDPH</NAME>
<GROUP_LABEL_1>Dexamethasone</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours dexamethasone</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.144630946217833" CI_START="0.05460275227270127" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.058665483307439543" LOG_CI_START="-1.2627854659633644" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2012-01-25 18:13:50 +0000" MODIFIED_BY="[Empty name]" ORDER="40" O_E="0.0" SE="0.7762268288893656" STUDY_ID="STD-Doroudian-2011" TOTAL_1="89" TOTAL_2="89" VAR="0.6025280898876404" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-05-02 10:08:34 +0100" MODIFIED_BY="[Empty name]" ORDER="45" O_E="0.0" SE="0.0" STUDY_ID="STD-Yousefshahi-2012" TOTAL_1="186" TOTAL_2="186" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-010.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2012-11-14 15:02:49 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="186" TOTAL_2="186" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants with any headache</NAME>
<GROUP_LABEL_1>Dexamethasone</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours dexamethasone</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="6.208146820890964" CI_START="0.779620737014945" EFFECT_SIZE="2.2" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.792961979311468" LOG_CI_START="-0.10811661766705537" LOG_EFFECT_SIZE="0.3424226808222063" MODIFIED="2012-05-02 15:54:20 +0100" MODIFIED_BY="[Empty name]" ORDER="46" O_E="0.0" SE="0.5292980282761762" STUDY_ID="STD-Yousefshahi-2012" TOTAL_1="186" TOTAL_2="186" VAR="0.2801564027370479" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-010.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2012-11-14 15:03:22 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="275" TOTAL_2="275" WEIGHT="0.0" Z="0.0">
<NAME>Number of missing data (withdrawals, drop-outs and participants lost to follow-up)</NAME>
<GROUP_LABEL_1>Dexamethasone</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours dexamethasone</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-01-25 18:15:39 +0000" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="0.0" STUDY_ID="STD-Doroudian-2011" TOTAL_1="89" TOTAL_2="89" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.6319049561975971" CI_START="0.15319519623404412" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.212694861402581" LOG_CI_START="-0.8147548527305433" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2012-05-02 11:01:21 +0100" MODIFIED_BY="[Empty name]" ORDER="47" O_E="0.0" SE="0.6035290480399075" STUDY_ID="STD-Yousefshahi-2012" TOTAL_1="186" TOTAL_2="186" VAR="0.364247311827957" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" MODIFIED="2012-09-20 23:01:06 +0100" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Caffeine versus placebo</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.588970598110223" CI_START="0.5201142689327515" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="22" I2="0.0" I2_Q="0.0" ID="CMP-011.01" LOG_CI_END="0.20111586121202096" LOG_CI_START="-0.2839012315284711" LOG_EFFECT_SIZE="-0.04139268515822506" METHOD="MH" MODIFIED="2012-09-20 09:03:59 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.7379740944308495" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="140" TOTAL_2="140" WEIGHT="100.00000000000001" Z="0.3345373734155563">
<NAME>Number of participants affected by PDPH of any severity</NAME>
<GROUP_LABEL_1>Caffeine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.00247079162352" CI_START="0.4127132762429395" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.3015661901099615" LOG_CI_START="-0.3843515604264116" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2012-06-03 21:43:29 +0100" MODIFIED_BY="[Empty name]" ORDER="48" O_E="0.0" SE="0.40291148201269017" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="0.16233766233766234" WEIGHT="50.00000000000001"/>
<DICH_DATA CI_END="2.00247079162352" CI_START="0.4127132762429395" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.3015661901099615" LOG_CI_START="-0.3843515604264116" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2012-06-03 21:43:48 +0100" MODIFIED_BY="[Empty name]" ORDER="49" O_E="0.0" SE="0.40291148201269017" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="0.16233766233766234" WEIGHT="50.00000000000001"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.033473212828544" CI_END="2.34767540322543" CI_START="0.3261204674837591" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" I2="50.82305517027153" I2_Q="0.0" ID="CMP-011.02" LOG_CI_END="0.3706380498442727" LOG_CI_START="-0.4866219437996462" LOG_EFFECT_SIZE="-0.057991946977686754" METHOD="MH" MODIFIED="2012-09-20 09:03:41 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.15386903757026016" P_Q="1.0" P_Z="0.7908743510660735" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="140" TOTAL_2="140" WEIGHT="100.0" Z="0.2651753920919223">
<NAME>Number of participants with severe PDPH</NAME>
<GROUP_LABEL_1>Caffeine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.181087758626191" CI_START="0.028655426519548714" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.33867314027852674" LOG_CI_START="-1.5427931229344514" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2012-01-24 22:58:40 +0000" MODIFIED_BY="[Empty name]" ORDER="35" O_E="0.0" SE="1.105182596419511" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="1.2214285714285715" WEIGHT="50.0"/>
<DICH_DATA CI_END="5.085887573602296" CI_START="0.44240065621551716" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7063667556226622" LOG_CI_START="-0.3541842375112997" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2012-01-24 22:58:05 +0000" MODIFIED_BY="[Empty name]" ORDER="34" O_E="0.0" SE="0.622972903178973" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="0.38809523809523805" WEIGHT="50.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.02629720262010429" CI_END="1.242489733006835" CI_START="0.5075477250376386" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7941176470588235" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="34" I2="0.0" I2_Q="100.0" ID="CMP-011.03" LOG_CI_END="0.09429280873985686" LOG_CI_START="-0.2945231145063926" LOG_EFFECT_SIZE="-0.10011515288326783" METHOD="MH" MODIFIED="2012-09-20 09:04:11 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8711766340877827" P_Q="0.0" P_Z="0.3128156561135672" Q="1.4768527234644842E-32" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="140" TOTAL_2="140" WEIGHT="100.0" Z="1.009331574281502">
<NAME>Number of participants with any headache</NAME>
<GROUP_LABEL_1>Caffeine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours caffeine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5385273267968183" CI_START="0.4408115996571358" EFFECT_SIZE="0.8235294117647058" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.18710521444221564" LOG_CI_START="-0.35574698584228753" LOG_EFFECT_SIZE="-0.08432088570003593" MODIFIED="2012-01-24 22:56:11 +0000" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="0.31887406960884657" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="0.10168067226890753" WEIGHT="50.0"/>
<DICH_DATA CI_END="1.4526385305988598" CI_START="0.40256063307374396" EFFECT_SIZE="0.7647058823529411" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="17" LOG_CI_END="0.16215755944849453" LOG_CI_START="-0.3951686975913689" LOG_EFFECT_SIZE="-0.11650556907143719" MODIFIED="2012-01-24 22:57:02 +0000" MODIFIED_BY="[Empty name]" ORDER="33" O_E="0.0" SE="0.3273762021946816" STUDY_ID="STD-Esmaoglu-2005" TOTAL_1="70" TOTAL_2="70" VAR="0.10717517776341307" WEIGHT="50.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" MODIFIED="2012-09-20 23:00:35 +0100" MODIFIED_BY="[Empty name]" NO="12">
<NAME>Aminophylline versus no intervention</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="33" I2="0.0" I2_Q="0.0" ID="CMP-012.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2012-09-13 12:31:41 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="120" TOTAL_2="120" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants affected by PDPH of any severity</NAME>
<GROUP_LABEL_1>Aminophylline</GROUP_LABEL_1>
<GROUP_LABEL_2>No intervention</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours aminophylline</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no intervention</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="19" I2="0.0" ID="CMP-012.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-07-23 17:58:38 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants affected by PDPH of any severity at 24 hours</NAME>
<DICH_DATA CI_END="0.5056323844542547" CI_START="0.04930607431196525" EFFECT_SIZE="0.15789473684210525" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="19" LOG_CI_END="-0.296165118389875" LOG_CI_START="-1.3070995740764582" LOG_EFFECT_SIZE="-0.8016323462331666" MODIFIED="2012-07-23 17:58:38 +0100" MODIFIED_BY="[Empty name]" ORDER="49" O_E="0.0" SE="0.5938279034765614" STUDY_ID="STD-Sadeghi-2012" TOTAL_1="60" TOTAL_2="60" VAR="0.3526315789473684" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="14" I2="0.0" ID="CMP-012.01.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-07-23 17:58:57 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="0.0" Z="0.0">
<NAME>Number of participants affected by PDPH of any severity at 48 hours</NAME>
<DICH_DATA CI_END="0.7075505762766656" CI_START="0.06489764673583391" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.15024251097990587" LOG_CI_START="-1.1877710509372454" LOG_EFFECT_SIZE="-0.6690067809585756" MODIFIED="2012-07-23 17:58:57 +0100" MODIFIED_BY="[Empty name]" ORDER="48" O_E="0.0" SE="0.609449400220044" STUDY_ID="STD-Sadeghi-2012" TOTAL_1="60" TOTAL_2="60" VAR="0.37142857142857144" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-01-28 12:10:17 +0000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-01-24 12:33:50 +0000" MODIFIED_BY="[Empty name]" NO="1" NOTES="&lt;p&gt;JRT 140612: I'm concerned this may not publish very well as the left hand side line is missing...may be worth altering and re-importing?&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;XB: modified and updated&lt;/p&gt;" NOTES_MODIFIED="2013-01-24 12:33:50 +0000" NOTES_MODIFIED_BY="[Empty name]" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAjMAAAG+CAYAAABmlIVZAABFNElEQVR42u2df2SW3//H3yRJkpi8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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-01-28 12:10:17 +0000" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAADnCAMAAAD4paggAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2013-01-28 12:10:17 +0000" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAATEAAAKBCAIAAACwJQvXAAAf80lEQVR42u2dsY4UR9eGR0JCBBNs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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-01-28 12:17:24 +0000" MODIFIED_BY="Jessica R Thomas">
<APPENDIX ID="APP-01" MODIFIED="2013-01-28 12:17:24 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2013-01-28 12:17:24 +0000" MODIFIED_BY="Jessica R Thomas">Cochrane Central Register of Controlled Trials (CENTRAL) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-08-23 16:54:33 +0100" MODIFIED_BY="[Empty name]">
<P>#1 explode 'Anesthesia, Epidural' / all subheadings</P>
<P>#2 explode 'Anesthesia, Spinal' / all subheadings</P>
<P>#3 explode 'Injections, Spinal' / all subheadings</P>
<P>#4 explode 'Myelography' / all subheadings</P>
<P>#5 explode 'Spinal Puncture' / all subheadings</P>
<P>#6 (spine or spinal or intraspinal or dura* or intradural or epidural or lumbar* or theca* or intrathecal or subarachnoid*) near/10 (puncture* or inject* or anesth* or anaesth* or needle*)</P>
<P>#7 myelogra*</P>
<P>#8 #1 or #2 or #3 or #4 or #5 or #6 or #7</P>
<P>#9 explode 'Headache disorders' / all subheadings</P>
<P>#10 headach* or cephalgia or (head near/2 pain) or (cranial adj2 pain)</P>
<P>#11 #9 or #10</P>
<P>#12 #8 and #11</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="Jessica R Thomas" NO="2">
<TITLE MODIFIED="2008-05-28 18:08:31 +0100" MODIFIED_BY="Jessica R Thomas">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="Jessica R Thomas">
<P>#1 explode 'Anesthesia, Epidural' / all subheadings</P>
<P>#2 explode 'Anesthesia, Spinal' / all subheadings</P>
<P>#3 explode 'Injections, Spinal' / all subheadings</P>
<P>#4 explode 'Myelography' / all subheadings</P>
<P>#5 explode 'Spinal Puncture' / all subheadings</P>
<P>#6 (spine or spinal or intraspinal or dura* or intradural or epidural or lumbar* or theca* or intrathecal or subarachnoid*) adj10 (puncture* or inject* or anesth* or anaesth* or needle*)</P>
<P>#7 myelogra*</P>
<P>#8 #1 or #2 or #3 or #4 or #5 or #6 or #7</P>
<P>#9 explode 'Headache disorders' / all subheadings</P>
<P>#10 headach* or cephalgia or (head adj2 pain) or (cranial adj2 pain)</P>
<P>#11 #9 or #10</P>
<P>#12 #8 and #11</P>
<P>The MEDLINE search strategy above was combined with the following highly sensitive search strategy for identifying randomised trials in MEDLINE: sensitivity-maximising version (2008 revision); Ovid format.</P>
<SUBSECTION>
<HEADING LEVEL="3">Cochrane Highly Sensitive Search Strategy for identifying randomised trials</HEADING>
<P>1. randomised controlled trial.pt.</P>
<P>2. controlled clinical trial.pt.</P>
<P>3. randomized.ab.</P>
<P>4. placebo.ab.</P>
<P>5. drug therapy.fs.</P>
<P>6. randomly.ab.</P>
<P>7. trial.ab.</P>
<P>8. groups.ab.</P>
<P>9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8</P>
<P>10. humans.sh.</P>
<P>11. 9 and 10</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="Jessica R Thomas" NO="3">
<TITLE MODIFIED="2008-05-28 18:08:47 +0100" MODIFIED_BY="Jessica R Thomas">EMBASE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2013-01-28 12:10:16 +0000" MODIFIED_BY="Jessica R Thomas">
<P>#1 explode 'Spinal Anesthesia' / all subheadings</P>
<P>#2 explode 'Lumbar Puncture' / all subheadings</P>
<P>#3 explode 'Myelography' / all subheadings</P>
<P>#4 (spine or spinal or intraspinal or dura* or intradural or epidural or lumbar* or theca* or intrathecal or subarachnoid*) adj10 (puncture* or inject* or anesth* or anaesth* or needle*)</P>
<P>#5 myelogra*</P>
<P>#6 #1 or #2 or #3 or #4 or #5</P>
<P>#7 explode 'Headache and facial pain' / all subheadings</P>
<P>#8 headach* or cephalgia or (head adj2 pain) or (cranial adj2 pain)</P>
<P>#9 #7 or #8</P>
<P>The above EMBASE search strategy was combined with the following filter developed for EMBASE to identify randomised trials.</P>
<SUBSECTION>
<HEADING LEVEL="3">Search filter for EMBASE (Ovid format) 2008</HEADING>
<P>1. random*.ti,ab.</P>
<P>2. factorial*.ti,ab. (5987)</P>
<P>3. (crossover* or cross over* or cross-over*).ti,ab.</P>
<P>4. placebo*.ti,ab.</P>
<P>5. (doubl* adj blind*).ti,ab.</P>
<P>6. (singl* adj blind*).ti,ab.</P>
<P>7. assign*.ti,ab.</P>
<P>8. allocat*.ti,ab.</P>
<P>9. volunteer*.ti,ab.</P>
<P>10. CROSSOVER PROCEDURE.sh.</P>
<P>11. DOUBLE-BLIND PROCEDURE.sh.</P>
<P>12. RANDOMIZED CONTROLLED TRIAL.sh.</P>
<P>13. SINGLE BLIND PROCEDURE.sh.</P>
<P>14. or/1-13</P>
<P>15. ANIMAL/ or NONHUMAN/ or ANIMAL EXPERIMENT/</P>
<P>16. HUMAN/</P>
<P>17. 15 and 16</P>
<P>18. 15 not 17</P>
<P>19. 14 not 18</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2012-08-23 16:55:06 +0100" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2012-03-02 11:25:19 +0000" MODIFIED_BY="[Empty name]">CINAHL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-08-23 16:55:06 +0100" MODIFIED_BY="[Empty name]">
<P>1 anaesthesia, epidural/ or analgesia, epidural/ or &#8220;epidural analgesia administration (iowa nic)&#8221;/ or exp injections, epidural/ </P>
<P>2 exp injections, intraspinal/&#8232;</P>
<P>3 myelography/&#8232;</P>
<P>4 spinal puncture/ or anaesthesia, spinal/</P>
<P>5 ((spine or spinal or intraspinal or dura* or intradural or epidural or lumbar* or theca* or intrathecal or subarachnoid*) and (puncture* or inject* or anesthe* or anaesthe* or needle*)).ti,ab</P>
<P>&#8232;6 myelogra*.ti,ab</P>
<P>&#8232;7 1 or 2 or 3 or 4 or 5 or 6</P>
<P>8 *headache/&#8232;</P>
<P>9 (headach* or cephalgi* or cephalalgi*).ti,ab&#8232;</P>
<P>10 8 or 9&#8232;</P>
<P>11 7 and 10</P>
<P>&#8232;12 exp clinical trials/&#8232;</P>
<P>13 (clinical and trial*).ti&#8232;</P>
<P>14 ((singl* or doubl* or trebl* or tripl*) and (blind* or mask*)).ti</P>
<P>15 (randomi?ed and control* and trial*).ti&#8232;</P>
<P>16 random assignment/&#8232;</P>
<P>17 (random* and allocat*).ti&#8232;</P>
<P>18 placebo*.ti&#8232;</P>
<P>19 placebos/</P>
<P>20 quantitative studies/&#8232;</P>
<P>21 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20</P>
<P>22 11 and 21</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;10 studies included in qualitative synthesis&lt;/p&gt;" WIDTH="303">
<FLOWCHARTBOX TEXT="&lt;p&gt;137 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="175">
<FLOWCHARTBOX TEXT="&lt;p&gt;1894 records identified through database searching&lt;/p&gt;" WIDTH="365">
<OUT TEXT="&lt;p&gt;1768 articles eliminated after screening titles and abstracts&lt;/p&gt;" WIDTH="117"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;127 full-text articles excluded&lt;/p&gt;&lt;p&gt;Reasons for exclusion:&lt;/p&gt;&lt;p&gt;- Study not focus at PDPH (45%)&lt;/p&gt;&lt;p&gt;- Not describing the orthostatic component of headache (35%)&lt;/p&gt;&lt;p&gt;- Others (20%)&lt;/p&gt;" WIDTH="160"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>